"ChEMBL ID";"Assay Type";"Description";"Organism";"Compounds";"Activities";"BAO Format ID";"BAO Format";"Confidence Score";"Confidence Label";"Strain";"Source";"Tax ID";"Tissue ChEMBL ID";"Tissue Name";"Cell Type";"Subcellular Fraction";"Document ChEMBL ID";"PubMed ID";"DOI";"Year";"Journal";"Volume";"First Page";"Last Page";"Assay Parameters";"Assay Classification L1";"Assay Classification L2";"Assay Classification L3";"Variant Sequence Accession";"Variant Sequence Mutation"
"CHEMBL707922";"F";"Concentration required for 50% inhibition of cell growth of L1210 leukemic cell lines in mouse.";"Mus musculus";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL1613914";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ";"Homo sapiens";"39332";"39754";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL679422";"F";"Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 0 uM (Cell number 1*10 e-4)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"G-401";"";"CHEMBL1127382";"7932594";"10.1021/jm00047a024";"1994";"J Med Chem";"37";"3668";"3670";"";"";"";"";"";""
"CHEMBL970837";"B";"Inhibition of rat brain protein kinase C";"Rattus norvegicus";"19";"19";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL1156703";"18055068";"10.1016/j.ejmech.2007.10.011";"2008";"Eur J Med Chem";"43";"1376";"1389";"";"";"";"";"";""
"CHEMBL844951";"F";"Ratio of IC50 for Parental L1210 to that of multidrug resistant L1210.";"";"18";"20";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1125271";"1906107";"10.1021/jm00111a004";"1991";"J Med Chem";"34";"1947";"1951";"";"";"";"";"";""
"CHEMBL679587";"F";"Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 100 uM (Cell number 1*10 e-4)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"G-401";"";"CHEMBL1127382";"7932594";"10.1021/jm00047a024";"1994";"J Med Chem";"37";"3668";"3670";"";"";"";"";"";""
"CHEMBL1738444";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1477, AID1484]";"Homo sapiens";"56";"58";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL734250";"F";"In vivo activity against transplanted Squam lung-LC12 tumors of mice";"Mus musculus";"11";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL737240";"F";"Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 200 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL746653";"F";"Death due to toxicity occurring at a maximum body weight decrease of 10 to 22% from the average post injection body weight at 75 mg/kg; 5 / 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:75.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL741868";"F";"Anticancer activity carried out in vitro against murine leukemia P388";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1134486";"11356110";"10.1021/jm0004446";"2001";"J Med Chem";"44";"1749";"1757";"";"";"";"";"";""
"CHEMBL1004764";"F";"Antiviral activity against HSV1 F infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay";"Human herpesvirus 1";"11";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"F";"Scientific Literature";"10298";"";"";"Vero";"";"CHEMBL1150133";"12444692";"10.1021/np020234r";"2002";"J Nat Prod";"65";"1649";"1656";"";"";"";"";"";""
"CHEMBL1014839";"F";"Cytotoxicity against mouse L1210 cells after 3 days by trypan blue exclusion technique";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1158984";"1800632";"10.1021/np50077a010";"1991";"J Nat Prod";"54";"1298";"1302";"";"";"";"";"";""
"CHEMBL739859";"F";"Increase of life span was determined against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 5";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL1810521";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 0.089 umol/kg, ip qd administered 1 day after tumor inoculation for 7 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL1014843";"F";"Cytotoxicity against human HeLaS3 cells after 3 days by trypan blue exclusion technique";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa S3";"";"CHEMBL1158984";"1800632";"10.1021/np50077a010";"1991";"J Nat Prod";"54";"1298";"1302";"";"";"";"";"";""
"CHEMBL1810511";"F";"Antiproliferative activity against human K562 cells after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL705727";"F";"Inhibition of cell growth against human myeloid leukemia K562(S) cells";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1131873";"10560743";"10.1016/s0960-894x(99)00547-8";"1999";"Bioorg Med Chem Lett";"9";"3153";"3158";"";"";"";"";"";""
"CHEMBL712033";"F";"Inhibitory concentration on parentral (sensitive) L1210 leukemia cells.";"Mus musculus";"18";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125271";"1906107";"10.1021/jm00111a004";"1991";"J Med Chem";"34";"1947";"1951";"";"";"";"";"";""
"CHEMBL965578";"B";"Inhibition of mouse brain MAOA";"Mus musculus";"385";"391";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL1225709";"F";"Antitumor activity against mouse S180 cells transplanted in ICR mouse assessed as inhibition of tumor weight at 89 umol/kg, ip";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1221334";"20692841";"10.1016/j.bmc.2010.07.043";"2010";"Bioorg Med Chem";"18";"6220";"6229";"";"";"";"";"";""
"CHEMBL1918585";"F";"Cytotoxicity against human KB cells assessed as cell survival after 72 hrs by sulforhodamine B colorimetric assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1914360";"21945463";"10.1016/j.bmc.2011.08.069";"2011";"Bioorg Med Chem";"19";"6375";"6382";"";"";"";"";"";""
"CHEMBL957685";"F";"Antiproliferative activity against human K562 cells";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1153870";"18571290";"10.1016/j.ejmech.2008.05.001";"2009";"Eur J Med Chem";"44";"745";"754";"";"";"";"";"";""
"CHEMBL741472";"F";"Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1)";"Mus musculus";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL703789";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 25 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 9.5/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1820601";"F";"Ratio of IC50 for homoharringtonine300-resistant human K562 cells to IC50 for human K562 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL919716";"F";"Growth inhibition of human CCRF-HSB-2 cells by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-HSB-2";"";"CHEMBL1144504";"17049252";"10.1016/j.bmc.2006.09.063";"2007";"Bioorg Med Chem";"15";"242";"256";"";"";"";"";"";""
"CHEMBL748524";"F";"Mean body weight change on 5th day at a dose of 200 mg/kg/day";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL700229";"F";"In vitro inhibitory effect on growth of human chronic myelogenous leukemic K562 cell lines.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL686516";"F";"Anticancer activity was evaluated for the compound against parent promyelocytic leukemia cell line (HL-60-GHPRT+/dCK+)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1123319";"3027329";"10.1021/jm00157a031";"1986";"J Med Chem";"29";"1293";"1295";"";"";"";"";"";""
"CHEMBL1909184";"B";"DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909097";"B";"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)";"Sus scrofa";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9823";"CHEMBL3638187";"Heart";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613941";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells. (Class of assay: confirmatory) ";"Homo sapiens";"308";"309";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL761204";"F";"In vitro inhibitory effect on growth of human lung squamous cell carcinoma cell lines (PC10).";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC10";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL1909291";"T";"FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of most concern for DILI";"";"136";"136";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909281";"21624500";"10.1016/j.drudis.2011.05.007";"2011";"Drug Discov Today";"16";"697";"703";"";"";"";"";"";""
"CHEMBL1004763";"A";"Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay";"Chlorocebus sabaeus";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL1150133";"12444692";"10.1021/np020234r";"2002";"J Nat Prod";"65";"1649";"1656";"";"";"";"";"";""
"CHEMBL1614009";"F";"PUBCHEM_BIOASSAY: Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells. (Class of assay: confirmatory) ";"Homo sapiens";"116";"116";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL906781";"F";"Antitumor activity against human CCRF-HSB2 cells by modified MTT assay";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-HSB-2";"";"CHEMBL1143758";"17644399";"10.1016/j.bmc.2007.06.058";"2007";"Bioorg Med Chem";"15";"6336";"6352";"";"";"";"";"";""
"CHEMBL1613805";"F";"PUBCHEM_BIOASSAY: Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells. (Class of assay: confirmatory) ";"Homo sapiens";"270";"271";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"MEF";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697779";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents";"Rodentia";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9989";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL1909130";"B";"DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909155";"B";"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"5";"5 - Multiple direct protein targets may be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638246";"Spinal cord";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909156";"B";"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL710144";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 0/8";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1909148";"B";"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909206";"B";"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909111";"B";"DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909089";"B";"DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909143";"B";"DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909214";"B";"DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909139";"B";"DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909162";"B";"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909168";"B";"DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909188";"B";"DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909192";"B";"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909137";"B";"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909112";"B";"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909211";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909191";"B";"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)";"Bos taurus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9913";"CHEMBL3638197";"Uterus";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909095";"B";"DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638191";"Lens of camera-type eye";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614079";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ";"Homo sapiens";"22998";"23070";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909215";"B";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909129";"B";"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"1321-N1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909177";"B";"DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"IMR-32";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909181";"B";"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909131";"B";"DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf21";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909132";"B";"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909153";"B";"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909166";"B";"DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL653253";"F";"Concentration required to inhibit replication of CCRF-CEM deoxycytidine kinase deficient variant CCRF-CEM(dCK-)";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"";"";"";"";"";""
"CHEMBL929830";"F";"Antitumor activity against human CCRF-HSB2 cells by MTT assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-HSB-2";"";"CHEMBL1143144";"17962027";"10.1016/j.bmc.2007.10.014";"2008";"Bioorg Med Chem";"16";"922";"940";"";"";"";"";"";""
"CHEMBL929831";"F";"Antitumor activity against human KB cells by MTT assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1143144";"17962027";"10.1016/j.bmc.2007.10.014";"2008";"Bioorg Med Chem";"16";"922";"940";"";"";"";"";"";""
"CHEMBL810388";"F";"Compound was evaluated for its antiproliferative activity on human T-lymphocyte CEM cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1129846";"None";"10.1016/S0960-894X(97)00044-9";"1997";"Bioorg Med Chem Lett";"7";"473";"478";"";"";"";"";"";""
"CHEMBL701744";"F";"In vitro inhibitory effect on growth of mouse leukemic L1210 cell lines.";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL704562";"F";"Tested for its antiproliferative activity on murine leukemia L1210 cells";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1129846";"None";"10.1016/S0960-894X(97)00044-9";"1997";"Bioorg Med Chem Lett";"7";"473";"478";"";"";"";"";"";""
"CHEMBL880074";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL651490";"F";"Anticancer activity carried out in vitro against breast carcinoma MCF-7";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1134486";"11356110";"10.1021/jm0004446";"2001";"J Med Chem";"44";"1749";"1757";"";"";"";"";"";""
"CHEMBL754761";"F";"Percent inhibition of [123I]UdR incorporation in the DNA synthesis assay in P388 cell lines at a concentration of 10 E-3 M";"Mus musculus";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122387";"6415284";"10.1021/jm00365a003";"1983";"J Med Chem";"26";"1556";"1561";"";"";"";"";"";""
"CHEMBL824451";"F";"In vitro antiviral activity against Vaccinia virus strain Elstree was evaluated in african green monkey kidney";"Vaccinia virus";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10245";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL1614310";"F";"PUBCHEM_BIOASSAY: Validation of Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ";"Homo sapiens";"280";"280";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL820111";"F";"In vitro cytotoxicity against Vero cells.";"Chlorocebus sabaeus";"12";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL690817";"F";"In vitro antiviral activity against Herpes simplex virus -2 strain MS was evaluated in african green monkey kidney";"Human herpesvirus 2";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10310";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL699582";"F";"In vitro antitumor activity against L1210 cell line in mice.";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL1820602";"F";"Ratio of IC50 for vinblastine100-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL756296";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent increase in life span at 500 mg/kg (treatment of 1qd schedule) dosage";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL748521";"F";"Mean body weight change on 17th day at a dose of 100 mg/kg/day";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL1909185";"B";"DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909203";"B";"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909183";"B";"DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)";"Mus musculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"ICR";"DrugMatrix";"10090";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909124";"B";"DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909136";"B";"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909121";"B";"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909098";"B";"DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638251";"Adrenal gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909199";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909109";"B";"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909127";"B";"DRUGMATRIX: Chemokine CXCR1 (IL-8A)";"";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909135";"B";"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909141";"B";"DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738600";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504591]";"Homo sapiens";"184";"185";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909171";"B";"DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909208";"B";"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand albino";"DrugMatrix";"9986";"CHEMBL3638205";"Urinary bladder";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909209";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909101";"B";"DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"T47D";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL886768";"B";"Inhibition of HSV1 TK assessed as [methyl-3H]dThd phosphorylation";"Human herpesvirus 1";"28";"28";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10298";"";"";"";"";"CHEMBL1139173";"17324575";"10.1016/j.bmc.2007.01.049";"2007";"Bioorg Med Chem";"15";"3065";"3081";"";"";"";"";"";""
"CHEMBL1737980";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493163, AID504444, AID504648]";"Homo sapiens";"338";"338";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL726142";"F";"Compound was tested for the ability to suppress humoral immune response in mice treated for days 0,+1,and +2 at dose of 25 mg/kg (control = 7.0)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121811";"7265126";"10.1021/jm00136a008";"1981";"J Med Chem";"24";"393";"398";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL734248";"F";"In vivo activity against transplanted Panc-02 tumors of mice";"Mus musculus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL651477";"F";"In vitro inhibitory effect on growth of human T-cell acute lymphoblastoid leukemic CCRFCEM cell lines.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL1217186";"F";"Antimicrobial activity against Pneumocystis carinii";"Pneumocystis carinii";"209";"209";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"4754";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL1217012";"F";"Antimicrobial activity against Cryptosporidium parvum";"Cryptosporidium parvum";"258";"258";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5807";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL1217008";"F";"Antimicrobial activity against Leishmania amazonensis";"Leishmania amazonensis";"207";"207";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5659";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL710289";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 0/7";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1217011";"F";"Antimicrobial activity against Leishmania major";"Leishmania major";"211";"211";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5664";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL761890";"F";"In vitro antiviral activity against Para influenza virus type 3 strain C243 was evaluated in african green monkey kidney";"para influenza virus type 3";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11309";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL740408";"F";"In vivo percent inhibition of Lewis Lung Carcinoma cell line in mice at 100 mg/Kg per day (p<0.001) compared with NCDAC";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Carcinoma Oncology Models | Carcinoma Oncology Models";"Carcinoma | Lewis Lung Carcinoma";"";""
"CHEMBL704801";"F";"Evaluated for erythroid induction of benzidine-positive K562 cells at concentration 3 mM";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1131873";"10560743";"10.1016/s0960-894x(99)00547-8";"1999";"Bioorg Med Chem Lett";"9";"3153";"3158";"";"";"";"";"";""
"CHEMBL1614174";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ";"Bacillus subtilis";"24077";"24320";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"1423";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855500";"F";"Ratio of AUC for araCTP level in liver to bone marrow of Swiss Webster mouse";"Mus musculus";"3";"3";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"Swiss Webster";"Scientific Literature";"10090";"CHEMBL3559723";"Liver";"";"";"CHEMBL1138220";"17181153";"10.1021/jm0607449";"2006";"J Med Chem";"49";"7711";"7720";"";"";"";"";"";""
"CHEMBL1772302";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 100 umol/kg/day, ip qd for 7 days measured 24 hrs after last dose relative to control";"Mus musculus";"20";"20";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1770136";"21414693";"10.1016/j.ejmech.2011.02.017";"2011";"Eur J Med Chem";"46";"1672";"1681";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL886771";"B";"Inhibition of VZV TK assessed as [methyl-3H]dThd phosphorylation";"Human herpesvirus 3";"28";"28";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"10335";"";"";"";"";"CHEMBL1139173";"17324575";"10.1016/j.bmc.2007.01.049";"2007";"Bioorg Med Chem";"15";"3065";"3081";"";"";"";"";"";""
"CHEMBL801460";"F";"Concentration required to inhibit replication of S-180 cell lines by 50% after 72 hr incubation";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"";"";"";"";"";""
"CHEMBL1613933";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]";"Homo sapiens";"7185";"7272";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL984954";"F";"Cytotoxicity against mouse Panc03 cells at 1.5 ug/disk by corbett disk diffusion assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1147292";"2809606";"10.1021/np50064a011";"1989";"J Nat Prod";"52";"732";"739";"";"";"";"";"";""
"CHEMBL854848";"F";"Production of araCTP in rat hepatocytes at 100 uM measured as AUC (0-4h)";"Rattus norvegicus";"13";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"Hepatocyte";"";"CHEMBL1138220";"17181153";"10.1021/jm0607449";"2006";"J Med Chem";"49";"7711";"7720";"";"";"";"";"";""
"CHEMBL810058";"B";"Phosphorylating activity of viral HSV -2 (333) induced thymidine kinase relative to dThdK was determined";"Human herpesvirus 2";"2";"2";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"10310";"";"";"";"";"CHEMBL1123554";"2822932";"10.1021/jm00394a039";"1987";"J Med Chem";"30";"2154";"2157";"";"";"";"";"";""
"CHEMBL1794303";"F";"PUBCHEM_BIOASSAY: Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504586]";"Homo sapiens";"663";"664";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HEK293";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL987364";"F";"Antimicrobial activity against Streptococcus sp. 07706-1 after 20 hrs";"Streptococcus sp.";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1306";"";"";"";"";"CHEMBL1155163";"17526755";"10.1128/aac.00081-07";"2007";"Antimicrob Agents Chemother";"51";"2726";"2732";"";"";"";"";"";""
"CHEMBL987368";"F";"Antimicrobial activity against Streptococcus pyogenes AP1 after 20 hrs";"Streptococcus pyogenes";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"AP1";"Scientific Literature";"1314";"";"";"";"";"CHEMBL1155163";"17526755";"10.1128/aac.00081-07";"2007";"Antimicrob Agents Chemother";"51";"2726";"2732";"";"";"";"";"";""
"CHEMBL688795";"F";"Differentiating activity of compound in HL60 cells at conc 0.016 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1130401";"9371251";"10.1021/jm9602322";"1997";"J Med Chem";"40";"3851";"3857";"";"";"";"";"";""
"CHEMBL704627";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent median survival rate (treated/control) at 300 mg/kg (treatment of 1-5qd schedule) dosage; 16.0/7.0";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:300.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL734253";"F";"In vivo activity against transplanted colon-51 tumors of mice";"Mus musculus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1963969";"F";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3). (Class of assay: confirmatory) ";"";"240";"240";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL721973";"F";"In vivo activity against transplanted Mam-16/C/Adr tumors of mice; Not active";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL886766";"B";"Inhibition of human TK1 assessed as [methyl-3H]dThd phosphorylation";"Homo sapiens";"28";"28";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1139173";"17324575";"10.1016/j.bmc.2007.01.049";"2007";"Bioorg Med Chem";"15";"3065";"3081";"";"";"";"";"";""
"CHEMBL886767";"B";"Inhibition of human TK2 assessed as [methyl-3H]dThd phosphorylation";"Homo sapiens";"28";"28";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1139173";"17324575";"10.1016/j.bmc.2007.01.049";"2007";"Bioorg Med Chem";"15";"3065";"3081";"";"";"";"";"";""
"CHEMBL886770";"B";"Inhibition of Drosophila melanogaster dNK assessed as [methyl-3H]dThd phosphorylation";"Drosophila melanogaster";"28";"28";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"7227";"";"";"";"";"CHEMBL1139173";"17324575";"10.1016/j.bmc.2007.01.049";"2007";"Bioorg Med Chem";"15";"3065";"3081";"";"";"";"";"";""
"CHEMBL867669";"F";"Antiproliferative activity against NCI60 cell line";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel NCI-60 (60 carcinoma cell lines)";"";"CHEMBL1138988";"16539384";"10.1021/jm051029m";"2006";"J Med Chem";"49";"1964";"1979";"";"";"";"";"";""
"CHEMBL710344";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL652485";"F";"In vitro concentration required for 50% inhibition of growth of human leukemia cell line CCRF-CEM with hPAP (0.2 unit/mL)";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1133824";"11597404";"10.1016/s0960-894x(01)00513-3";"2001";"Bioorg Med Chem Lett";"11";"2803";"2805";"";"";"";"";"";""
"CHEMBL1613776";"F";"PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ";"Homo sapiens";"4283";"4313";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL689919";"F";"Antiviral activity against Herpes simplex virus -1 strain KOS was evaluated in african green monkey kidney";"Human herpesvirus 1";"11";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL857778";"F";"Cross resistance profile versus L1210/R71 cells.";"Mus musculus";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL741473";"F";"Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1,5,9)";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL1045388";"F";"Cytotoxicity against mouse L1210 cells assessed as inhibition of cell proliferation after 48 hrs";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1156792";"20000418";"10.1021/jm901590f";"2010";"J Med Chem";"53";"559";"572";"";"";"";"";"";""
"CHEMBL750172";"F";"Concentration required to inhibit replication of P388 cell lines by 50% after 72 hr incubation";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"";"";"";"";"";""
"CHEMBL738154";"F";"Percentage increase in life span after 7-8 days";"Mus musculus";"2";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL703723";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 208 mg/kg dose (post inoculation life span, days)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:208.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1168911";"F";"Cytotoxicity against human SF268 cells after 3 days by MTT assay";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1165908";"20356655";"10.1016/j.ejmech.2010.02.011";"2010";"Eur J Med Chem";"45";"2336";"2344";"";"";"";"";"";""
"CHEMBL704563";"F";"Tested in vitro inhibitory activity against murine leukemia L1210";"Mus musculus";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL708574";"F";"Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL703682";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 5 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 13.5/9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL872041";"F";"In vitro inhibitory effect measured against human stomach adenocarcinoma ST-KM tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ST-KM-1";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL669614";"B";"Inhibitory activity against dihydrofolate reductase (DHFR) isolated from murine L5178Y tumor cells resistant and sensitive to methotrexate";"";"109";"185";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"L5178Y";"";"CHEMBL1122587";"6699880";"10.1021/jm00369a019";"1984";"J Med Chem";"27";"347";"357";"";"";"";"";"";""
"CHEMBL741452";"F";"Range of survival days for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL695855";"F";"In vitro inhibitory effect measured against human lung suamous-cell carcinoma QG-56 tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"QG-56";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL737995";"F";"Percentage increase in life span after 12-13days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL691768";"F";"In vitro antiviral activity against Herpes simplex virus -1 strain KOS was evaluated in african green monkey kidney";"Human herpesvirus 1";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL702613";"F";"Antitumor activity against the ic implanted L1210 lymphoid leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL701479";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent median survival rate (treated/control) at 400 mg/kg (treatment of 1qd schedule) dosage; 9.5/8.0";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:400.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL737997";"F";"Percentage increase in life span after 15-18 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL705948";"F";"Effective dose to inhibit the replication of L1210 cell line in vitro.";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125248";"1995894";"10.1021/jm00106a034";"1991";"J Med Chem";"34";"693";"701";"";"";"";"";"";""
"CHEMBL1014841";"F";"Cytotoxicity against human KB cells after 3 days by trypan blue exclusion technique";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1158984";"1800632";"10.1021/np50077a010";"1991";"J Nat Prod";"54";"1298";"1302";"";"";"";"";"";""
"CHEMBL1041582";"F";"Cytotoxicity against deoxynucleoside analogue-sensitive human CCRF-CEM cells after 3 days by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL720521";"F";"Percent increase in life span calculated as (T/C-1)X100 at a dose of 10 mg/kg/day *5";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL1809503";"T";"Toxicity in ICR mouse xenografted with mouse S180 cells assessed as effect on liver weight at 2 umol/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ICR";"Scientific Literature";"10090";"CHEMBL3559723";"Liver";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL1055754";"F";"Cytotoxicity against human HL60 cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL1059214";"P";"Lipophilicity, log P of the compound";"";"16";"16";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1153578";"19321234";"10.1016/j.ejmech.2009.02.028";"2009";"Eur J Med Chem";"44";"3596";"3600";"";"";"";"";"";""
"CHEMBL1027767";"A";"Volume of distribution at steady state in human administered 1 to 12 g doses with 2 to 3.5 hrs iv infusion";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1158480";"19603833";"10.1021/jm9004658";"2009";"J Med Chem";"52";"4488";"4495";"";"";"";"";"";""
"CHEMBL2013703";"F";"Growth inhibition of against human HCT116 cells after 24 hrs by WST-1 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL2010709";"22264170";"10.1021/np200523b";"2012";"J Nat Prod";"75";"135";"141";"";"";"";"";"";""
"CHEMBL707116";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 34 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:34.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1217006";"F";"Antimicrobial activity against Leishmania mexicana";"Leishmania mexicana";"207";"207";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5665";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL650359";"F";"Percent inhibition of [123I]UdR incorporation in the DNA synthesis assay in bone marrow cells at a concentration of 10 e-3 M";"Mus musculus";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3638214";"Bone element";"Osteoclast-like";"";"CHEMBL1122387";"6415284";"10.1021/jm00365a003";"1983";"J Med Chem";"26";"1556";"1561";"";"";"";"";"";""
"CHEMBL744543";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL707117";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 56 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:56.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL663661";"B";"Inhibitory concentration against Drosophila melanogaster deoxyribonucleoside kinase (Dm-dNK)";"";"10";"10";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1134069";"11392548";"10.1016/s0960-894x(01)00207-4";"2001";"Bioorg Med Chem Lett";"11";"1329";"1332";"";"";"";"";"";""
"CHEMBL714952";"F";"In vitro lethal dose was measured in mouse myeloma MPC-11 cell line";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"MPC-11";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL879238";"F";"In vitro cytotoxicity was evaluated againstCNS SNB-7 cells; 1 x 10E1";"Mus sp.";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10095";"";"";"SNB-7";"";"CHEMBL1133006";"10780904";"10.1021/jm990417j";"2000";"J Med Chem";"43";"1484";"1488";"";"";"";"";"";""
"CHEMBL664537";"F";"In vitro cytotoxicity was evaluated against colon DLD-1 cells";"Mus sp.";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10095";"";"";"DLD-1";"";"CHEMBL1133006";"10780904";"10.1021/jm990417j";"2000";"J Med Chem";"43";"1484";"1488";"";"";"";"";"";""
"CHEMBL745281";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL697964";"F";"In vitro inhibitory effect measured against human lung adenocarcinoma PC-8 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-8";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL691778";"F";"Antiviral activity against herpes simplex virus-1.";"Human herpesvirus 1";"20";"20";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"";"";"";"";"CHEMBL1159161";"None";"10.1016/S0960-894X(97)00117-0";"1997";"Bioorg Med Chem Lett";"7";"789";"792";"";"";"";"";"";""
"CHEMBL703942";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by change in tumor weight at 400 mg/kg (treatment of 1qd schedule) dosage";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:400.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1106343";"F";"Antitumor activity against human H460 cells after 24 hrs by MTT assay";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1156336";"20211564";"10.1016/j.bmc.2010.02.023";"2010";"Bioorg Med Chem";"18";"2704";"2712";"";"";"";"";"";""
"CHEMBL1041585";"F";"Cytotoxicity against deoxycytidine kinase deficient and nucleoside analogue-resistant mouse L1210 10K cells after 3 days by MTT assay";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL742649";"F";"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 250 mg/kg; Value represented as Test/Control = 9/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL730605";"F";"Change in weight in mice bearing ip-implanted L1210 lymphoid leukemia on day 8 at 100 mg/kg or 411 umol/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL664749";"B";"The compound was tested for its ability to inhibit the incorporation of tritiated thymidine into mammalian epithelial cells (DNA) at 30 uM dose";"";"7";"8";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"Epithelial cell";"";"CHEMBL1125851";"None";"10.1016/S0960-894X(01)81161-6";"1991";"Bioorg Med Chem Lett";"1";"607";"610";"";"";"";"";"";""
"CHEMBL696003";"F";"In vitro inhibitory effect measured against human osteosarcoma KHOS-321H tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KHOS-321H ";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL1030633";"F";"Antiviral activity against HSV1 assessed as inhibition of virus-induced cytopathicity";"Human herpesvirus 1";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"";"";"";"";"CHEMBL1136856";"19147352";"10.1016/j.bmcl.2008.12.103";"2009";"Bioorg Med Chem Lett";"19";"1126";"1128";"";"";"";"";"";""
"CHEMBL729824";"F";"Dose producing greatest increase in life span of mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.";"Mus musculus";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL819084";"B";"Rate of phosphorylation relative to human CytodThdK was determined";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1123554";"2822932";"10.1021/jm00394a039";"1987";"J Med Chem";"30";"2154";"2157";"";"";"";"";"";""
"CHEMBL819083";"B";"Rate of phosphorylation relative to human CytodCydK was determined";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1123554";"2822932";"10.1021/jm00394a039";"1987";"J Med Chem";"30";"2154";"2157";"";"";"";"";"";""
"CHEMBL1794345";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"170142";"170462";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1041588";"F";"Cytotoxicity against deoxynucleoside analogue-sensitive human MCF7 cells after 3 days by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL1041586";"F";"Cytotoxicity against deoxynucleoside analogue-sensitive human MESSA cells after 3 days by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL815115";"F";"In vitro inhibitory activity against Human histiocytic lymphoma (U-937) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL1041584";"F";"Cytotoxicity against deoxynucleoside analogue-sensitive mouse L1210 cells after 3 days by MTT assay";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL1614065";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of 5&apos;UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";"";"183";"183";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697798";"A";"FDA HLAED, alkaline phosphatase increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL957693";"F";"Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells at 500 mM after 6 days";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1153870";"18571290";"10.1016/j.ejmech.2008.05.001";"2009";"Eur J Med Chem";"44";"745";"754";"";"";"";"";"";""
"CHEMBL700090";"F";"Effect of compound on erythroid differentiation of K562 cells was determined after a period of 7 days at concentration 500 nM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1131873";"10560743";"10.1016/s0960-894x(99)00547-8";"1999";"Bioorg Med Chem Lett";"9";"3153";"3158";"";"";"";"";"";""
"CHEMBL1909122";"B";"DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909138";"B";"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909170";"B";"DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909142";"B";"DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909119";"B";"DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HT-29";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909120";"B";"DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909105";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL758407";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by change in tumor weight at 500 mg/kg (treatment of 1qd schedule) dosage";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1053111";"F";"Cytotoxicity against human K562 cells by sulforhodamine B method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1152442";"19691349";"10.1021/jm900852b";"2009";"J Med Chem";"52";"5303";"5306";"";"";"";"";"";""
"CHEMBL744030";"F";"Tested for in vivo antitumor activity against Lewis Lung Carcinoma cell line in mice and tumor weight change at 200 mg/Kg per day";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Carcinoma Oncology Models | Carcinoma Oncology Models | Neoplasm Oncology Models";"Carcinoma | Lewis Lung Carcinoma | Neoplasms";"";""
"CHEMBL1772309";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as decrease of tumor weight at 100 umol/kg, ip qd for 7 days measured 24 hrs after last dose";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1770136";"21414693";"10.1016/j.ejmech.2011.02.017";"2011";"Eur J Med Chem";"46";"1672";"1681";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL1810805";"T";"Toxicity in ICR mouse xenografted with mouse S180 cells assessed as increase in spleen index at 2 umol/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ICR";"Scientific Literature";"10090";"CHEMBL3559722";"Spleen";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL653264";"F";"Cytotoxicity against CCRF-CEM/ara-C human leukemic lymphoblastoid cell lines";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM/ara-C";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"";"";"";"";"";""
"CHEMBL812941";"F";"Anticancer activity carried out in vitro against human T-lymphocyte Molt4/C8";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1134486";"11356110";"10.1021/jm0004446";"2001";"J Med Chem";"44";"1749";"1757";"";"";"";"";"";""
"CHEMBL701932";"F";"The compound was tested for anticancer activity against L5178Y (sensitive) cell lines of mouse leukemia";"Mus musculus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL1121538";"7420353";"10.1021/jm00184a006";"1980";"J Med Chem";"23";"1088";"1094";"";"";"";"";"";""
"CHEMBL3137738";"T";"Comments (NB not yet translated). [column 'COMMENTAIRES' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137736";"T";"Animal toxicity known. [column 'TOXIC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1045386";"F";"Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation after 48 hrs";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1156792";"20000418";"10.1021/jm901590f";"2010";"J Med Chem";"53";"559";"572";"";"";"";"";"";""
"CHEMBL710353";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL665311";"B";"Inhibitory constant was measured on cytidine/deoxycytidine deaminase";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"";"";"";"";"";""
"CHEMBL656070";"F";"Cytotoxicity against CCRF-CEM human leukemic lymphoblastoid cell lines";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"";"";"";"";"";""
"CHEMBL1697778";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans";"Homo sapiens";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL653265";"F";"Antiproliferative effects on CCRF-HSB-2 (human leukemia) cells.";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-HSB-2";"";"CHEMBL1130421";"9216836";"10.1021/jm9701536";"1997";"J Med Chem";"40";"2177";"2183";"";"";"";"";"";""
"CHEMBL2363789";"F";"SANGER: Inhibition of human TE-11 cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363663";"F";"SANGER: Inhibition of human SN12C cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SN12C";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL702617";"F";"Antitumor activity against the ip implanted L1210 leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined";"Mus musculus";"8";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL701008";"F";"Apparent inhibition of incorporation of labeled thymidine into DNA in murine leukemia L1210 cell;No inhibition";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123684";"3806625";"10.1021/jm00385a032";"1987";"J Med Chem";"30";"437";"440";"";"";"";"";"";""
"CHEMBL4155617";"A";"Cytotoxicity against human LO2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4155623";"F";"Growth inhibition of human SMMC7721 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3256546";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 25 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1614211";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ";"";"36499";"36798";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137729";"T";"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL970838";"F";"Growth inhibition of human KB cells by MTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1156703";"18055068";"10.1016/j.ejmech.2007.10.011";"2008";"Eur J Med Chem";"43";"1376";"1389";"";"";"";"";"";""
"CHEMBL3137727";"T";"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL743220";"T";"Toxicity in mice after 7 days at a dose of 200 mg/kg/day; 7/9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL4339856";"F";"Induction of apoptosis in human U937 cells assessed as necrotic cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 2.5 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL4339847";"F";"Induction of apoptosis in human U937 cells assessed as late apoptotic cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 1.75 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL714951";"F";"In vitro antiproliferative activity was measured in mouse myeloma MPC-11 cell line";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"MPC-11";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL729670";"F";"Change in weight of mouse on day 8 was measured in L1210 lymphoid leukemia inoculated mice after ip administration at dose of 20 mg/kg/day X5";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL694611";"F";"Antiviral activity against Herpes simplex virus -2 strain MS was evaluated in african green monkey kidney";"Human herpesvirus 2";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10310";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL953283";"F";"Antitumor activity against human KB cells by MTT assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1151793";"18723355";"10.1016/j.bmc.2008.07.089";"2008";"Bioorg Med Chem";"16";"8685";"8696";"";"";"";"";"";""
"CHEMBL714945";"F";"Concentration required for 50% inhibition of cell growth of MOLT-4 leukemic cell lines in human.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL3137731";"T";"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1738442";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404]";"Homo sapiens";"90360";"91293";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738610";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962]";"Homo sapiens";"593";"594";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL689656";"F";"Concentration required for 50% inhibition of cell growth of HL60 leukemic cell lines in human.";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL648676";"F";"In vitro inhibitory activity against Mouse melanoma (B16) cell line.";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL720526";"F";"Percent increase in life span in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.";"Mus musculus";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL2363648";"F";"SANGER: Inhibition of human SK-MEL-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363157";"F";"SANGER: Inhibition of human CaR-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CaR-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363159";"F";"SANGER: Inhibition of human Calu-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Calu-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363716";"F";"SANGER: Inhibition of human 8-MG-BA cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"8-MG-BA";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909176";"B";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"KAN-TS";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363711";"F";"SANGER: Inhibition of human 639-V cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"639-V";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909161";"B";"DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363654";"F";"SANGER: Inhibition of human SK-N-AS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-N-AS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363692";"F";"SANGER: Inhibition of human SW872 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW872";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363808";"F";"SANGER: Inhibition of human U-2-OS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-2-OS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363694";"F";"SANGER: Inhibition of human SW948 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW948";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3039491";"A";"Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM";"Cricetulus griseus";"1878";"1881";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3039007";"23571415";"10.1124/mol.112.084152";"2013";"Mol Pharmacol";"83";"1257";"1267";"";"";"";"";"";""
"CHEMBL2363361";"F";"SANGER: Inhibition of human KYSE-520 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-520 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363215";"F";"SANGER: Inhibition of human ES7 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363737";"F";"SANGER: Inhibition of human ACN cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ACN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909151";"B";"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363743";"F";"SANGER: Inhibition of human ATN-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ATN-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363187";"F";"SANGER: Inhibition of human DSH1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DSH1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363769";"F";"SANGER: Inhibition of human C-33-A cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C-33-A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296190";"F";"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";"Cryptococcus neoformans";"6133";"6235";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 208821";"CO-ADD antimicrobial screening data";"5207";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL4296185";"F";"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)";"Escherichia coli";"4585";"4681";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 25922";"CO-ADD antimicrobial screening data";"562";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL4296184";"F";"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)";"Staphylococcus aureus subsp. aureus";"4588";"4684";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 43300";"CO-ADD antimicrobial screening data";"46170";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2363260";"F";"SANGER: Inhibition of human HCC1806 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1806";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363748";"F";"SANGER: Inhibition of human BB49-HNC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BB49-HNC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363541";"F";"SANGER: Inhibition of human NCI-H69 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H69";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363349";"F";"SANGER: Inhibition of human KS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363383";"F";"SANGER: Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LNCaP-Clone-FGC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL874178";"F";"The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against HeLa human cell lines after 72 hr";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1123889";"3625714";"10.1021/jm00392a029";"1987";"J Med Chem";"30";"1686";"1688";"";"";"";"";"";""
"CHEMBL688698";"F";"In vitro inhibitory activity against Human promyelocytic leukemia (HL-60) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL1909108";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909092";"B";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL704632";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent median survival rate (treated/control) at 200 mg/kg (treatment of 1-5qd schedule) dosage; 17.0/7.0";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1909172";"B";"DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909179";"B";"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909198";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909102";"B";"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909154";"B";"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697802";"A";"FDA HLAED, gamma-glutamyl transferase (GGT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1909194";"B";"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL815477";"B";"Inhibitory concentration against mitochondrial thymidine kinase (TK-2)";"Homo sapiens";"12";"12";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1134069";"11392548";"10.1016/s0960-894x(01)00207-4";"2001";"Bioorg Med Chem Lett";"11";"1329";"1332";"";"";"";"";"";""
"CHEMBL1909117";"B";"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909096";"B";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909099";"B";"DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)";"Bacillus cereus";"871";"1742";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"1396";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL697962";"F";"In vitro inhibitory effect measured against human lung adenocarcinoma PC-3 tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL1909213";"B";"DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3232068";"A";"Cytotoxicity against mouse L5178Y cells assessed as growth inhibition after 96 hrs";"Mus musculus";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL3227997";"218006";"10.1021/jm00187a005";"1979";"J Med Chem";"22";"21";"24";"";"";"";"";"";""
"CHEMBL2363783";"F";"SANGER: Inhibition of human CAL-51 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-51";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363153";"F";"SANGER: Inhibition of human CTV-1 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CTV-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363140";"F";"SANGER: Inhibition of human COLO-800 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-800";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363142";"F";"SANGER: Inhibition of human COLO-829 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-829";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363333";"F";"SANGER: Inhibition of human KG-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KG-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363838";"F";"SANGER: Inhibition of human CFPAC-1 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CFPAC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363528";"F";"SANGER: Inhibition of human NCI-H441 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H441";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363638";"F";"SANGER: Inhibition of human SJRH30 cell growth in a cell viability assay.";"Homo sapiens";"89";"89";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SJRH30";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363639";"F";"SANGER: Inhibition of human SJSA-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SJSA-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363806";"F";"SANGER: Inhibition of human TYK-nu cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TYK-nu";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363220";"F";"SANGER: Inhibition of human EW-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363364";"F";"SANGER: Inhibition of human L-428 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"L-428";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363768";"F";"SANGER: Inhibition of human BxPC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BXPC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363319";"F";"SANGER: Inhibition of human JAR cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JAR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363163";"F";"SANGER: Inhibition of human Capan-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Capan-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363819";"F";"SANGER: Inhibition of human UMC-11 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UMC-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363257";"F";"SANGER: Inhibition of human HCC1419 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1419";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363391";"F";"SANGER: Inhibition of human LU-134-A cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-134-A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363294";"F";"SANGER: Inhibition of human HT-144 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-144";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363826";"F";"SANGER: Inhibition of human YH-13 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"YH-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363362";"F";"SANGER: Inhibition of human KYSE-70 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-70 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363756";"F";"SANGER: Inhibition of human BFTC-909 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BFTC-909";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363535";"F";"SANGER: Inhibition of human NCI-H526 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H526";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363422";"F";"SANGER: Inhibition of human MG-63 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MG-63";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363281";"F";"SANGER: Inhibition of human HN cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL732987";"F";"In vivo antitumor activity against intraperitoneally inoculated L1210 lymphoid leukemic mice (Weight change observed on day 8.Treatment schedule is 1-9 qd)";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL981353";"F";"Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL2363156";"F";"SANGER: Inhibition of human Ca9-22 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Ca9-22";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363649";"F";"SANGER: Inhibition of human SK-MEL-30 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-30";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363651";"F";"SANGER: Inhibition of human SK-MES-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MES-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363809";"F";"SANGER: Inhibition of human U-266 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-266";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363520";"F";"SANGER: Inhibition of human NCI-H2452 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2452";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363573";"F";"SANGER: Inhibition of human ONS-76 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ONS-76";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363684";"F";"SANGER: Inhibition of human SW1990 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1990";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363503";"F";"SANGER: Inhibition of human NCI-H2087 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2087";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363424";"F";"SANGER: Inhibition of human MHH-ES-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MHH-ES-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363457";"F";"SANGER: Inhibition of human NB5 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363243";"F";"SANGER: Inhibition of human GI-ME-N cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GI-ME-N";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363317";"F";"SANGER: Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"J-RT3-T3-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363762";"F";"SANGER: Inhibition of human BPH-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BPH-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363314";"F";"SANGER: Inhibition of human IST-MES1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IST-MES1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363348";"F";"SANGER: Inhibition of human KP-N-YS cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KP-N-YS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363712";"F";"SANGER: Inhibition of human 647-V cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"647-V";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363252";"F";"SANGER: Inhibition of human HAL-01 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HAL-01";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363661";"F";"SANGER: Inhibition of human SKG-IIIa cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SKG-IIIa";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363468";"F";"SANGER: Inhibition of human NCI-H1304 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1304";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363469";"F";"SANGER: Inhibition of human NCI-H1355 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1355";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363289";"F";"SANGER: Inhibition of human HSC-4 cell growth in a cell viability assay.";"Homo sapiens";"73";"74";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HSC-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363188";"F";"SANGER: Inhibition of human DU-145 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DU-145";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL817606";"F";"Concentration required for 50% inhibition of cell growth of U937 leukemic cell lines in human.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL2363463";"F";"SANGER: Inhibition of human NCI-H1048 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1048";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363506";"F";"SANGER: Inhibition of human NCI-H2122 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2122";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363374";"F";"SANGER: Inhibition of human LB831-BLC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB831-BLC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL721882";"F";"Percent increase in life span of drug-treated mice relative to tumored, vehicle treated controls at a dose of 500 mg/kg orally in the presence of 500 mg/kg of zebularine.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125796";"1956046";"10.1021/jm00115a017";"1991";"J Med Chem";"34";"3280";"3284";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1059099";"F";"Cytotoxicity against human H441 cells after 72 hrs by trypan blue cell exclusion assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H441";"";"CHEMBL1154024";"19574048";"10.1016/j.bmcl.2009.06.056";"2009";"Bioorg Med Chem Lett";"19";"4764";"4767";"";"";"";"";"";""
"CHEMBL707468";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by 45-day survivors in mice at 200 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL872828";"F";"Compound was tested for the inhibition of non- small cell lung cancer";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Non-small cell lung cancer cell line";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL707126";"F";"Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1614458";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]";"Homo sapiens";"75376";"75927";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL711690";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers";"Mus musculus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL2363298";"F";"SANGER: Inhibition of human HTC-C3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HTC-C3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363499";"F";"SANGER: Inhibition of human NCI-H2029 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2029";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363212";"F";"SANGER: Inhibition of human ES4 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1106929";"F";"Antiproliferative activity against wild type FLT3 expressing human MV411 cells after 72 hrs by WST8 assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL1155384";"20153646";"10.1016/j.bmcl.2010.01.039";"2010";"Bioorg Med Chem Lett";"20";"2033";"2037";"";"";"";"";"";""
"CHEMBL2150100";"F";"Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"54";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150101";"F";"Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150102";"F";"Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150105";"F";"Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150109";"F";"Ratio of IC50 for human CCRF-CEM/C2 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL714950";"F";"In vitro antiproliferative activity was measured in mouse myeloma L1210 cell line";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL3284435";"F";"Antiviral activity against Herpes Simplex virus HF infected in African green monkey BGM cells assessed as plaque reduction measured on day 5 by disk diffusion assay";"unidentified herpesvirus";"41";"41";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"HF";"Scientific Literature";"39059";"";"";"BGM";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"";"";"";"";"";""
"CHEMBL720524";"F";"Percent increase in life span calculated as (T/C-1)X100 at a dose of 40 mg/kg/day X5";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL3299590";"F";"Cytotoxicity against human SNU638 cells by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-638";"";"CHEMBL3297674";"24956556";"10.1016/j.ejmech.2014.06.031";"2014";"Eur J Med Chem";"83";"208";"225";"";"";"";"";"";""
"CHEMBL1217009";"F";"Antimicrobial activity against Leishmania donovani";"Leishmania donovani";"287";"287";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5661";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL743067";"T";"Toxicity in mice after 9-12 days at a dose of 200 mg/kg/day; 10.5/9.5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL1175570";"F";"Antiproliferative activity against mouse r/m HM-SFME-1 cells after 24 hrs by MTT assay";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1177862";"20398972";"10.1016/j.ejmech.2010.03.021";"2010";"Eur J Med Chem";"45";"2943";"2948";"";"";"";"";"";""
"CHEMBL1175569";"A";"Antiproliferative activity against mouse SFME cells after 24 hrs by MTT assay";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"SFME";"";"CHEMBL1177862";"20398972";"10.1016/j.ejmech.2010.03.021";"2010";"Eur J Med Chem";"45";"2943";"2948";"";"";"";"";"";""
"CHEMBL1106055";"F";"Antiproliferative activity against human RS4:11 cells having FLT3-ITD mutation after 72 hrs by WST8 assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RS4-11";"";"CHEMBL1155384";"20153646";"10.1016/j.bmcl.2010.01.039";"2010";"Bioorg Med Chem Lett";"20";"2033";"2037";"";"";"";"";"";""
"CHEMBL1106340";"F";"Antitumor activity against human HCT116 cells after 24 hrs by MTT assay";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1156336";"20211564";"10.1016/j.bmc.2010.02.023";"2010";"Bioorg Med Chem";"18";"2704";"2712";"";"";"";"";"";""
"CHEMBL703722";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 156 mg/kg dose (post inoculation life span, days)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:156.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL3254573";"T";"Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 18.2 mg/kg, ip qd administered for 5 days measured on day 8 (Rvb = 1.81 +/- 0.79 g)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"C3D2F1/J";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:18.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4029349";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL743666";"F";"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 50 mg/kg; Value represented as Test/Control = 14/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL734247";"F";"In vivo activity against transplanted Mam-17/Adr tumors of mice";"Mus musculus";"9";"9";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL819086";"B";"Rate of phosphorylation relative to human MitoThdK was determined";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1123554";"2822932";"10.1021/jm00394a039";"1987";"J Med Chem";"30";"2154";"2157";"";"";"";"";"";""
"CHEMBL3541969";"A";"Activity of human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells assessed as intrinsic clearance for arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"P32320";"A70T"
"CHEMBL1017485";"F";"Cytotoxicity against human EH118MG cells after 3 days by trypan blue exclusion technique";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1158984";"1800632";"10.1021/np50077a010";"1991";"J Nat Prod";"54";"1298";"1302";"";"";"";"";"";""
"CHEMBL981349";"F";"Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL4772205";"T";"Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human U-87 MG cells";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL4772206";"T";"Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human A549 cells";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL707528";"F";"The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against the L1210 murine cell lines after 72 hours";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123889";"3625714";"10.1021/jm00392a029";"1987";"J Med Chem";"30";"1686";"1688";"";"";"";"";"";""
"CHEMBL1697801";"A";"FDA HLAED, lactate dehydrogenase (LDH) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL652997";"F";"Inhibition of cellular DNA synthesis in BSCL cells at the dose of 1.4 ug/mL.";"Cercopithecidae";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9527";"";"";"BSC-1";"";"CHEMBL1122461";"6298419";"10.1021/jm00355a007";"1983";"J Med Chem";"26";"30";"34";"";"";"";"";"";""
"CHEMBL700257";"F";"Effect of compound on erythroid differentiation of K562 cells was determined after a period of 9 days at concentration 500 nM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1131873";"10560743";"10.1016/s0960-894x(99)00547-8";"1999";"Bioorg Med Chem Lett";"9";"3153";"3158";"";"";"";"";"";""
"CHEMBL1647299";"F";"Cytotoxicity against human KB cells assessed as inhibition of protein biosynthesis";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1641486";"21194944";"10.1016/j.bmcl.2010.11.127";"2011";"Bioorg Med Chem Lett";"21";"723";"726";"";"";"";"";"";""
"CHEMBL743098";"F";"Long time survivors are the number mice that survived for >60 days relative to the number of treated mice at 50 mg/kg; 0 / 5";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL657234";"B";"Rate of deamination was determined against deaminase purified from human acute myeloblastic leukemia cells";"Homo sapiens";"3";"3";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1123554";"2822932";"10.1021/jm00394a039";"1987";"J Med Chem";"30";"2154";"2157";"";"";"";"";"";""
"CHEMBL742652";"F";"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 500 mg/kg; Value represented as Test/Control = 9/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL702618";"F";"Antitumor activity against the ip implanted L1210 leukemia in mice expressed as optimal dose (1 qd treatment schedule) required to produce greatest increase in life span was determined";"Mus musculus";"9";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL758686";"F";"Effective dose to inhibit the replication of P388 cell line in vitro.";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125248";"1995894";"10.1021/jm00106a034";"1991";"J Med Chem";"34";"693";"701";"";"";"";"";"";""
"CHEMBL729753";"F";"Median survival time expressed as (T/C) was measured at dose of 10 mg/kg/day *5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL1102063";"F";"Cytotoxicity against mouse L1210 cells after 2 days";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1153735";"19910080";"10.1016/j.ejmech.2009.10.032";"2010";"Eur J Med Chem";"45";"831";"839";"";"";"";"";"";""
"CHEMBL2363793";"F";"SANGER: Inhibition of human TE-5 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363204";"F";"SANGER: Inhibition of human EFO-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EFO-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363782";"F";"SANGER: Inhibition of human CAL-39 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-39";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363719";"F";"SANGER: Inhibition of human A101D cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A101D";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363754";"F";"SANGER: Inhibition of human BEN cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BEN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363496";"F";"SANGER: Inhibition of human NCI-H1975 cell growth in a cell viability assay.";"Homo sapiens";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1975";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363421";"F";"SANGER: Inhibition of human MFM-223 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MFM-223";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363545";"F";"SANGER: Inhibition of human NCI-H727 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H727";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363273";"F";"SANGER: Inhibition of human HDLM-2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HDLM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363480";"F";"SANGER: Inhibition of human NCI-H1648 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1648";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363562";"F";"SANGER: Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NTERA-2-cl-D1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363631";"F";"SANGER: Inhibition of human SF268 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-268";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363224";"F";"SANGER: Inhibition of human EW-16 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-16";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363553";"F";"SANGER: Inhibition of human NCI-SNU-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420582";"F";"Ratio of cytotoxic IC50 for human THP1 cells with constitutively expressing high SAMHD1 expression to cytotoxic IC50 for parental human THP1 cells expressing low SAMHD1 expression";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL770524";"F";"Concentration required to reduce protein synthesis in primary rabbit kidney cells usingi [3H2-4,5]leucine incorporation";"Oryctolagus cuniculus";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9986";"";"";"kidney";"";"CHEMBL1123394";"3950905";"10.1021/jm00152a007";"1986";"J Med Chem";"29";"203";"213";"";"";"";"";"";""
"CHEMBL743884";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1909307";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909315";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL3252706";"F";"Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 1 uM after 6 days by [3H]thymidine incorporation method relative to control";"Rattus norvegicus";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"T-cell";"";"CHEMBL3244180";"209191";"10.1021/jm00205a025";"1978";"J Med Chem";"21";"706";"709";"";"";"";"";"";""
"CHEMBL3299591";"F";"Cytotoxicity against human T47D cells by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T47D";"";"CHEMBL3297674";"24956556";"10.1016/j.ejmech.2014.06.031";"2014";"Eur J Med Chem";"83";"208";"225";"";"";"";"";"";""
"CHEMBL687280";"F";"The cytotoxic activity in HL-60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1130401";"9371251";"10.1021/jm9602322";"1997";"J Med Chem";"40";"3851";"3857";"";"";"";"";"";""
"CHEMBL1738197";"F";"PUBCHEM_BIOASSAY: Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029]";"Homo sapiens";"168";"168";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Jurkat";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1918586";"F";"Cytotoxicity against human MCF7 cells assessed as cell survival after 72 hrs by sulforhodamine B colorimetric assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1914360";"21945463";"10.1016/j.bmc.2011.08.069";"2011";"Bioorg Med Chem";"19";"6375";"6382";"";"";"";"";"";""
"CHEMBL981352";"F";"Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL957686";"F";"Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells after 6 days";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1153870";"18571290";"10.1016/j.ejmech.2008.05.001";"2009";"Eur J Med Chem";"44";"745";"754";"";"";"";"";"";""
"CHEMBL854867";"A";"Distribution of araCTP in Swiss Webster mouse liver at 100 mg/kg, ip measured as AUC (0-4h)";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Swiss Webster";"Scientific Literature";"10090";"CHEMBL3559723";"Liver";"";"";"CHEMBL1138220";"17181153";"10.1021/jm0607449";"2006";"J Med Chem";"49";"7711";"7720";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL743044";"F";"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 250 mg/kg; Value represented as Test/Control = 13/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1738402";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) ";"Homo sapiens";"582";"656";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738043";"F";"PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489029]";"";"168";"168";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3538240";"A";"Drug metabolism assessed as intrinsic clearance for human recombinant N-terminal His-tagged wild type DCK-mediated cytosine-beta-D-arabinofuranoside-5'-MP formation expressed in Escherichia coli BL21(DE3) incubated for 3 mins by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL1738599";"F";"PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489019, AID489029]";"";"168";"168";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1820600";"F";"Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL882027";"F";"In vitro cytotoxicity was evaluated against lung NCI-H23 cells; 1 x 10E1";"Mus sp.";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10095";"";"";"NCI-H23";"";"CHEMBL1133006";"10780904";"10.1021/jm990417j";"2000";"J Med Chem";"43";"1484";"1488";"";"";"";"";"";""
"CHEMBL1964055";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ";"";"251";"251";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909134";"B";"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909086";"B";"DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909118";"B";"DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HUVEC";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3232582";"F";"Antiviral activity against Vaccinia virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically";"Vaccinia virus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10245";"";"";"KB ";"";"CHEMBL3227966";"458802";"10.1021/jm00191a011";"1979";"J Med Chem";"22";"514";"518";"";"";"";"";"";""
"CHEMBL765756";"F";"Tested in vitro against QG-95 human squamous cell carcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"QG-95";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL702615";"F";"Antitumor activity against the ic implanted L1210 lymphoid leukemia in mice expressed as optimal dose (1-9qd treatment schedule) required to produce greatest increase in life span was determined";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL1909190";"B";"DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909158";"B";"DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909114";"B";"DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909174";"B";"DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL743095";"F";"Long time survivors are the number mice that survived for >60 days relative to the number of treated mice at 75 mg/kg; 0 / 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:75.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL1909196";"B";"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"Rheumatoid synovial fibroblasts";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909090";"B";"DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909128";"B";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2071972";"A";"Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH";"Homo sapiens";"221";"221";"BAO_0000251";"microsome format";"2";"2 - Target assigned is subcellular fraction";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"Microsome";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL2114788";"F";"PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ";"Homo sapiens";"103470";"103901";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL736675";"F";"Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL737231";"F";"Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL733941";"F";"Average survival time includes only those mice that died prior to day 60 at 25 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL742270";"T";"Toxicity in mice after 12-13 days at a dose of 100 mg/kg/day; 12/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL814170";"F";"In vitro inhibitory activity against Human esophagus adenocarcinoma (TE-2) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"TE-2";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL743097";"F";"Long time survivors are the number mice that survived for >60 days relative to the number of treated mice 25 mg/kg; 0 / 5";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL745457";"F";"Ratio of survival time of treated to control mice at 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL1810512";"F";"Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay";"Mus musculus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL3541970";"A";"Activity of human recombinant N-terminal His-SUMO fused CDA Lys27Gln mutant expressed in Escherichia coli BL21(DE3) cells assessed as intrinsic clearance for arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"P32320";"K27N"
"CHEMBL1013705";"F";"Antiviral activity against Hepatitis C virus infected human 2209-23 cells by genotype 1b replicon assay";"Hepatitis C virus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11103";"";"";"2209-23";"";"CHEMBL1139326";"19055482";"10.1021/jm800981y";"2009";"J Med Chem";"52";"219";"223";"";"";"";"";"";""
"CHEMBL1013706";"A";"Cytotoxicity against human 2209-23 cells by WST1 cell ciability assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"WST1";"";"CHEMBL1139326";"19055482";"10.1021/jm800981y";"2009";"J Med Chem";"52";"219";"223";"";"";"";"";"";""
"CHEMBL4028921";"A";"Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay";"Homo sapiens";"629";"629";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL3538239";"A";"Drug metabolism assessed as intrinsic clearance for human recombinant N-terminal His-tagged DCK Ala119Gly mutant-mediated cytosine-beta-D-arabinofuranoside-5'-MP formation expressed in Escherichia coli BL21(DE3) incubated for 3 mins by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL744535";"F";"Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 60 mg/kg/day (qd=1-9)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL1217004";"F";"Antimicrobial activity against Trichomonas vaginalis";"Trichomonas vaginalis";"244";"244";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5722";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL1217010";"F";"Antimicrobial activity against Leishmania infantum";"Leishmania infantum";"273";"273";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5671";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL745286";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL741974";"F";"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 100 mg/kg; Value represented as Test/Control = 16/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4432285";"F";"Cytotoxicity against human KB cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL1217002";"F";"Antimicrobial activity against Leishmania";"Leishmania";"207";"207";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5658";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL707114";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 156 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:156.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL656080";"F";"In vitro cytotoxicity of compounds were determined on Inhibition of human leukemia cell line(CCRF-CEM). ";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1129397";"8917645";"10.1021/jm9603680";"1996";"J Med Chem";"39";"4569";"4575";"";"";"";"";"";""
"CHEMBL633721";"P";"Partition coefficient (logP)";"";"9";"9";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1122587";"6699880";"10.1021/jm00369a019";"1984";"J Med Chem";"27";"347";"357";"";"";"";"";"";""
"CHEMBL702177";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by range in survival days at 200 mg/kg (treatment of 1-5qd schedule) dosage; Range is 15-17";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL758404";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by change in tumor weight at 200 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL705245";"F";"Antitumor activity against ic implanted L1210 lymphoid leukemia in mice expressed as active dose range (1-9qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 100-300";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL729672";"F";"Change in weight of mouse on day 8 was measured in L1210 lymphoid leukemia inoculated mice after ip administration at dose of 40 mg/kg/day X5";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL720522";"F";"Percent increase in life span calculated as (T/C-1)X100 at a dose of 20 mg/kg/day X5";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL729825";"F";"In vivo antitumor activity against intraperitoneally inoculated L1210 Lymphoid leukemic mice (Dose producing greatest increase in life span, treatment schedule is 1- 9 qd)";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL703887";"F";"Compound was tested for percent increase in life span against L1210 lymphoid leukemia";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123674";"3806615";"10.1021/jm00385a016";"1987";"J Med Chem";"30";"340";"347";"";"";"";"";"";""
"CHEMBL742542";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL738727";"F";"Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL742019";"F";"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 100 mg/kg; Value represented as Test/Control = 7/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL743774";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL700750";"F";"In vitro inhibitory activity against Human gastric carcinoma (KATO III) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KATO III stomach cancer cell line";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL691710";"F";"Inhibition of viral DNA synthesis in HSV-1 virus at the dose of 1.4 ug/mL.";"Human herpesvirus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"";"";"";"";"CHEMBL1122461";"6298419";"10.1021/jm00355a007";"1983";"J Med Chem";"26";"30";"34";"";"";"";"";"";""
"CHEMBL1041589";"F";"Cytotoxicity against deoxynucleoside analogue-resistant human MCF7 1K cells overexpressing ribonucleotide reductase after 3 days by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL1102065";"F";"Cytotoxicity against human CEM cells after 2 days";"Homo sapiens";"16";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1153735";"19910080";"10.1016/j.ejmech.2009.10.032";"2010";"Eur J Med Chem";"45";"831";"839";"";"";"";"";"";""
"CHEMBL694103";"F";"In vitro inhibitory effect measured against human osteosarcoma SAOS-2 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SAOS-2";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL760569";"F";"Antitumor activity against the ip implanted P388 leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL659398";"F";"Compound was tested for the inhibition of CML/BC(chronic myeloid leukemia, blast crisis)";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CML/BC";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL735646";"F";"Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL694686";"F";"In vitro inhibitory effect measured against human osteosarcoma SK-ES-1 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-ES1";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL699945";"F";"The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against KB human cell lines after 72 hr";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1123889";"3625714";"10.1021/jm00392a029";"1987";"J Med Chem";"30";"1686";"1688";"";"";"";"";"";""
"CHEMBL1055751";"F";"Cytotoxicity against human CCRF-CEM cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL1055752";"F";"Cytotoxicity against human CCRF-CEM/C2 cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL1059100";"F";"Cytotoxicity in human H441 cells at 2 uM after 72 hrs by trypan blue cell exclusion assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H441";"";"CHEMBL1154024";"19574048";"10.1016/j.bmcl.2009.06.056";"2009";"Bioorg Med Chem Lett";"19";"4764";"4767";"";"";"";"";"";""
"CHEMBL758638";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by range in survival days at 200 mg/kg (treatment of 1-5qd schedule) dosage; Range is 22-24";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL698911";"F";"In vitro inhibitory effect measured against human osteosarcoma MG-63 tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MG-63";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL690288";"F";"In vitro concentration required to induce apoptosis in HL60R cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL701092";"F";"Effect of compound on erythroid differentiation of K562 cells was determined after a period of 5 days at concentration 500 nM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1131873";"10560743";"10.1016/s0960-894x(99)00547-8";"1999";"Bioorg Med Chem Lett";"9";"3153";"3158";"";"";"";"";"";""
"CHEMBL735645";"F";"Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL855499";"F";"Ratio of AUC for araCTP level in liver to plasma of Swiss Webster mouse";"Mus musculus";"3";"3";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"Swiss Webster";"Scientific Literature";"10090";"CHEMBL3559723";"Liver";"";"";"CHEMBL1138220";"17181153";"10.1021/jm0607449";"2006";"J Med Chem";"49";"7711";"7720";"";"";"";"";"";""
"CHEMBL770523";"F";"Concentration required to reduce RNA synthesis in primary rabbit kidney cells using [3H-5]-Urd incorporation";"Oryctolagus cuniculus";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9986";"";"";"kidney";"";"CHEMBL1123394";"3950905";"10.1021/jm00152a007";"1986";"J Med Chem";"29";"203";"213";"";"";"";"";"";""
"CHEMBL703725";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 93 mg/kg dose (post inoculation life span, days)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:93.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL745456";"F";"Ratio of survival time of treated to control mice at 25 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL1614433";"F";"PUBCHEM_BIOASSAY: Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV. (Class of assay: confirmatory) [Related pubchem assays: 1705, 1707 ]";"Escherichia coli";"423";"425";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"562";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL657627";"F";"Inhibit the replication of CCRF-CEM cell line in vitro.";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1125248";"1995894";"10.1021/jm00106a034";"1991";"J Med Chem";"34";"693";"701";"";"";"";"";"";""
"CHEMBL681014";"F";"Compound was tested for the inhibition of glioblastoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Glioblastoma cell line";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL812944";"F";"Compound was evaluated for its antiproliferative activity on human T-lymphocyte Molt4/C8 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1129846";"None";"10.1016/S0960-894X(97)00044-9";"1997";"Bioorg Med Chem Lett";"7";"473";"478";"";"";"";"";"";""
"CHEMBL695997";"F";"In vitro inhibitory effect measured against human osteosarcoma HOS tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HOS";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL696463";"F";"In vitro inhibitory effect measured against human stomach adenocarcinoma NUGC-4 tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NUGC-4";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL742967";"F";"No of survivors after 45 days at a dose of 60 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL697856";"F";"In vitro inhibitory effect measured against human osteosarcoma U20-S tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U2OS";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL698909";"F";"In vitro inhibitory effect measured against human malignant fibrous histiocytoma MFH-ST tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MFH-ST";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL699064";"F";"Tested in vitro against HT1080 cell line human fibrosarcoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-1080";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL745292";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL761205";"F";"Concentration required for 50% inhibition of human lung squamous cell carcinoma PC10 solid cell lines. ";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC10";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL919717";"F";"Growth inhibition of human KB cells by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1144504";"17049252";"10.1016/j.bmc.2006.09.063";"2007";"Bioorg Med Chem";"15";"242";"256";"";"";"";"";"";""
"CHEMBL720527";"F";"Percent increase in life span in mice bearing lymphoid leukemia, treatment schedule is 1-9 qd.";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL744528";"F";"Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 100 mg/kg/day (qd=1,5,9)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL742961";"F";"No of survivors after 45 days at a dose of 100 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL718517";"F";"Number of animals survived after 30-days in mice bearing lymphoid leukemia, treatment schedule is 1-9 qd.";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL2150110";"F";"Ratio of IC50 for human CCRF-CEM/VM-1-5 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL1225710";"F";"Antitumor activity against mouse S180 cells transplanted in ICR mouse assessed as inhibition of tumor weight at 0.89 umol/kg, ip";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1221334";"20692841";"10.1016/j.bmc.2010.07.043";"2010";"Bioorg Med Chem";"18";"6220";"6229";"";"";"";"";"";""
"CHEMBL1225705";"F";"Cytotoxicity against human Bel7402 cells after 24 hrs by MTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Bel-7402";"";"CHEMBL1221334";"20692841";"10.1016/j.bmc.2010.07.043";"2010";"Bioorg Med Chem";"18";"6220";"6229";"";"";"";"";"";""
"CHEMBL1217005";"F";"Antimicrobial activity against Toxoplasma gondii";"Toxoplasma gondii";"232";"233";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5811";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL747525";"F";"Survival time treated / survival time (T/C) for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 5;10/7";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1738184";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]";"Homo sapiens";"77876";"78260";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3257010";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 6.25 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:6.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1697797";"A";"FDA HLAED, liver enzyme composite activity";"Homo sapiens";"486";"1470";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1697780";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents";"";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL1013707";"F";"Antiproliferative activity against human 2209-23 cells by [3H]thymidine incorporation scintillation proximity assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"2209-23";"";"CHEMBL1139326";"19055482";"10.1021/jm800981y";"2009";"J Med Chem";"52";"219";"223";"";"";"";"";"";""
"CHEMBL987365";"F";"Antimicrobial activity against Streptococcus sp. 07686-2 after 20 hrs";"Streptococcus sp.";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1306";"";"";"";"";"CHEMBL1155163";"17526755";"10.1128/aac.00081-07";"2007";"Antimicrob Agents Chemother";"51";"2726";"2732";"";"";"";"";"";""
"CHEMBL987366";"F";"Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 20 hrs";"Staphylococcus aureus";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1280";"";"";"";"";"CHEMBL1155163";"17526755";"10.1128/aac.00081-07";"2007";"Antimicrob Agents Chemother";"51";"2726";"2732";"";"";"";"";"";""
"CHEMBL4432292";"U";"Selectivity index, ratio of IC50 for HDF to IC50 for human MCF7 cells";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL736522";"F";"Increase of life span was determined against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 200 mg/kg per day after treatment 1-5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL712032";"F";"Inhibitory concentration on multidrug-resistant L1210 leukemia cells.";"Mus musculus";"18";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125271";"1906107";"10.1021/jm00111a004";"1991";"J Med Chem";"34";"1947";"1951";"";"";"";"";"";""
"CHEMBL992584";"F";"Growth inhibition of human KB cells by MTT method";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1142473";"18819815";"10.1016/j.bmc.2008.09.022";"2008";"Bioorg Med Chem";"16";"9161";"9170";"";"";"";"";"";""
"CHEMBL742018";"F";"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 1000 mg/kg; Value represented as Test/Control = 8/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL743180";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL736826";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 468 mg/kg";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:468.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1053108";"F";"Cytotoxicity against human SNU638 cells by sulforhodamine B method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-638";"";"CHEMBL1152442";"19691349";"10.1021/jm900852b";"2009";"J Med Chem";"52";"5303";"5306";"";"";"";"";"";""
"CHEMBL1909087";"B";"DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909160";"B";"DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909180";"B";"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909100";"B";"DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909106";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909200";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909104";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909197";"B";"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909201";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909210";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909202";"B";"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909150";"B";"DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa S3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909152";"B";"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2076870";"F";"TP_TRANSPORTER: uptake in Xenopus laevis oocytes";"Xenopus laevis";"3";"3";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"8355";"";"";"Oocyte";"";"CHEMBL2074159";"10825466";"10.1016/s0006-2952(00)00334-8";"2000";"Biochem Pharmacol";"60";"215";"219";"";"";"";"";"";""
"CHEMBL4432286";"F";"Cytotoxicity against human MCF7 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL2363191";"F";"SANGER: Inhibition of human Daoy cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Daoy";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363207";"F";"SANGER: Inhibition of human EKVX cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EKVX ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363339";"F";"SANGER: Inhibition of human KMOE-2 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KMOE-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363445";"F";"SANGER: Inhibition of human MZ1-PC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MZ1-PC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363561";"F";"SANGER: Inhibition of human NOS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NOS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363265";"F";"SANGER: Inhibition of human HCC2998 cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC 2998";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363409";"F";"SANGER: Inhibition of human MDA-MB-361 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-361";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363396";"F";"SANGER: Inhibition of human LU-99A cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-99A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363600";"F";"SANGER: Inhibition of human RH-18 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RH-18";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363635";"F";"SANGER: Inhibition of human SHP-77 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SHP-77";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363334";"F";"SANGER: Inhibition of human KGN cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KGN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL757452";"F";"Antitumor activity against ip implanted P388 leukemia in mice expressed as active dose range (1-5qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 20-200";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL705244";"F";"Antitumor activity against ic implanted L1210 lymphoid leukemia in mice expressed as active dose range (1-5qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 50-300";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL703526";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by change in tumor weight at 100 mg/kg (treatment of 1-9qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL744533";"F";"Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 60 mg/kg/day (qd=1-15)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL2363446";"F";"SANGER: Inhibition of human MZ2-MEL cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MZ2-MEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL710262";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 5 mg/kg/day x 5 was determined as Survival time in days; Range is 9-22 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL2363540";"F";"SANGER: Inhibition of human NCI-H661 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H661";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214913";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ";"";"4591";"5133";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363377";"F";"SANGER: Inhibition of human LC-2-ad cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LC-2-ad";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363414";"F";"SANGER: Inhibition of human MEG-01 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MEG-01";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363235";"F";"SANGER: Inhibition of human G-402 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"G-402";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL697063";"F";"In vitro inhibitory effect measured against human lung large-cell carcinoma PC-13 tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-13";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL3562085";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL741865";"F";"Anticancer activity carried out in vitro against murine leukemia L1210";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1134486";"11356110";"10.1021/jm0004446";"2001";"J Med Chem";"44";"1749";"1757";"";"";"";"";"";""
"CHEMBL4155624";"F";"Growth inhibition of human SMMC7721 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL857658";"F";"Antiviral activity against Para influenza virus type 3 strain C243 was evaluated in african green monkey kidney";"para influenza virus type 3";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11309";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL2363258";"F";"SANGER: Inhibition of human HCC1569 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1569";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363226";"F";"SANGER: Inhibition of human EW-22 cell growth in a cell viability assay.";"Homo sapiens";"76";"76";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-22";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363264";"F";"SANGER: Inhibition of human HCC2218 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC2218";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363788";"F";"SANGER: Inhibition of human TE-10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363679";"F";"SANGER: Inhibition of human SW1417 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1417";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363301";"F";"SANGER: Inhibition of human HuCCT1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuCCT1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363812";"F";"SANGER: Inhibition of human U031 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UO-31";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363634";"F";"SANGER: Inhibition of human SH-4 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SH-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363278";"F";"SANGER: Inhibition of human HL-60 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HL-60";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363139";"F";"SANGER: Inhibition of human COLO-792 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-792";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363734";"F";"SANGER: Inhibition of human A704 cell growth in a cell viability assay.";"Homo sapiens";"117";"118";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A704";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL705942";"F";"Concentration required to inhibit replication of L1210 cell lines by 50% after 72 hr incubation";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"";"";"";"";"";""
"CHEMBL2150104";"F";"Ratio of IC50 for human HL60/ADR cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL1909314";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL742966";"F";"No of survivors after 45 days at a dose of 60 mg/kg/day";"Mus musculus";"1";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL2363613";"F";"SANGER: Inhibition of human RT-112 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RT-112";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363833";"F";"SANGER: Inhibition of human CAPAN-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAPAN-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363210";"F";"SANGER: Inhibition of human ES1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363211";"F";"SANGER: Inhibition of human ES3 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363167";"F";"SANGER: Inhibition of human D-283MED cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D283 Med";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363725";"F";"SANGER: Inhibition of human A3-KAW cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A3-KAW";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363544";"F";"SANGER: Inhibition of human NCI-H720 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H720";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363726";"F";"SANGER: Inhibition of human A375 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A-375";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363839";"F";"SANGER: Inhibition of human CGTH-W-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CGTH-W-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363831";"F";"SANGER: Inhibition of human no-11 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"no-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363568";"F";"SANGER: Inhibition of human OCI-AML2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OCI-AML2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2150106";"F";"Ratio of IC50 for doxorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL1614317";"F";"PUBCHEM_BIOASSAY: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis. (Class of assay: confirmatory) ";"";"1237";"1237";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4155963";"F";"Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL4152304";"29906687";"10.1016/j.ejmech.2018.06.003";"2018";"Eur J Med Chem";"155";"406";"417";"";"";"";"";"";""
"CHEMBL3078120";"F";"Cytotoxicity against Homo sapiens (human) U937 cells assessed as growth inhibition at 2 ug/ml after 24 hr by MTT assay relative to untreated control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL3045269";"None";"10.1007/s00044-012-0001-6";"2013";"Med Chem Res";"22";"22";"27";"";"";"";"";"";""
"CHEMBL1014840";"F";"Cytotoxicity against human TMOLT3 cells after 3 days by trypan blue exclusion technique";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-3";"";"CHEMBL1158984";"1800632";"10.1021/np50077a010";"1991";"J Nat Prod";"54";"1298";"1302";"";"";"";"";"";""
"CHEMBL2428707";"F";"Cytotoxicity against human HeLa cells after 72 hrs by SRB assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2424525";"23867603";"10.1016/j.ejmech.2013.06.047";"2013";"Eur J Med Chem";"67";"188";"195";"";"";"";"";"";""
"CHEMBL744531";"F";"Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 200 mg/kg/day (qd=1)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL741765";"T";"Toxicity in mice after 17-21 days at a dose of 60 mg/kg/day; 21/8.5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL695272";"F";"Compound was tested for the inhibition of human HL60 Leukemia";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL736683";"F";"Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL880070";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL2382975";"F";"Cytotoxicity against human MA9.3 cells after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2380239";"23578690";"10.1016/j.bmcl.2013.03.048";"2013";"Bioorg Med Chem Lett";"23";"2951";"2954";"";"";"";"";"";""
"CHEMBL2071963";"A";"Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins";"Homo sapiens";"221";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL1794355";"F";"PUBCHEM_BIOASSAY: Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504586]";"";"304";"304";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL742964";"F";"No of survivors after 45 days at a dose of 200 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL743186";"F";"Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C II) (qd 1-5)";"Mus musculus";"2";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL707718";"F";"Tested in vitro against MKN-45 human stomach adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638185";"Stomach";"MKN-45";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL730606";"F";"Change in weight in mice bearing ip-implanted L1210 lymphoid leukemia on day 8 at 200 mg/kg or 822 umol/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL1909204";"B";"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909147";"B";"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909144";"B";"DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL819108";"B";"Inhibitory concentration against Varicella- zoster virus thymidine kinase(VZV TK)";"Human herpesvirus 3";"12";"12";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"10335";"";"";"";"";"CHEMBL1134069";"11392548";"10.1016/s0960-894x(01)00207-4";"2001";"Bioorg Med Chem Lett";"11";"1329";"1332";"";"";"";"";"";""
"CHEMBL919713";"F";"Growth inhibition of human NCI-H460 cells by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1144504";"17049252";"10.1016/j.bmc.2006.09.063";"2007";"Bioorg Med Chem";"15";"242";"256";"";"";"";"";"";""
"CHEMBL4155628";"A";"Growth inhibition of human LO2 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL1614221";"F";"PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]";"Plasmodium falciparum";"475";"477";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL755832";"F";"In vitro antitumor activity against P388 cell line in mice.";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL1614279";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]";"Trypanosoma brucei";"648";"649";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"185431";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1106342";"F";"Antitumor activity against human MCF7 cells after 24 hrs by MTT assay";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1156336";"20211564";"10.1016/j.bmc.2010.02.023";"2010";"Bioorg Med Chem";"18";"2704";"2712";"";"";"";"";"";""
"CHEMBL1106339";"F";"Antitumor activity against human MOLT4 cells after 24 hrs by MTT assay";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1156336";"20211564";"10.1016/j.bmc.2010.02.023";"2010";"Bioorg Med Chem";"18";"2704";"2712";"";"";"";"";"";""
"CHEMBL745276";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL679425";"F";"Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 1 uM (Cell number 1*10 e-4)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"G-401";"";"CHEMBL1127382";"7932594";"10.1021/jm00047a024";"1994";"J Med Chem";"37";"3668";"3670";"";"";"";"";"";""
"CHEMBL819111";"B";"Inhibitory concentration against cytosolic thymidine kinase (TK-1)";"Homo sapiens";"12";"12";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1134069";"11392548";"10.1016/s0960-894x(01)00207-4";"2001";"Bioorg Med Chem Lett";"11";"1329";"1332";"";"";"";"";"";""
"CHEMBL711141";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 1/7";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL803791";"F";"Effective dose to inhibit the replication of S180 cell line in vitro.";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1125248";"1995894";"10.1021/jm00106a034";"1991";"J Med Chem";"34";"693";"701";"";"";"";"";"";""
"CHEMBL1614550";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based HTS Dose Confirmation to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";"";"184";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL770522";"F";"Concentration required to reduce DNA synthesis in primary rabbit kidney cells using [3H-Methyl]-dThd incorporation";"Oryctolagus cuniculus";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9986";"";"";"kidney";"";"CHEMBL1123394";"3950905";"10.1021/jm00152a007";"1986";"J Med Chem";"29";"203";"213";"";"";"";"";"";""
"CHEMBL759722";"F";"In vitro inhibitory activity against Human lung small-cell carcinoma (PC-6) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-6";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL731006";"F";"Dose producing greatest increase in life span >/=25% in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd; 5-80 [mg(umol)/kg] /day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL728568";"F";"Dose producing greatest increase in life span >/=25% in mice bearing lymphoid leukemia, treatment schedule is 1-9 qd; 5-20 [mg(umol)/kg] /day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL723571";"F";"Median survival day of mice bearing lymphoid leukemia was determined, treatment schedule is 1-9 qd.; 25/10.5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL744518";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL736687";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL743770";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 200 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1738312";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391]";"Homo sapiens";"55525";"55724";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL709478";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined as Survival time in days; Range is 14-42 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL724308";"F";"Percent increase in life span of drug-treated mice relative to tumored, vehicle treated controls at a dose of 100 mg/kg oral treatment";"Mus musculus";"1";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125796";"1956046";"10.1021/jm00115a017";"1991";"J Med Chem";"34";"3280";"3284";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1059104";"F";"Cytotoxicity against human H441 cells by serum lactate dehydrogenase assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H441";"";"CHEMBL1154024";"19574048";"10.1016/j.bmcl.2009.06.056";"2009";"Bioorg Med Chem Lett";"19";"4764";"4767";"";"";"";"";"";""
"CHEMBL2354225";"F";"PubChem BioAssay. Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ";"";"32";"32";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2071967";"A";"Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins";"Homo sapiens";"221";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL707115";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 208 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:208.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL696461";"F";"In vitro inhibitory effect measured against human renal cell carcinoma NCC-nu tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCC";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL705481";"F";"Tested for in vitro cytotoxicity against KB human oral epidermoid carcinoma cell line";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL756469";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by 45-day survivors in mice at 200 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL731179";"F";"Median survival day of mice bearing lymphoid leukemia was determined, treatment schedule is 1-5 qd.; 15.5/9.5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL742965";"F";"No of survivors after 45 days at a dose of 300 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL746214";"F";"Survival time treated / survival time (T/C) for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 200 mg/kg per day after treatment 1-5;16/7";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL744515";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL744546";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL756732";"F";"The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against the P388 murine cell lines after 72 hours";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123889";"3625714";"10.1021/jm00392a029";"1987";"J Med Chem";"30";"1686";"1688";"";"";"";"";"";""
"CHEMBL1041583";"F";"Cytotoxicity against nucleoside transporter deficient and deoxynucleoside analogue-resistant human CEM/ARAC8C cells after 3 days by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CEM/ARAC8C";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL1106341";"F";"Antitumor activity against human SW620 cells after 24 hrs by MTT assay";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW-620";"";"CHEMBL1156336";"20211564";"10.1016/j.bmc.2010.02.023";"2010";"Bioorg Med Chem";"18";"2704";"2712";"";"";"";"";"";""
"CHEMBL804021";"F";"Concentration required for 50% inhibition of human lung squamous cell carcinoma SW 480 solid cell lines. ";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW480";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL3790096";"F";"Selectivity index, ratio of IC50 for HDF cells to IC50 for human MCF7 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL703724";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 34 mg/kg dose (post inoculation life span, days)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:34.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1053106";"F";"Cytotoxicity against human HCT116 cells by sulforhodamine B method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1152442";"19691349";"10.1021/jm900852b";"2009";"J Med Chem";"52";"5303";"5306";"";"";"";"";"";""
"CHEMBL4387672";"U";"Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human HepG2 cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL748523";"F";"Mean body weight change on 5th day at a dose of 100 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL2363567";"F";"SANGER: Inhibition of human OC-314 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OC-314";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1810804";"T";"Toxicity in ICR mouse xenografted with mouse S180 cells assessed as increase in body weight at 2 umol/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ICR";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL702186";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by range in survival days at 400 mg/kg (treatment of 1qd schedule) dosage; Range is 9-11";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:400.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL803889";"F";"In vitro inhibitory activity against Human colon adenocarcinoma (SW-480) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW480";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL1059211";"F";"Cytotoxicity against human HeLa cells after 48 hrs by MTT assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1153578";"19321234";"10.1016/j.ejmech.2009.02.028";"2009";"Eur J Med Chem";"44";"3596";"3600";"";"";"";"";"";""
"CHEMBL656083";"F";"In vitro inhibitory activity against Human T-cell acute lymphoblastoid leukemia (CCRF CEM) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL811354";"F";"In vitro inhibitory activity against Human bladder transitional-cell carcinoma (T-24) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T-24";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL1053109";"F";"Cytotoxicity against human T47D cells by sulforhodamine B method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T47D";"";"CHEMBL1152442";"19691349";"10.1021/jm900852b";"2009";"J Med Chem";"52";"5303";"5306";"";"";"";"";"";""
"CHEMBL872512";"F";"Concentration required for 50% inhibition of cell growth of K562 leukemic cell lines in human.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL700753";"F";"Concentration required for 50% inhibition of human lung squamous cell carcinoma KATO III solid cell lines. ";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KATO III stomach cancer cell line";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL1041587";"F";"Cytotoxicity against deoxycytidine kinase deficient and deoxynucleoside analogue-resistant human MESSA 10K cells after 3 days by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MESSA 10K";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL1964081";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ";"";"1025";"1028";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL707124";"F";"Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 9.2 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1216999";"F";"Antimicrobial activity against Trypanosoma brucei brucei";"Trypanosoma brucei brucei";"251";"251";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5702";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL1217013";"F";"Antimicrobial activity against Trypanosoma brucei rhodesiense";"Trypanosoma brucei rhodesiense";"232";"232";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"31286";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL1217007";"F";"Antimicrobial activity against Entamoeba histolytica";"Entamoeba histolytica";"304";"304";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5759";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL743179";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL810055";"B";"Phosphorylating activity of viral HSV -1 (KOS) induced thymidine kinase relative to dThdK was determined";"Human herpesvirus 1";"4";"4";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10298";"";"";"";"";"CHEMBL1123554";"2822932";"10.1021/jm00394a039";"1987";"J Med Chem";"30";"2154";"2157";"";"";"";"";"";""
"CHEMBL2363820";"F";"SANGER: Inhibition of human VA-ES-BJ cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"VA-ES-BJ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363571";"F";"SANGER: Inhibition of human OE33 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OE33";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363601";"F";"SANGER: Inhibition of human RKO cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RKO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363747";"F";"SANGER: Inhibition of human BB30-HNC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BB30-HNC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363843";"F";"SANGER: Inhibition of human CHP-212 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CHP-212";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363169";"F";"SANGER: Inhibition of human D-392MG cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-392MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363578";"F";"SANGER: Inhibition of human OVCAR-5 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1216998";"F";"Antimicrobial activity against Trypanosoma cruzi";"Trypanosoma cruzi";"269";"270";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5693";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL1697855";"A";"Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset";"";"484";"485";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1697821";"20020916";"10.1080/15376510701857262";"2008";"Toxicol Mech Methods";"18";"217";"227";"";"";"";"";"";""
"CHEMBL2363234";"F";"SANGER: Inhibition of human G-401 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"G-401";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL882655";"F";"Dose required to reduce primary rabbit kidney cell growth";"Oryctolagus cuniculus";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9986";"";"";"kidney";"";"CHEMBL1123394";"3950905";"10.1021/jm00152a007";"1986";"J Med Chem";"29";"203";"213";"";"";"";"";"";""
"CHEMBL1614293";"F";"PUBCHEM_BIOASSAY: High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells. (Class of assay: confirmatory) ";"Homo sapiens";"176";"176";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794308";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]";"Homo sapiens";"61908";"62243";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HEK293";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1041601";"F";"Resistance ratio of IC50 for deoxynucleoside analogue-resistant human MCF7 1K cells to IC50 for deoxynucleoside analogue-sensitive human MCF7 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL973960";"F";"Cytotoxicity against human HeLa S3 cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1144073";"10425135";"10.1021/np9805185";"1999";"J Nat Prod";"62";"1030";"1032";"";"";"";"";"";""
"CHEMBL987367";"F";"Antimicrobial activity against Staphylococcus aureus CCM 885 after 20 hrs";"Staphylococcus aureus";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1280";"";"";"";"";"CHEMBL1155163";"17526755";"10.1128/aac.00081-07";"2007";"Antimicrob Agents Chemother";"51";"2726";"2732";"";"";"";"";"";""
"CHEMBL953282";"F";"Antitumor activity against human CCRF-HSB2 cells by MTT assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-HSB-2";"";"CHEMBL1151793";"18723355";"10.1016/j.bmc.2008.07.089";"2008";"Bioorg Med Chem";"16";"8685";"8696";"";"";"";"";"";""
"CHEMBL3538244";"A";"Activity of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL3538237";"A";"Drug metabolism assessed as intrinsic clearance for cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins in presence of human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL737220";"F";"Percentage increase in life span after 9-12 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL1614544";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ";"Homo sapiens";"36150";"36356";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL734243";"F";"In vivo activity against transplanted Mam-16/C tumors of mice";"Mus musculus";"11";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL859316";"F";"In vivo activity against transplanted Mel-B16 tumors of mice";"Mus musculus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL649978";"F";"Concentration required for 50% inhibition of cell growth of CCRF CEM leukemic cell lines in human.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL1909116";"B";"DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909140";"B";"DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909207";"B";"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909189";"B";"DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HIT-T15";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL733942";"F";"Average survival time includes only those mice that died prior to day 60 at 50 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL987363";"F";"Antimicrobial activity against Streptococcus sp. 07941-1 after 20 hrs";"Streptococcus sp.";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1306";"";"";"";"";"CHEMBL1155163";"17526755";"10.1128/aac.00081-07";"2007";"Antimicrob Agents Chemother";"51";"2726";"2732";"";"";"";"";"";""
"CHEMBL987362";"F";"Antimicrobial activity against Escherichia coli ATCC 25922 after 20 hrs";"Escherichia coli";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL1155163";"17526755";"10.1128/aac.00081-07";"2007";"Antimicrob Agents Chemother";"51";"2726";"2732";"";"";"";"";"";""
"CHEMBL1810516";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 8.9 umol/kg, ip administered 1 day after tumor inoculation qd for 7 days";"Mus musculus";"22";"22";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL705897";"F";"Tested in vitro against MCF-7 human breast adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL741866";"F";"Inhibitory activity against murine leukemia L1210 cells";"Mus musculus";"41";"41";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125745";"1992143";"10.1021/jm00105a064";"1991";"J Med Chem";"34";"421";"429";"";"";"";"";"";""
"CHEMBL1794424";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771]";"";"30566";"30997";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2212310";"F";"Antitumor activity against human BxPC3 cells xenografted in SCID mouse assessed as tumor growth inhibition at 10 mg/kg, ip administered 5 times a week for one cycle relative to control";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"BXPC-3";"";"CHEMBL2202989";"23094992";"10.1021/jm3013008";"2012";"J Med Chem";"55";"10241";"10261";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL3541979";"A";"Ratio of Km for human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells to Km for human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL992583";"F";"Growth inhibition of human CCRF-HSB-2 cells by MTT method";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-HSB-2";"";"CHEMBL1142473";"18819815";"10.1016/j.bmc.2008.09.022";"2008";"Bioorg Med Chem";"16";"9161";"9170";"";"";"";"";"";""
"CHEMBL1014844";"F";"Cytotoxicity against human MB9812 cells after 3 days by trypan blue exclusion technique";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MB9812";"";"CHEMBL1158984";"1800632";"10.1021/np50077a010";"1991";"J Nat Prod";"54";"1298";"1302";"";"";"";"";"";""
"CHEMBL3039488";"A";"Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM";"Cricetulus griseus";"1862";"1865";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3039007";"23571415";"10.1124/mol.112.084152";"2013";"Mol Pharmacol";"83";"1257";"1267";"";"";"";"";"";""
"CHEMBL2363744";"F";"SANGER: Inhibition of human AU565 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AU565";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363174";"F";"SANGER: Inhibition of human DB cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363225";"F";"SANGER: Inhibition of human EW-18 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-18";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363371";"F";"SANGER: Inhibition of human LB373-MEL-D cell growth in a cell viability assay.";"Homo sapiens";"117";"119";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB373-MEL-D";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363247";"F";"SANGER: Inhibition of human GR-ST cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GR-ST";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL761060";"F";"In vitro inhibitory activity against Human lung squamous cell carcinoma (PC-10) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC10";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL757832";"F";"In vitro inhibitory activity against Human melanoma (P-36) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-MEL-28";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL4387662";"F";"Cytotoxicity in human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL2363509";"F";"SANGER: Inhibition of human NCI-H2170 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2170";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363658";"F";"SANGER: Inhibition of human SK-OV-3 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-OV-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL743176";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1041600";"F";"Resistance ratio of IC50 for deoxynucleoside analogue-resistant human MESSA 10K cells to IC50 for deoxynucleoside analogue-sensitive human MESSA cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL1909091";"B";"DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697799";"A";"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL654283";"F";"Concentration required to inhibit replication of CCRF-CEM cell lines by 50% after 72 hr incubation";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"";"";"";"";"";""
"CHEMBL689641";"F";"In vitro concentration required to induce apoptosis in HL60 cells";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL1909187";"B";"DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909103";"B";"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909123";"B";"DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Erythrocyte";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL734252";"F";"In vivo activity against transplanted colon-38 tumors of mice";"Mus musculus";"11";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1909157";"B";"DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1043046";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as inhibition of tumor growth at 89 umol/kg, ip administered 24 hrs after tumor implantation once daily for 7 consecutive days measured after 24 hrs last post dose";"Mus musculus";"17";"17";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1154089";"19535177";"10.1016/j.ejmech.2009.05.006";"2009";"Eur J Med Chem";"44";"4153";"4161";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL1909167";"B";"DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909175";"B";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"SK-N-MC";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL729383";"F";"In vivo activity against iv transplanted AML Leukemia 1498 tumors of mice";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1014842";"F";"Cytotoxicity against human SW480 cells after 3 days by trypan blue exclusion technique";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW480";"";"CHEMBL1158984";"1800632";"10.1021/np50077a010";"1991";"J Nat Prod";"54";"1298";"1302";"";"";"";"";"";""
"CHEMBL814175";"F";"Concentration required for 50% inhibition of human lung squamous cell carcinoma TE2 solid cell lines. ";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"TE-2";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL759532";"F";"The compound was tested for anticancer activity against P815 (sensitive) cell lines of mouse leukemia";"Mus musculus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P815";"";"CHEMBL1121538";"7420353";"10.1021/jm00184a006";"1980";"J Med Chem";"23";"1088";"1094";"";"";"";"";"";""
"CHEMBL711767";"F";"In vitro inhibitory effect on growth of human T-cell acute lymphoblastic leukemic MOLT 4 cell lines.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL906782";"F";"Antitumor activity against human KB cells by modified MTT assay";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1143758";"17644399";"10.1016/j.bmc.2007.06.058";"2007";"Bioorg Med Chem";"15";"6336";"6352";"";"";"";"";"";""
"CHEMBL721972";"F";"In vivo activity against transplanted Mam-16/C/ Taxol tumors of mice; Not active";"Mus musculus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL734249";"F";"In vivo activity against transplanted Panc-03 tumors of mice";"Mus musculus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL814174";"F";"In vitro inhibitory effect on growth of human esophagus adenocarcinoma cell lines (TE2).";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"TE-2";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL1004765";"F";"Antiviral activity against HSV2 MS infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTT assay";"Human herpesvirus 2";"11";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"MS";"Scientific Literature";"10310";"";"";"Vero";"";"CHEMBL1150133";"12444692";"10.1021/np020234r";"2002";"J Nat Prod";"65";"1649";"1656";"";"";"";"";"";""
"CHEMBL918058";"A";"Cytotoxicity against mouse L1210/0 cells after 48 hrs";"Mus musculus";"257";"258";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"L1210/0";"";"CHEMBL1142978";"17341060";"10.1021/jm061445m";"2007";"J Med Chem";"50";"1537";"1545";"";"";"";"";"";""
"CHEMBL701931";"F";"The compound was tested for anticancer activity against L5178Y (arc-C resistant) cell lines of mouse leukemia";"Mus musculus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL1121538";"7420353";"10.1021/jm00184a006";"1980";"J Med Chem";"23";"1088";"1094";"";"";"";"";"";""
"CHEMBL736825";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL739318";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL839847";"F";"Number of survivors in mice bearing ip-implanted L1210 lymphoid leukemia after 45 day";"Mus musculus";"12";"20";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL753722";"F";"Tested in vitro against OST human osteosarcoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OST";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL684637";"F";"Differentiating activity of compound in HL60 cells at conc 0.08 ug/mL";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1130401";"9371251";"10.1021/jm9602322";"1997";"J Med Chem";"40";"3851";"3857";"";"";"";"";"";""
"CHEMBL708741";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent increase in life span at 400 mg/kg (treatment of 1qd schedule) dosage";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:400.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL733505";"F";"Median T/C calculated based on survivors at 200 mg/kg (822 umol) per day against Ip-implanted L1210 lymphoid leukemia mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL824280";"F";"Antiviral activity against Vaccinia virus strain Elstree was evaluated in african green monkey kidney";"Vaccinia virus";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10245";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1122970";"2984417";"10.1021/jm00382a005";"1985";"J Med Chem";"28";"418";"422";"";"";"";"";"";""
"CHEMBL810945";"F";"In vitro inhibitory effect on growth of human bladder transitional-carcinoma cell lines (T24).";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T-24";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL876078";"F";"Effect on cross resistance of CHO cells resistant to colchicine (CHRC5)";"Cricetulus griseus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL698914";"F";"In vitro inhibitory effect measured against human stomach adenocarcinoma MKN-28 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MKN-28";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL3078117";"F";"Cytotoxicity against Homo sapiens (human) K562 cells assessed as growth inhibition at 2 ug/ml after 24 hr by MTT assay relative to untreated control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3045269";"None";"10.1007/s00044-012-0001-6";"2013";"Med Chem Res";"22";"22";"27";"";"";"";"";"";""
"CHEMBL4029350";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1909310";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909316";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909320";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909311";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909313";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL4028922";"A";"Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay";"Homo sapiens";"598";"598";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL4028923";"A";"Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay";"Homo sapiens";"629";"629";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL770692";"F";"Cytotoxicity against RPMI-6410 human leukemic lymphoblastoid cell lines";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RPMI 6410";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"";"";"";"";"";""
"CHEMBL687002";"F";"In vitro concentration required to induce apoptosis in HL60R cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL716139";"F";"Number of animals survived after 30-days in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.";"Mus musculus";"11";"11";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL1909319";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL762698";"F";"Concentration required for 50% inhibition of human lung squamous cell carcinoma PC14 solid cell lines. ";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-14";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL729761";"F";"Median survival time expressed as (T/C) was measured at dose of 40 mg/kg/day X5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL732991";"F";"Weight change observed on day 8 in mice bearing lymphoid leukemia, treatment schedule is 1-5 qd.";"Mus musculus";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL881731";"F";"Ratio of GI50 without hPAP/ GI50 with hPAP";"";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1133824";"11597404";"10.1016/s0960-894x(01)00513-3";"2001";"Bioorg Med Chem Lett";"11";"2803";"2805";"";"";"";"";"";""
"CHEMBL2354290";"F";"PubChem BioAssay. Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ";"";"47";"47";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3047252";"F";"Antitumor activity against Mus musculus (mouse) S180 cells xenografted in ICR Mus musculus (mouse) assessed as tumor growth inhibition at 89 umol/kg, ip qd for 7 days measured after 24 hr of last dose relative to control";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL3044617";"None";"10.1007/s00044-010-9504-1";"2012";"Med Chem Res";"21";"116";"123";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL1108963";"P";"Octanol-water partition coefficient, log P of the compound";"";"55";"55";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1157036";"20106561";"10.1016/j.ejmech.2009.12.043";"2010";"Eur J Med Chem";"45";"1639";"1647";"";"";"";"";"";""
"CHEMBL697965";"F";"In vitro inhibitory effect measured against human lung adenocarcinoma PC-9 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-9";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL810051";"B";"Inhibitory concentration against Herpes simplex virus type 1 thymidine kinase(HSV-1 TK)";"Herpes simplex virus (type 1 / strain SC16)";"13";"13";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10309";"";"";"";"";"CHEMBL1134069";"11392548";"10.1016/s0960-894x(01)00207-4";"2001";"Bioorg Med Chem Lett";"11";"1329";"1332";"";"";"";"";"";""
"CHEMBL807503";"F";"Tested in vitro against ST-KM human stomach adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638185";"Stomach";"ST-KM-1";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL720584";"F";"Percent increase in life span at 71 mg/kg (292 umol) per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:71.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL734242";"F";"In vivo activity against iv transplanted Leukemia L1210 tumors of mice";"Mus musculus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL761193";"F";"Tested in vitro against PC-8 human lung adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-8";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL1043049";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as decrease in tumor weight at 89 umol/kg, ip administered 24 hrs after tumor implantation once daily for 7 consecutive days measured after 24 hrs last post dose";"Mus musculus";"17";"17";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1154089";"19535177";"10.1016/j.ejmech.2009.05.006";"2009";"Eur J Med Chem";"44";"4153";"4161";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL981346";"F";"Antiproliferative activity against human HT-29 cells at 10 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL984102";"F";"Cytotoxicity against mouse L1210 cells at 0.15 ug/disk by corbett disk diffusion assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1147292";"2809606";"10.1021/np50064a011";"1989";"J Nat Prod";"52";"732";"739";"";"";"";"";"";""
"CHEMBL709281";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent increase in life span at 200 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL759382";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent increase in life span at 200 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL970839";"B";"Inhibition of pp60c-src";"";"1";"1";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1156703";"18055068";"10.1016/j.ejmech.2007.10.011";"2008";"Eur J Med Chem";"43";"1376";"1389";"";"";"";"";"";""
"CHEMBL2363393";"F";"SANGER: Inhibition of human LU-139 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-139";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363216";"F";"SANGER: Inhibition of human ES8 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363513";"F";"SANGER: Inhibition of human NCI-H2228 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2228";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363823";"F";"SANGER: Inhibition of human WM-115 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"WM-115";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363668";"F";"SANGER: Inhibition of human SNU-449 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-449";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363790";"F";"SANGER: Inhibition of human TE-12 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL759531";"F";"The compound was tested for anticancer activity against P815(arc-C resistant) cell lines of mouse leukemia";"Mus musculus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P815";"";"CHEMBL1121538";"7420353";"10.1021/jm00184a006";"1980";"J Med Chem";"23";"1088";"1094";"";"";"";"";"";""
"CHEMBL919714";"F";"Growth inhibition of human HCT116 cells by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1144504";"17049252";"10.1016/j.bmc.2006.09.063";"2007";"Bioorg Med Chem";"15";"242";"256";"";"";"";"";"";""
"CHEMBL919715";"F";"Growth inhibition of human A431 cells by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A-431";"";"CHEMBL1144504";"17049252";"10.1016/j.bmc.2006.09.063";"2007";"Bioorg Med Chem";"15";"242";"256";"";"";"";"";"";""
"CHEMBL3562088";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562112";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL710355";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined as percentage increase in the life span as compared with control tumor bearers";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL696160";"F";"The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against HeLa human cell lines after 144 hr";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1123889";"3625714";"10.1021/jm00392a029";"1987";"J Med Chem";"30";"1686";"1688";"";"";"";"";"";""
"CHEMBL1030634";"F";"Antiviral activity against HSV2 assessed as inhibition of virus-induced cytopathicity";"Human herpesvirus 2";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10310";"";"";"";"";"CHEMBL1136856";"19147352";"10.1016/j.bmcl.2008.12.103";"2009";"Bioorg Med Chem Lett";"19";"1126";"1128";"";"";"";"";"";""
"CHEMBL1810514";"F";"Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL652486";"F";"In vitro concentration required for 50% inhibition of growth of human leukemia cell line CCRF-CEM without hPAP (0.2 unit/mL)";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1133824";"11597404";"10.1016/s0960-894x(01)00513-3";"2001";"Bioorg Med Chem Lett";"11";"2803";"2805";"";"";"";"";"";""
"CHEMBL701734";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by range in survival days at 300 mg/kg (treatment of 1-5qd schedule) dosage; Range is 15-18";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:300.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL730609";"F";"Change in weight in mice bearing ip-implanted L1210 lymphoid leukemia on day 8 at 71 mg/kg or 292 umol/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:71.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL3214923";"F";"PubChem BioAssay. HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_CherryPick_Activity_Set3. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ";"";"237";"239";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL912074";"F";"Cytotoxicity against A549 cells after 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1147151";"17419604";"10.1021/jm0612923";"2007";"J Med Chem";"50";"2249";"2253";"";"";"";"";"";""
"CHEMBL912075";"F";"Cytotoxicity against SW1573 cells after 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW1573";"";"CHEMBL1147151";"17419604";"10.1021/jm0612923";"2007";"J Med Chem";"50";"2249";"2253";"";"";"";"";"";""
"CHEMBL2363309";"F";"SANGER: Inhibition of human IGROV-1 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IGROV-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363342";"F";"SANGER: Inhibition of human KNS-62 cell growth in a cell viability assay.";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KNS-62";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363408";"F";"SANGER: Inhibition of human MDA-MB-231 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-231";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363413";"F";"SANGER: Inhibition of human ME-180 cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ME-180";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363448";"F";"SANGER: Inhibition of human Mewo cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MeWo";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363483";"F";"SANGER: Inhibition of human NCI-H1666 cell growth in a cell viability assay.";"Homo sapiens";"58";"58";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1666";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562133";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3254088";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 50 mg/kg, ip qd administered for 5 days (Rvb = 9 days)";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3299592";"F";"Cytotoxicity against human PC3 cells by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3297674";"24956556";"10.1016/j.ejmech.2014.06.031";"2014";"Eur J Med Chem";"83";"208";"225";"";"";"";"";"";""
"CHEMBL734251";"F";"In vivo activity against transplanted colon-26 tumors of mice";"Mus musculus";"9";"9";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL742611";"F";"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 1000 mg/kg; Value represented as Test/Control = 15/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3284434";"F";"Antiviral activity against Vaccinia virus IHD infected in African green monkey BGM cells assessed as plaque reduction measured on day 5 by disk diffusion assay";"Vaccinia virus";"41";"41";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"IHD";"Scientific Literature";"10245";"";"";"BGM";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"";"";"";"";"";""
"CHEMBL3232587";"F";"Antiviral activity against Herpes simplex virus type 1 infected in Swiss albino mouse assessed as increase in mouse survival at 0.033 mg/kg, ic single dose after 6 hrs of infection relative to control";"Human herpesvirus 1";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"";"";"";"";"CHEMBL3227966";"458802";"10.1021/jm00191a011";"1979";"J Med Chem";"22";"514";"518";"standard_type:DOSE standard_relation:= standard_value:0.033 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL978893";"F";"Cytotoxicity against human SF268 cells by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1138617";"19345581";"10.1016/j.bmcl.2009.03.069";"2009";"Bioorg Med Chem Lett";"19";"2420";"2428";"";"";"";"";"";""
"CHEMBL1059210";"F";"Cytotoxicity against human HL60 cells after 48 hrs by MTT assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1153578";"19321234";"10.1016/j.ejmech.2009.02.028";"2009";"Eur J Med Chem";"44";"3596";"3600";"";"";"";"";"";""
"CHEMBL1909133";"B";"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614052";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ";"Homo sapiens";"14862";"14887";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909085";"B";"DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3987361";"Submaxillary gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909205";"B";"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL965580";"B";"Inhibition of mouse brain MAOB";"Mus musculus";"241";"244";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL1909186";"B";"DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614137";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";"";"2104";"2104";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3232585";"F";"Antiviral activity against Pseudorabies virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically";"Suid herpesvirus 1";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10345";"";"";"KB ";"";"CHEMBL3227966";"458802";"10.1021/jm00191a011";"1979";"J Med Chem";"22";"514";"518";"";"";"";"";"";""
"CHEMBL1909318";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909312";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909317";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909308";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909309";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL758465";"F";"In vitro inhibitory activity against Human lung large-cell carcinoma (PC-13) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-13";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL1041598";"F";"Resistance ratio of IC50 for deoxynucleoside analogue-resistant human CEM/ARAC8C cells to IC50 for deoxynucleoside analogue-sensitive human CCRF-CEM cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL1041599";"F";"Resistance ratio of IC50 for deoxynucleoside analogue-resistant mouse L1210 10K cells to IC50 for deoxynucleoside analogue-sensitive mouse L1210 cells";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1152537";"19674903";"10.1016/j.bmc.2009.07.038";"2009";"Bioorg Med Chem";"17";"6340";"6347";"";"";"";"";"";""
"CHEMBL809664";"F";"Anticancer activity carried out in vitro against human T-lymphocyte CEM/0";"Homo sapiens";"9";"9";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1134486";"11356110";"10.1021/jm0004446";"2001";"J Med Chem";"44";"1749";"1757";"";"";"";"";"";""
"CHEMBL1614459";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ";"Drosophila";"88408";"88432";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"7215";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL867670";"F";"Activity against NCI60 cell line xenograft in nude mouse by HF assay";"Mus musculus";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"NCI60";"";"CHEMBL1138988";"16539384";"10.1021/jm051029m";"2006";"J Med Chem";"49";"1964";"1979";"";"";"";"";"";""
"CHEMBL689647";"F";"In vitro inhibitory concentration against proliferation of HL60 cells";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL654989";"F";"In vitro cytotoxicity was evaluated against renal CAKI-1 cells";"Mus sp.";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10095";"";"";"CAKI-1";"";"CHEMBL1133006";"10780904";"10.1021/jm990417j";"2000";"J Med Chem";"43";"1484";"1488";"";"";"";"";"";""
"CHEMBL1697800";"A";"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL3256346";"T";"Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 18.2 mg/kg, ip qd administered for 5 days measured on day 8 co-administered with 27 mg/kg prednisolone (Rvb = 1.81 +/- 0.79 g)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"C3D2F1/J";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"";"";"";"";"";""
"CHEMBL650218";"F";"Beta-blocking activity measured by applying the stepwise linear discriminate analysis; Inactive";"";"48";"48";"BAO_0000019";"assay format";"4";"4 - Multiple homologous protein targets may be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1129855";"None";"10.1016/S0960-894X(97)00046-2";"1997";"Bioorg Med Chem Lett";"7";"567";"572";"";"";"";"";"";""
"CHEMBL818067";"B";"Inhibition of thymidylate synthase in L1210 cells";"";"2";"2";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"L1210";"";"CHEMBL1123319";"3027329";"10.1021/jm00157a031";"1986";"J Med Chem";"29";"1293";"1295";"";"";"";"";"";""
"CHEMBL709467";"F";"Cytotoxicity against MOLT-4 human leukemic lymphoblastoid cell lines";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"";"";"";"";"";""
"CHEMBL1794553";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860]";"Homo sapiens";"58172";"58459";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HepG2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614171";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity. (Class of assay: confirmatory) ";"Homo sapiens";"696";"699";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614318";"F";"PUBCHEM_BIOASSAY: Luminescence-based dose response cell-based high throughput screening assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line. (Class of assay: confirmatory) [Related pubchem assays: 1858 (Summary AID.), 1825 (Counterscreen.), 1907 (Confirmation screen.)]";"";"122";"122";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"Epithelial cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL743174";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 200 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL708572";"F";"Antitumor activity in mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined as weight change (g/mouse) on 8th day";"Mus musculus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL1738479";"F";"PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435022, AID465, AID489020, AID489029]";"";"168";"168";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3257012";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 3.12 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:3.12 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL756472";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by 45-day survivors in mice at 500 mg/kg (treatment of 1qd schedule) dosage";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2363223";"F";"SANGER: Inhibition of human EW-13 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363231";"F";"SANGER: Inhibition of human FADU cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"FaDu";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363569";"F";"SANGER: Inhibition of human OCUB-M cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OCUB-M";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363619";"F";"SANGER: Inhibition of human S-117 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"S-117";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363720";"F";"SANGER: Inhibition of human A172 cell growth in a cell viability assay.";"Homo sapiens";"89";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A 172";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363722";"F";"SANGER: Inhibition of human A2058 cell growth in a cell viability assay.";"Homo sapiens";"95";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A2058";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363758";"F";"SANGER: Inhibition of human BHY cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BHY";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909193";"B";"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909173";"B";"DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909182";"B";"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909107";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638255";"Striatum";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909084";"B";"DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909088";"B";"DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909115";"B";"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)";"Escherichia coli";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909126";"B";"DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909146";"B";"DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909164";"B";"DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909110";"B";"DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Jurkat";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909113";"B";"DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909094";"B";"DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"MDCK";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909149";"B";"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL720574";"F";"Percent increase in life span at 200 mg/kg (822 umol) per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL1794483";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623]";"";"114923";"115311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4772198";"F";"Antiproliferative activity against human PC-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay";"Homo sapiens";"35";"35";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL4772202";"T";"Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human SK-BR-3 cells";"Homo sapiens";"35";"35";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL1909178";"B";"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638233";"Cerebellum";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909145";"B";"DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909159";"B";"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1053107";"F";"Cytotoxicity against human A549 cells by sulforhodamine B method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1152442";"19691349";"10.1021/jm900852b";"2009";"J Med Chem";"52";"5303";"5306";"";"";"";"";"";""
"CHEMBL702246";"F";"Tested in vitro against KKLS human stomach adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638185";"Stomach";"KKLS";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL3256550";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 6.25 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:6.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4296187";"F";"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";"Pseudomonas aeruginosa";"24161";"24267";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 27853";"CO-ADD antimicrobial screening data";"287";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2363666";"F";"SANGER: Inhibition of human SNU-387 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-387";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363326";"F";"SANGER: Inhibition of human K5 cell growth in a cell viability assay.";"Homo sapiens";"128";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"K5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1225708";"F";"Antitumor activity against mouse S180 cells transplanted in ICR mouse assessed as inhibition of tumor weight at 8.9 umol/kg, ip";"Mus musculus";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1221334";"20692841";"10.1016/j.bmc.2010.07.043";"2010";"Bioorg Med Chem";"18";"6220";"6229";"";"";"";"";"";""
"CHEMBL873018";"F";"Inhibition of L1210 lymphoid leukemia cells 72 hr after administration (length of preincubation=0 hr)";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126194";"1527783";"10.1021/jm00096a006";"1992";"J Med Chem";"35";"3344";"3349";"";"";"";"";"";""
"CHEMBL704862";"F";"In vitro inhibitory activity against Human oral epidermoid carcinoma (KB) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL1794375";"B";"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]";"";"83389";"88483";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4346911";"A";"Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4346655";"30852384";"10.1016/j.ejmech.2019.02.071";"2019";"Eur J Med Chem";"169";"21";"28";"";"";"";"";"";""
"CHEMBL1809504";"F";"Antiproliferative activity against mouse S180 cells after 48 hrs by MTT assay";"Mus musculus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL1794367";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588349, AID588380]";"";"376";"378";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1810513";"F";"Antiproliferative activity against mouse H22 cells after 48 hrs by MTT assay";"Mus musculus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL729757";"F";"Median survival time expressed as (T/C) was measured at dose of 20 mg/kg/day X5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL694852";"F";"In vitro inhibitory effect measured against human bladder transitional cell carcinoma T-24 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T-24";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL696629";"F";"In vitro inhibitory effect measured against human osteosarcoma OST tumor cells at 100 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OST";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL4339843";"F";"Cytotoxicity against human U937 cells assessed as reduction in cell viability at 10 uM measured after 3 days by CCK8 assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL4339846";"F";"Induction of apoptosis in human U937 cells assessed as early apoptotic cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 0.7 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL701088";"F";"Effect of compound on erythroid differentiation of K562 cells was determined after a period of 3 days at concentration 500 nM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1131873";"10560743";"10.1016/s0960-894x(99)00547-8";"1999";"Bioorg Med Chem Lett";"9";"3153";"3158";"";"";"";"";"";""
"CHEMBL748522";"F";"Mean body weight change on 17th day at a dose of 200 mg/kg/day";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL706147";"F";"Tested in vitro inhibitory activity against human oral epidermoid carcinoma KB cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL744534";"F";"Weight change on day 8 in L1210/ara-C (I) Lymphoid Leukemia in mice( ip implanted) at a dose of 60 mg/kg/day (qd=1-5)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL741763";"T";"Toxicity in mice after 15-18 days at a dose of 60 mg/kg/day; 15.5/8.5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL2363752";"F";"SANGER: Inhibition of human BCPAP cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BCPAP";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363482";"F";"SANGER: Inhibition of human NCI-H1651 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1651";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363246";"F";"SANGER: Inhibition of human GP5d cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GP5d";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363338";"F";"SANGER: Inhibition of human KM12 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KM12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363282";"F";"SANGER: Inhibition of human HO-1-N-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HO-1-N-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363420";"F";"SANGER: Inhibition of human MFH-ino cell growth in a cell viability assay.";"Homo sapiens";"109";"110";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MFH-ino";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363765";"F";"SANGER: Inhibition of human BT-549 cell growth in a cell viability assay.";"Homo sapiens";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BT-549";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363848";"F";"SANGER: Inhibition of human COLO-678 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-678";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363740";"F";"SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AM-38";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363184";"F";"SANGER: Inhibition of human DMS-79 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-79";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363776";"F";"SANGER: Inhibition of human CAKI-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAKI-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363646";"F";"SANGER: Inhibition of human SK-MEL-24 cell growth in a cell viability assay.";"Homo sapiens";"94";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-24";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363687";"F";"SANGER: Inhibition of human SW626 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW626";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363283";"F";"SANGER: Inhibition of human HOP-62 cell growth in a cell viability assay.";"Homo sapiens";"117";"119";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HOP-62";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215038";"F";"PubChem BioAssay. Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"605";"605";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363697";"F";"SANGER: Inhibition of human SW982 cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW982";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363357";"F";"SANGER: Inhibition of human KYSE-270 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-270";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363429";"F";"SANGER: Inhibition of human MKN28 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363299";"F";"SANGER: Inhibition of human HUTU-80 cell growth in a cell viability assay.";"Homo sapiens";"116";"118";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HUTU-80";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363621";"F";"SANGER: Inhibition of human SBC-1 cell growth in a cell viability assay.";"Homo sapiens";"124";"125";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SBC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363522";"F";"SANGER: Inhibition of human NCI-H28 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363431";"F";"SANGER: Inhibition of human MKN7 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363266";"F";"SANGER: Inhibition of human HCC38 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC38";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363586";"F";"SANGER: Inhibition of human PANC-10-05 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Panc1005";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363624";"F";"SANGER: Inhibition of human SCC-25 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-25";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363165";"F";"SANGER: Inhibition of human D-247MG cell growth in a cell viability assay.";"Homo sapiens";"113";"115";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-247MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363370";"F";"SANGER: Inhibition of human LB2518-MEL cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB2518-MEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363608";"F";"SANGER: Inhibition of human RPMI-7951 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-7951";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363644";"F";"SANGER: Inhibition of human SK-MEL-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363799";"F";"SANGER: Inhibition of human TGBC24TKB cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TGBC24TKB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363500";"F";"SANGER: Inhibition of human NCI-H2030 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2030";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363382";"F";"SANGER: Inhibition of human LN-405 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LN-405";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL730146";"F";"Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration in the presence of 100 mg/kg of zebularine.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125796";"1956046";"10.1021/jm00115a017";"1991";"J Med Chem";"34";"3280";"3284";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL741475";"F";"Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1-5)";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL710604";"F";"Tested in vitro against MNNG/HOS cell line human osteosarcoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HOS-TE85";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL665304";"B";"Inhibition of cytidine deaminase partially purified from mouse kidney.";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"";"";"";"";"";""
"CHEMBL684640";"F";"Differentiating activity of compound in HL60 cells at conc 0.4 ug/mL";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1130401";"9371251";"10.1021/jm9602322";"1997";"J Med Chem";"40";"3851";"3857";"";"";"";"";"";""
"CHEMBL806558";"F";"In vitro inhibitory effect on growth of human colon adenocarcinoma cell lines (SW480).";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW480";"";"CHEMBL1124118";"3373480";"10.1021/jm00401a001";"1988";"J Med Chem";"31";"1063";"1064";"";"";"";"";"";""
"CHEMBL854761";"F";"In vitro inhibitory activity against Human T-cell acute lymphoblastic leukemia (MOLT-4) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL736828";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL732365";"F";"Average survival time includes only those mice that died prior to day 60 at 75 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:75.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL2114780";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ";"Homo sapiens";"58729";"58906";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"SW480";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL879666";"F";"In vivo activity against transplanted Mam-17 tumors of mice";"Mus musculus";"9";"9";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1134487";"11356111";"10.1021/jm0005149";"2001";"J Med Chem";"44";"1758";"1776";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL747523";"F";"Survival time treated / survival time (T/C) for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 1;8/7";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL809110";"F";"In vitro cytotoxicity was evaluated against melanoma SK-MEL-28 cells";"Mus sp.";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10095";"";"";"SK-MEL-28";"";"CHEMBL1133006";"10780904";"10.1021/jm990417j";"2000";"J Med Chem";"43";"1484";"1488";"";"";"";"";"";""
"CHEMBL746652";"F";"Death due to toxicity occurring at a maximum body weight decrease of 10 to 22% from the average post injection body weight at 50 mg/kg; 5 / 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL756914";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent median survival rate (treated/control) at 500 mg/kg (treatment of 1qd schedule) dosage; 15.0/11.0";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL702952";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent median survival rate (treated/control) at 100 mg/kg (treatment of 1-9qd schedule) dosage; 14/7.0";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL730148";"F";"Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125796";"1956046";"10.1021/jm00115a017";"1991";"J Med Chem";"34";"3280";"3284";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL618622";"F";"Tested in vitro against A-375 cell line human melanoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A-375";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL760571";"F";"Antitumor activity against the ip implanted P388 leukemia in mice expressed as optimal dose (1 qd treatment schedule) required to produce greatest increase in life span was determined";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL736827";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL745280";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL2071971";"A";"Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis";"Homo sapiens";"107";"107";"BAO_0000251";"microsome format";"2";"2 - Target assigned is subcellular fraction";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"Microsome";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL2114775";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ";"";"75093";"75549";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114843";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ";"Homo sapiens";"68426";"68635";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL880807";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 56 mg/kg dose (post inoculation life span, days)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:56.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL744541";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 200 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL3215236";"F";"PubChem BioAssay. HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Other_Dose_CherryPick_Activity_Set2. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ";"";"483";"483";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909165";"B";"DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"";"";"Reticulocytes";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909212";"B";"DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3232070";"F";"Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 0.1 ug/ml after 24 hrs relative to control";"Human herpesvirus 1";"17";"17";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"2931";"Scientific Literature";"10298";"";"";"Vero";"";"CHEMBL3227997";"218006";"10.1021/jm00187a005";"1979";"J Med Chem";"22";"21";"24";"";"";"";"";"";""
"CHEMBL3232065";"F";"Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 1 ug/ml after 24 hrs relative to control";"Human herpesvirus 1";"17";"17";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"2931";"Scientific Literature";"10298";"";"";"Vero";"";"CHEMBL3227997";"218006";"10.1021/jm00187a005";"1979";"J Med Chem";"22";"21";"24";"";"";"";"";"";""
"CHEMBL3232067";"F";"Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 100 ug/ml after 24 hrs relative to control";"Human herpesvirus 1";"17";"17";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"2931";"Scientific Literature";"10298";"";"";"Vero";"";"CHEMBL3227997";"218006";"10.1021/jm00187a005";"1979";"J Med Chem";"22";"21";"24";"";"";"";"";"";""
"CHEMBL1909125";"B";"DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3232063";"A";"Cytotoxicity against mouse P815 cells assessed as growth inhibition after 96 hrs";"Mus musculus";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P815";"";"CHEMBL3227997";"218006";"10.1021/jm00187a005";"1979";"J Med Chem";"22";"21";"24";"";"";"";"";"";""
"CHEMBL1909163";"B";"DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)";"Cavia porcellus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10141";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909169";"B";"DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909195";"B";"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909093";"B";"DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL802155";"F";"Tested in vitro against SW-48 human colon adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638202";"Colon";"SW48";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL1614217";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ]";"Homo sapiens";"2829";"2870";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2013705";"F";"Growth inhibition of human NUGC3 cells after 24 hrs by WST-1 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NUGC-3";"";"CHEMBL2010709";"22264170";"10.1021/np200523b";"2012";"J Nat Prod";"75";"135";"141";"";"";"";"";"";""
"CHEMBL981345";"F";"Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981347";"F";"Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981348";"F";"Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL1810803";"T";"Toxicity in ICR mouse xenografted with mouse S180 cells assessed as effect on kidney weight at 2 umol/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ICR";"Scientific Literature";"10090";"CHEMBL3638241";"Kidney";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL878125";"F";"Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration in the presence of 500 mg/kg of zebularine.";"Mus musculus";"1";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125796";"1956046";"10.1021/jm00115a017";"1991";"J Med Chem";"34";"3280";"3284";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1613871";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";"";"183";"183";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL699944";"F";"The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against KB human cell lines after 144 hr";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1123889";"3625714";"10.1021/jm00392a029";"1987";"J Med Chem";"30";"1686";"1688";"";"";"";"";"";""
"CHEMBL690823";"F";"Antiviral activity against herpes simplex virus-2.";"Human herpesvirus 2";"20";"20";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10310";"";"";"";"";"CHEMBL1159161";"None";"10.1016/S0960-894X(97)00117-0";"1997";"Bioorg Med Chem Lett";"7";"789";"792";"";"";"";"";"";""
"CHEMBL1963838";"F";"PUBCHEM_BIOASSAY: Luminescence-based cell-based high throughput dose response assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). (Class of assay: confirmatory) ";"";"240";"240";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1053110";"F";"Cytotoxicity against human PC3 cells by sulforhodamine B method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1152442";"19691349";"10.1021/jm900852b";"2009";"J Med Chem";"52";"5303";"5306";"";"";"";"";"";""
"CHEMBL872806";"F";"Tested in vitro against colo-320 human colon adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638202";"Colon";"COLO 320";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL737228";"F";"The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against the P388/doxorubicin resistant murine cell lines after 72 hours";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1123889";"3625714";"10.1021/jm00392a029";"1987";"J Med Chem";"30";"1686";"1688";"";"";"";"";"";""
"CHEMBL686517";"F";"Anticancer activity of the compound against ara-C resistant promyelocytic leukemia cell line that is Cyd-kinase deficient (HL-60-HGPRT-/dCK-) is determined";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1123319";"3027329";"10.1021/jm00157a031";"1986";"J Med Chem";"29";"1293";"1295";"";"";"";"";"";""
"CHEMBL707473";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by 45-day survivors in mice at 400 mg/kg (treatment of 1qd schedule) dosage";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:400.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1059105";"F";"Cytotoxicity against human H441 cells by glucosaminidase assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H441";"";"CHEMBL1154024";"19574048";"10.1016/j.bmcl.2009.06.056";"2009";"Bioorg Med Chem Lett";"19";"4764";"4767";"";"";"";"";"";""
"CHEMBL1045387";"F";"Cytotoxicity against human CEM cells assessed as inhibition of cell proliferation after 48 hrs";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1156792";"20000418";"10.1021/jm901590f";"2010";"J Med Chem";"53";"559";"572";"";"";"";"";"";""
"CHEMBL1055755";"F";"Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL2071962";"A";"Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins";"Homo sapiens";"221";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL635477";"P";"Partition coefficient (logD7.4)";"";"61";"66";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL1964023";"F";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). (Class of assay: confirmatory) ";"";"240";"240";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL764657";"F";"Tested in vitro against PC-13 human lung large cell carcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-13";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL743665";"F";"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 500 mg/kg; Value represented as Test/Control = 13/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL743573";"F";"Antitumor activity against L1210 leukemia in mice (median survival) at the dose of 200 mg/kg; Value represented as Test/Control = 17/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL761200";"F";"Tested in vitro against PC-9 human lung adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-9";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL734279";"F";"Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 250 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:250.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL742647";"F";"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 200 mg/kg; Value represented as Test/Control = 7/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL855498";"A";"Distribution of araCTP in Swiss Webster mouse bone marrow at 100 mg/kg, ip measured as AUC (0-4h)";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Swiss Webster";"Scientific Literature";"10090";"CHEMBL3638253";"Bone marrow";"";"";"CHEMBL1138220";"17181153";"10.1021/jm0607449";"2006";"J Med Chem";"49";"7711";"7720";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL703529";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by change in tumor weight at 300 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:300.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL4387667";"A";"Cytotoxicity in human NHDF cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NHDF";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL3790089";"F";"Cytotoxicity against human HeLa cells after 72 hrs by SRB assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL3790099";"F";"Cytotoxicity against human 143B cells after 72 hrs by SRB assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"143B";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL705950";"F";"In vitro cytotoxicity with cleavage by phosphodiesterase-I concentration for 50% loss of viability was determined at 72 hours.";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122886";"3968680";"10.1021/jm00380a004";"1985";"J Med Chem";"28";"171";"177";"";"";"";"";"";""
"CHEMBL764660";"F";"In vitro inhibitory activity against Human lung adenocarcinoma (PC-14) cell line.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-14";"";"CHEMBL1125609";"1995905";"10.1021/jm00106a049";"1991";"J Med Chem";"34";"812";"819";"";"";"";"";"";""
"CHEMBL810952";"F";"Concentration required for 50% inhibition of human lung squamous cell carcinoma T24 solid cell lines. ";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T-24";"";"CHEMBL1125887";"1992123";"10.1021/jm00105a037";"1991";"J Med Chem";"34";"234";"239";"";"";"";"";"";""
"CHEMBL740838";"T";"Toxicity in mice after 7-8 days at a dose of 100 mg/kg/day; 7/9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL758326";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by range in survival days at 500 mg/kg (treatment of 1qd schedule) dosage; Range is 14-15";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4387668";"U";"Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human HeLa cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL709276";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent increase in life span at 300 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:300.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL2363214";"F";"SANGER: Inhibition of human ES6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363194";"F";"SANGER: Inhibition of human DoTc2-4510 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DoTc2-4510";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363198";"F";"SANGER: Inhibition of human ECC10 cell growth in a cell viability assay.";"Homo sapiens";"44";"44";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ECC10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363518";"F";"SANGER: Inhibition of human NCI-H2347 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2347";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363558";"F";"SANGER: Inhibition of human NKM-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NKM-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363356";"F";"SANGER: Inhibition of human KYSE-180 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-180";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363559";"F";"SANGER: Inhibition of human NMC-G1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NMC-G1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363594";"F";"SANGER: Inhibition of human RCC10RGB cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RCC10RGB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363655";"F";"SANGER: Inhibition of human SK-N-DZ cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-N-DZ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363656";"F";"SANGER: Inhibition of human SK-N-FI cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-N-FI";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363327";"F";"SANGER: Inhibition of human KALS-1 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KALS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363360";"F";"SANGER: Inhibition of human KYSE-510 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-510";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363248";"F";"SANGER: Inhibition of human GT3TKB cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GT3TKB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363781";"F";"SANGER: Inhibition of human CAL-33 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-33";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363164";"F";"SANGER: Inhibition of human ChaGo-K-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ChaGo-K-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363732";"F";"SANGER: Inhibition of human A549 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A549";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363689";"F";"SANGER: Inhibition of human SW756 cell growth in a cell viability assay.";"Homo sapiens";"96";"97";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW756";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363447";"F";"SANGER: Inhibition of human MZ7-mel cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MZ7-mel";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363171";"F";"SANGER: Inhibition of human D-502MG cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-502MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363766";"F";"SANGER: Inhibition of human BV-173 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BV-173";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363144";"F";"SANGER: Inhibition of human COR-L23 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COR-L23";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363397";"F";"SANGER: Inhibition of human LXF-289 cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LXF-289 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363353";"F";"SANGER: Inhibition of human KY821 cell growth in a cell viability assay.";"Homo sapiens";"120";"121";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KY821";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363400";"F";"SANGER: Inhibition of human M14 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"M14";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363627";"F";"SANGER: Inhibition of human SCC-9 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363552";"F";"SANGER: Inhibition of human NCI-N87 cell growth in a cell viability assay.";"Homo sapiens";"105";"106";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-N87";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363584";"F";"SANGER: Inhibition of human PANC-03-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PANC-03-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363667";"F";"SANGER: Inhibition of human SNU-423 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-423";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363406";"F";"SANGER: Inhibition of human MDA-MB-157 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-157";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363432";"F";"SANGER: Inhibition of human ML-2 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ML-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363464";"F";"SANGER: Inhibition of human NCI-H1092 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1092";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363268";"F";"SANGER: Inhibition of human HCE-4 cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCE-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363296";"F";"SANGER: Inhibition of human HT-3 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363332";"F";"SANGER: Inhibition of human KE-37 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KE-37";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363802";"F";"SANGER: Inhibition of human TI-73 cell growth in a cell viability assay.";"Homo sapiens";"52";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TI-73";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363279";"F";"SANGER: Inhibition of human HLE cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HLE";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363458";"F";"SANGER: Inhibition of human NB6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4387671";"U";"Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human U87 cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL3215270";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"22759";"22913";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794384";"F";"PUBCHEM_BIOASSAY: TES1 - eGFP vs TES2 -dsRED Pathway Differentiation Measured in Cell-Based System Using Imaging - 2122-04_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504586]";"";"113";"113";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363240";"F";"SANGER: Inhibition of human GCT cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GCT";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4495582";"F";"SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate";"Severe acute respiratory syndrome coronavirus 2";"7218";"8702";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"SARS-CoV-2 Screening Data 2020-21";"2697049";"";"";"";"";"CHEMBL4495564";"None";"10.6019/CHEMBL4495564";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1225703";"F";"Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1221334";"20692841";"10.1016/j.bmc.2010.07.043";"2010";"Bioorg Med Chem";"18";"6220";"6229";"";"";"";"";"";""
"CHEMBL1225706";"F";"Cytotoxicity against human K562 cells after 24 hrs by MTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1221334";"20692841";"10.1016/j.bmc.2010.07.043";"2010";"Bioorg Med Chem";"18";"6220";"6229";"";"";"";"";"";""
"CHEMBL3232066";"F";"Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 10 ug/ml after 24 hrs relative to control";"Human herpesvirus 1";"17";"17";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"2931";"Scientific Literature";"10298";"";"";"Vero";"";"CHEMBL3227997";"218006";"10.1021/jm00187a005";"1979";"J Med Chem";"22";"21";"24";"";"";"";"";"";""
"CHEMBL4155961";"F";"Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL4152304";"29906687";"10.1016/j.ejmech.2018.06.003";"2018";"Eur J Med Chem";"155";"406";"417";"";"";"";"";"";""
"CHEMBL880123";"F";"Number of mice survived after 30 days";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"";"";"";"";"";""
"CHEMBL1613842";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ";"Homo sapiens";"33402";"33647";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613869";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";"";"2032";"2032";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL959867";"F";"Inhibition of erythroid differentiation in human K562 cell assessed benzidine positive cells at 200 uM after 6 days by benzidine staining assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1139356";"19072686";"10.1021/jm800982q";"2009";"J Med Chem";"52";"87";"94";"";"";"";"";"";""
"CHEMBL981350";"F";"Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay";"Mus musculus";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981351";"F";"Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL2363641";"F";"SANGER: Inhibition of human SK-HEP-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-HEP-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363642";"F";"SANGER: Inhibition of human SK-LMS-1 cell growth in a cell viability assay.";"Homo sapiens";"116";"118";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-LMS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL729669";"F";"Change in weight of mouse on day 8 was measured in L1210 lymphoid leukemia inoculated mice after ip administration at dose of 10 mg/kg/day *5";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121968";"7143370";"10.1021/jm00353a010";"1982";"J Med Chem";"25";"1322";"1329";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL1810801";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor growth inhibition at 0.89 umol/kg, ip administered 1 day after tumor inoculation qd for 7 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL2363276";"F";"SANGER: Inhibition of human HGC-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HGC-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137739";"T";"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1266185";"F";"Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay";"Mus musculus";"1252";"1259";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1255231";"17417631";"10.1038/nchembio873";"2007";"Nat Chem Biol";"3";"268";"273";"";"";"";"";"";""
"CHEMBL973959";"F";"Cytotoxicity against human KB cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1144073";"10425135";"10.1021/np9805185";"1999";"J Nat Prod";"62";"1030";"1032";"";"";"";"";"";""
"CHEMBL805566";"F";"Compound was tested for the inhibition of small cell lung cancer";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Small cell lung cancer cell line";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL880036";"F";"Growth inhibition against HSV-1 virus in BSCL cells at the dose of 1.4 ug/mL and 22h time of treatment.";"Human herpesvirus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"";"";"BSCL";"";"CHEMBL1122461";"6298419";"10.1021/jm00355a007";"1983";"J Med Chem";"26";"30";"34";"";"";"";"";"";""
"CHEMBL2071964";"A";"Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins";"Homo sapiens";"221";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL2363773";"F";"SANGER: Inhibition of human C3A cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C3A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363774";"F";"SANGER: Inhibition of human C8166 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C8166";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363575";"F";"SANGER: Inhibition of human OS-RC-2 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OS-RC-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363202";"F";"SANGER: Inhibition of human EFM-19 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EFM-19";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296189";"F";"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";"Candida albicans";"6134";"6236";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 90028";"CO-ADD antimicrobial screening data";"5476";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2363825";"F";"SANGER: Inhibition of human YAPC cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"YAPC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363696";"F";"SANGER: Inhibition of human SW962 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW 962";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363395";"F";"SANGER: Inhibition of human LU-65 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Lu-65";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363721";"F";"SANGER: Inhibition of human A204 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A204";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363598";"F";"SANGER: Inhibition of human RERF-LC-MS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RERF-LC-MS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363570";"F";"SANGER: Inhibition of human OE19 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OE19";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215040";"F";"PubChem BioAssay. Luminescence cell-based Retest at Dose assay to determine EWS/Fli1 dependent A673 mammalian cell cytotoxity  Measured in Cell-Based System Using Plate Reader - 7014-03_Inhibitor_Dose_CherryPick_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ";"";"410";"413";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363677";"F";"SANGER: Inhibition of human SW1116 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW 1116";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363402";"F";"SANGER: Inhibition of human MC-IXC cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MC-IXC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363154";"F";"SANGER: Inhibition of human CW-2 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CW-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363803";"F";"SANGER: Inhibition of human TK10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TK-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363160";"F";"SANGER: Inhibition of human Calu-6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Calu-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363715";"F";"SANGER: Inhibition of human 786-0 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"786-0";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363555";"F";"SANGER: Inhibition of human NCI-SNU-5 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363337";"F";"SANGER: Inhibition of human KM-H2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KM-H2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363403";"F";"SANGER: Inhibition of human MC116 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MC116";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363787";"F";"SANGER: Inhibition of human CAL-85-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-85-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363724";"F";"SANGER: Inhibition of human A2780 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A2780";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363239";"F";"SANGER: Inhibition of human GCIY cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GCIY";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363563";"F";"SANGER: Inhibition of human NUGC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NUGC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363596";"F";"SANGER: Inhibition of human RD cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RD";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363664";"F";"SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.";"Homo sapiens";"132";"134";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNB-75";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363193";"F";"SANGER: Inhibition of human Detroit562 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Detroit 562";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363416";"F";"SANGER: Inhibition of human MEL-JUSO cell growth in a cell viability assay.";"Homo sapiens";"81";"82";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MEL-JUSO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363452";"F";"SANGER: Inhibition of human NB10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363490";"F";"SANGER: Inhibition of human NCI-H1792 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1792";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363341";"F";"SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KNS-42";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4772203";"U";"Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human SK-OV-3 cells";"Homo sapiens";"35";"35";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL4772204";"T";"Selectivity index, ratio of IC50 for cytotoxicity against human HDF cells to IC50 for cytotoxicity against human PC-3 cells";"Homo sapiens";"35";"35";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL3257286";"P";"Retention time of the compound by liquid chromatography";"";"15";"15";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3244133";"214555";"10.1021/jm00209a010";"1978";"J Med Chem";"21";"1141";"1146";"";"";"";"";"";""
"CHEMBL2363461";"F";"SANGER: Inhibition of human NBsusSR cell growth in a cell viability assay.";"Homo sapiens";"52";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NBsusSR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3257220";"F";"Antiviral activity against Vesicular stomatitis virus infected in rabbit primary kidney cells assessed as inhibition of viral cytopathogenicity after 2 days";"Vesicular stomatitis virus";"61";"61";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11276";"";"";"kidney";"";"CHEMBL3244391";"222906";"10.1021/jm00191a010";"1979";"J Med Chem";"22";"510";"513";"";"";"";"";"";""
"CHEMBL3257221";"F";"Antiviral activity against Vaccinia virus infected in rabbit primary kidney cells assessed as inhibition of viral cytopathogenicity after 3 days";"Vaccinia virus";"61";"61";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10245";"";"";"kidney";"";"CHEMBL3244391";"222906";"10.1021/jm00191a010";"1979";"J Med Chem";"22";"510";"513";"";"";"";"";"";""
"CHEMBL740839";"T";"Toxicity in mice after 7-8 days at a dose of 200 mg/kg/day; 8/9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL741474";"F";"Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1-15)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL745289";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL745284";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change (%)) at the dose of 200 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL702726";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by range in survival days at 100 mg/kg (treatment of 1-9qd schedule) dosage; Range is 11-18";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL3282417";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 400 umol/kg/day, ip using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3538241";"A";"Activity of human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL720569";"F";"Percent increase in life span at 100 mg/kg (411 umol) per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL2363291";"F";"SANGER: Inhibition of human HT-1080 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-1080";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4772196";"F";"Antiproliferative activity against human SK-BR-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay";"Homo sapiens";"35";"35";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-BR-3";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL2363411";"F";"SANGER: Inhibition of human MDA-MB-453 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-453";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256547";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 20 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:20.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4387666";"F";"Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL3256813";"F";"Cytotoxicity against mouse S180 cells at 5 uM after 18 to 42 hrs relative to control";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL3244133";"214555";"10.1021/jm00209a010";"1978";"J Med Chem";"21";"1141";"1146";"";"";"";"";"";""
"CHEMBL3790092";"F";"Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL3254086";"F";"Cytotoxicity against mouse L1210 cells assessed as growth inhibition measured at 72 hrs by trypan blue exclusion assay";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"";"";"";"";"";""
"CHEMBL3256545";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 40 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:40.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3254101";"T";"Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 25 mg/kg, ip qd administered for 5 days measured on day 8 (Rvb = 1.81 +/- 0.79 g)";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"C3D2F1/J";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL709115";"F";"Inhibition of L1210 lymphoid leukemia cells 48 hr after administration (length of preincubation=0 hr)";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126194";"1527783";"10.1021/jm00096a006";"1992";"J Med Chem";"35";"3344";"3349";"";"";"";"";"";""
"CHEMBL724213";"F";"Percent increase in life span of leukemic mice administered, with compound at 50 mg/kgx5, intraperitoneally";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124443";"2704026";"10.1021/jm00124a013";"1989";"J Med Chem";"32";"799";"807";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL724210";"F";"Percent increase in life span of leukemic mice administered, with compound at 100 mg/kgx5, intraperitoneally";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124443";"2704026";"10.1021/jm00124a013";"1989";"J Med Chem";"32";"799";"807";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL1810802";"T";"Toxicity in ICR mouse xenografted with mouse S180 cells assessed as effect on brain weight at 2 umol/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ICR";"Scientific Literature";"10090";"CHEMBL3638188";"Brain";"CCRF S-180";"";"CHEMBL1806449";"21620529";"10.1016/j.ejmech.2011.05.004";"2011";"Eur J Med Chem";"46";"3410";"3419";"";"";"";"";"";""
"CHEMBL742963";"F";"No of survivors after 45 days at a dose of 200 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL742962";"F";"No of survivors after 45 days at a dose of 100 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL708559";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 9.2 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 17/9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL704300";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose of 18.2 mg/kg/day x 5 was determined as mean survival of treated group compared to untreated; 14.5/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL736686";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average weight per mouse on day 1.) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL878389";"F";"Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2363683";"F";"SANGER: Inhibition of human SW1783 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1783";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284431";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 100 mg/kg, ip administered as single dose relative to vehicle-treated control";"Mus musculus";"28";"28";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3284689";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 100 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control";"Mus musculus";"15";"15";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3283268";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 1000 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control";"Mus musculus";"15";"15";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL1217001";"F";"Antimicrobial activity against Trypanosoma brucei";"Trypanosoma brucei";"235";"235";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5691";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL1217000";"F";"Antimicrobial activity against Plasmodium falciparum";"Plasmodium falciparum";"630";"638";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1212812";"20185316";"10.1016/j.bmc.2010.01.068";"2010";"Bioorg Med Chem";"18";"2225";"2231";"";"";"";"";"";""
"CHEMBL2363695";"F";"SANGER: Inhibition of human SW954 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW 954";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363681";"F";"SANGER: Inhibition of human SW1573 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1573";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363407";"F";"SANGER: Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-175-VII";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363453";"F";"SANGER: Inhibition of human NB12 cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363764";"F";"SANGER: Inhibition of human BT-474 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BT-474";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363182";"F";"SANGER: Inhibition of human DMS-273 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-273";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363778";"F";"SANGER: Inhibition of human CAL-12T cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-12T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363850";"F";"SANGER: Inhibition of human COLO-680N cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-680N";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363549";"F";"SANGER: Inhibition of human NCI-H82 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H82";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3583702";"F";"Cytotoxicity against human SKHEP1 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-HEP1";"";"CHEMBL3580643";"26010585";"10.1021/acs.jmedchem.5b00553";"2015";"J Med Chem";"58";"5108";"5120";"";"";"";"";"";""
"CHEMBL2363275";"F";"SANGER: Inhibition of human HEL cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3254102";"T";"Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 50 mg/kg, ip qd administered for 5 days measured on day 8 (Rvb = 1.81 +/- 0.79 g)";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"C3D2F1/J";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3223294";"F";"Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay";"Mus musculus";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"";"";"";"";"";""
"CHEMBL733666";"F";"Median T/C calculated based on survivors at 71 mg/kg (292 umol) per day against Ip-implanted L1210 lymphoid leukemia mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:71.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL710361";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined as Survival time in days; Range is 10-19 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL731281";"F";"Median T/C calculated based on survivors at 100 mg/kg (411 umol) per day against Ip-implanted L1210 lymphoid leukemia mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127065";"8510106";"10.1021/jm00064a012";"1993";"J Med Chem";"36";"1785";"1790";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL746651";"F";"Death due to toxicity occurring at a maximum body weight decrease of 10 to 22% from the average post injection body weight at 25 mg/kg; 2 / 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL650753";"F";"Tested in vitro inhibitory activity against murine B16 melanoma cells line";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1126561";"8258836";"10.1021/jm00077a017";"1993";"J Med Chem";"36";"4113";"4120";"";"";"";"";"";""
"CHEMBL746038";"F";"Ratio of survival time of treated to control mice at 75 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125190";"1652024";"10.1021/jm00112a040";"1991";"J Med Chem";"34";"2607";"2615";"standard_type:DOSE standard_relation:= standard_value:75.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL736258";"F";"Antitumor activity against L1210 leukemia in mice (Average weight per mouse on day 1.) at the dose of 200 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL745293";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL707118";"F";"Antileukemic activity against L1210 leukemia cells in female B6D2F1/J mice at 93 mg/kg dose(Mean increased life span, calculated as (T/C-1)X100)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122440";"6827546";"10.1021/jm00356a032";"1983";"J Med Chem";"26";"280";"283";"standard_type:DOSE standard_relation:= standard_value:93.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL2363203";"F";"SANGER: Inhibition of human EFO-21 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EFO-21";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363626";"F";"SANGER: Inhibition of human SCC-4 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363205";"F";"SANGER: Inhibition of human EGI-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EGI-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363443";"F";"SANGER: Inhibition of human MSTO-211H cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MSTO-211H";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363404";"F";"SANGER: Inhibition of human MCF7 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MCF7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363477";"F";"SANGER: Inhibition of human NCI-H1581 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1581";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363523";"F";"SANGER: Inhibition of human NCI-H292 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H292";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363680";"F";"SANGER: Inhibition of human SW1463 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1463";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363659";"F";"SANGER: Inhibition of human SK-PN-DW cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-PN-DW";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363699";"F";"SANGER: Inhibition of human SiHa cell growth in a cell viability assay.";"Homo sapiens";"96";"97";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SiHa";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363700";"F";"SANGER: Inhibition of human T-24 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T-24";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363300";"F";"SANGER: Inhibition of human Hs-578-T cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Hs-578-T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363620";"F";"SANGER: Inhibition of human SAS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SAS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363755";"F";"SANGER: Inhibition of human BFTC-905 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BFTC-905";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363609";"F";"SANGER: Inhibition of human RPMI-8226 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-8226";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363350";"F";"SANGER: Inhibition of human KU-19-19 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KU-19-19";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363830";"F";"SANGER: Inhibition of human no-10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"no-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363233";"F";"SANGER: Inhibition of human G-361 cell growth in a cell viability assay.";"Homo sapiens";"78";"79";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"G-361";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363459";"F";"SANGER: Inhibition of human NB69 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB69";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363577";"F";"SANGER: Inhibition of human OVCAR-4 cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363746";"F";"SANGER: Inhibition of human BALL-1 cell growth in a cell viability assay.";"Homo sapiens";"52";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BALL-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420600";"F";"Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363840";"F";"SANGER: Inhibition of human CHL-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CHL-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL856525";"F";"Drug level in Swiss Webster mouse plasma at 100 mg/kg, ip measured as AUC (0-4h)";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Swiss Webster";"Scientific Literature";"10090";"CHEMBL3559721";"Plasma";"";"";"CHEMBL1138220";"17181153";"10.1021/jm0607449";"2006";"J Med Chem";"49";"7711";"7720";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL737232";"F";"Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4420606";"F";"Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5110567";"F";"Antiproliferative activity against human WI-38 cells measured after 48 hrs by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WI-38";"";"CHEMBL5108023";"35963130";"10.1016/j.ejmech.2022.114651";"2022";"Eur J Med Chem";"241";"114651";"114651";"";"";"";"";"";""
"CHEMBL695998";"F";"In vitro inhibitory effect measured against human fibrosarcoma HT1080 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-1080";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL2363427";"F";"SANGER: Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MIA PaCa-2 ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363460";"F";"SANGER: Inhibition of human NB7 cell growth in a cell viability assay.";"Homo sapiens";"100";"101";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363693";"F";"SANGER: Inhibition of human SW900 cell growth in a cell viability assay.";"Homo sapiens";"58";"58";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW900";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363691";"F";"SANGER: Inhibition of human SW837 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW837";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363213";"F";"SANGER: Inhibition of human ES5 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363475";"F";"SANGER: Inhibition of human NCI-H1563 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1563";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363355";"F";"SANGER: Inhibition of human KYSE-150 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-150 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2428706";"F";"Cytotoxicity against human KB cells after 72 hrs by SRB assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2424525";"23867603";"10.1016/j.ejmech.2013.06.047";"2013";"Eur J Med Chem";"67";"188";"195";"";"";"";"";"";""
"CHEMBL2363794";"F";"SANGER: Inhibition of human TE-6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363271";"F";"SANGER: Inhibition of human HCT-15 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCT-15";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363272";"F";"SANGER: Inhibition of human HD-MY-Z cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HD-MY-Z";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363344";"F";"SANGER: Inhibition of human KOSC-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KOSC-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363209";"F";"SANGER: Inhibition of human EPLC-272H cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EPLC-272H";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354254";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ";"";"153871";"156311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3538238";"A";"Drug metabolism assessed as intrinsic clearance for human recombinant N-terminal His-tagged DCK Ile24Val mutant-mediated cytosine-beta-D-arabinofuranoside-5'-MP formation expressed in Escherichia coli BL21(DE3) incubated for 3 mins by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL2363798";"F";"SANGER: Inhibition of human TGBC1TKB cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TGBC1TKB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4387663";"F";"Cytotoxicity in human KB cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL4387664";"F";"Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL3257231";"F";"Antiviral activity against Herpes simplex virus 2 Curtis assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method";"Human herpesvirus 2";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Curtis";"Scientific Literature";"10310";"";"";"";"";"CHEMBL3244039";"195055";"10.1021/jm00216a004";"1977";"J Med Chem";"20";"757";"761";"";"";"";"";"";""
"CHEMBL2363138";"F";"SANGER: Inhibition of human COLO-741 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-741";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363519";"F";"SANGER: Inhibition of human NCI-H2405 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2405";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363313";"F";"SANGER: Inhibition of human IST-MEL1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IST-MEL1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3285080";"F";"Antiviral activity against Herpes simplex virus 2 Curtis assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method";"Human herpesvirus 2";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Curtis";"Scientific Literature";"10310";"";"";"";"";"CHEMBL3272294";"195054";"10.1021/jm00216a003";"1977";"J Med Chem";"20";"750";"756";"";"";"";"";"";""
"CHEMBL2363526";"F";"SANGER: Inhibition of human NCI-H358 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H358";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363560";"F";"SANGER: Inhibition of human NOMO-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NOMO-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363671";"F";"SANGER: Inhibition of human SNU-C2B cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-C2B";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363218";"F";"SANGER: Inhibition of human ETK-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ETK-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363253";"F";"SANGER: Inhibition of human HC-1 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363255";"F";"SANGER: Inhibition of human HCC1187 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1187";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363565";"F";"SANGER: Inhibition of human OAW-28 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OAW-28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363440";"F";"SANGER: Inhibition of human MPP-89 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MPP-89";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137733";"T";"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137728";"T";"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137724";"T";"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL4420629";"F";"Cytotoxic activity against human T24 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"T-24";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3541974";"A";"Activity of human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells assessed as arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL4420632";"F";"Cytotoxic activity against human RT112 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"RT-112";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL697963";"F";"In vitro inhibitory effect measured against human lung small-cell carcinoma PC-6 tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-6";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL3137722";"T";"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3538243";"A";"Activity of human recombinant N-terminal His-tagged DCK Ala119Gly mutant expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL2150108";"F";"Ratio of IC50 for human K562/HHT300 cells to IC50 for human K562 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150111";"F";"Ratio of IC50 for human CCRF-CEM/VLB100 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL3256558";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 50 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3214929";"F";"PubChem BioAssay. Luminescence cell-based Retest at Dose assay to determine EWS/Fli1 dependent TC71 mammalian cell cytotoxity  Measured in Cell-Based System Using Plate Reader - 7014-04_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"637";"640";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137723";"T";"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3538242";"A";"Activity of human recombinant N-terminal His-tagged DCK Ile24Val mutant expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL3137734";"T";"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL4387665";"F";"Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-87MG ATCC";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL744149";"F";"Tested for in vivo antitumor activity against Lewis Lung Carcinoma cell line in mice and tumor weight change at 100 mg/Kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Carcinoma Oncology Models | Carcinoma Oncology Models | Neoplasm Oncology Models";"Carcinoma | Lewis Lung Carcinoma | Neoplasms";"";""
"CHEMBL3223292";"F";"Antiproliferative activity against mouse S180 cells after 48 hrs by MTT assay";"Mus musculus";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"";"";"";"";"";""
"CHEMBL4770560";"F";"Antitumor activity against human MV4-11 cells xenografted in Balb/c nude mouse assessed as reduction in tumor volume at 40 mg/kg, iv administered once daily for 21 days (Rvb = 1.00 g)";"Homo sapiens";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL4765336";"32447197";"10.1016/j.ejmech.2020.112424";"2020";"Eur J Med Chem";"200";"112424";"112424";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL4339848";"F";"Induction of apoptosis in human U937 cells assessed as necrotic cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 2.5 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL4339854";"F";"Induction of apoptosis in human U937 cells assessed as early apoptotic cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 0.7 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL3256351";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 18.3 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisone relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4339855";"F";"Induction of apoptosis in human U937 cells assessed as late apoptotic cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 1.75 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL3284687";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 1000 mg/kg, ip administered as single dose relative to vehicle-treated control";"Mus musculus";"22";"22";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3790097";"F";"Selectivity index, ratio of IC50 for HDF cells to IC50 for human HepG2 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL4155629";"A";"Growth inhibition of human LO2 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4420608";"F";"Cytotoxic activity against human THP1 cells assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420611";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420628";"F";"Cytotoxic activity against human TCCSUP cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"TCC-SUP";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256557";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 80 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:80.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3231979";"A";"Antimetabolic activity against primary rabbit kidney cells assessed as inhibition of [methyl-3H]dThd incorporation into DNA after 16 hrs";"Oryctolagus cuniculus";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9986";"";"";"kidney";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL3231973";"F";"Antiviral activity against Vaccinia virus infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection";"Vaccinia virus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10245";"";"";"kidney";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL3232581";"F";"Antiviral activity against Herpes simplex virus type 1 infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically";"Human herpesvirus 1";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"";"";"KB ";"";"CHEMBL3227966";"458802";"10.1021/jm00191a011";"1979";"J Med Chem";"22";"514";"518";"";"";"";"";"";""
"CHEMBL3223296";"F";"Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"";"";"";"";"";""
"CHEMBL3284685";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 200 mg/kg, ip administered as single dose relative to vehicle-treated control";"Mus musculus";"41";"41";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3283266";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 200 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control";"Mus musculus";"28";"28";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL2363380";"F";"SANGER: Inhibition of human LCLC-97TM1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LCLC-97TM1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3583610";"F";"Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3580643";"26010585";"10.1021/acs.jmedchem.5b00553";"2015";"J Med Chem";"58";"5108";"5120";"";"";"";"";"";""
"CHEMBL3583700";"F";"Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL3580643";"26010585";"10.1021/acs.jmedchem.5b00553";"2015";"J Med Chem";"58";"5108";"5120";"";"";"";"";"";""
"CHEMBL3282183";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 400 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3541971";"A";"Activity of human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells assessed as intrinsic clearance for arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL4155959";"F";"Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL4152304";"29906687";"10.1016/j.ejmech.2018.06.003";"2018";"Eur J Med Chem";"155";"406";"417";"";"";"";"";"";""
"CHEMBL4155646";"F";"Cytotoxicity against human HeLa cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4420601";"F";"Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4155627";"A";"Growth inhibition of human LO2 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3885882";"F";"In vitro activity on S. mansoni schistosomula at 50 uM";"Schistosoma mansoni";"654";"247666";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Puerto Rican";"DrugMatrix";"6183";"";"";"";"";"CHEMBL3885881";"None";"10.6019/CHEMBL3885881";"None";"None";"None";"None";"None";"standard_type:AGE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:GENDER standard_relation:None standard_value:None standard_units:None comments:None | standard_type:REGIMEN standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL2363797";"F";"SANGER: Inhibition of human TGBC11TKB cell growth in a cell viability assay.";"Homo sapiens";"52";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TGBC11TKB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256549";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 10 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4420605";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420585";"F";"Ratio of cytotoxic IC50 for human OCI-AML3 cells to cytotoxic IC50 for human OCI-AML3 cells in presence of SAMHD1 shRNA";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2382976";"A";"Cytotoxicity against human CD34-positive blood stem/progenitor cells after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2380239";"23578690";"10.1016/j.bmcl.2013.03.048";"2013";"Bioorg Med Chem Lett";"23";"2951";"2954";"";"";"";"";"";""
"CHEMBL3256551";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 5 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:5.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4339851";"F";"Induction of apoptosis in human U937 cells assessed as late apoptotic cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 1.75 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL4155626";"F";"Growth inhibition of human SMMC7721 cells at 5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4155630";"A";"Growth inhibition of human LO2 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4432287";"F";"Cytotoxicity against human HepG2 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL3256552";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 3.12 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:3.12 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4155631";"A";"Growth inhibition of human LO2 cells at 5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4420593";"F";"Cytotoxic activity against human HL60 cells assessed as reduction in cell viability at 10 to 50 ug/ml in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HL-60";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420633";"F";"Cytotoxic activity against human TCCSUP cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"TCC-SUP";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420596";"F";"Cytotoxic activity against human THP1 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420598";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420621";"F";"Cytotoxic activity against human KU-19-19 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"KU-19-19";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4339850";"F";"Induction of apoptosis in human U937 cells assessed as early apoptotic cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 0.7 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL3254094";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 50 mg/kg, ip qd administered for 5 days relative to control";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4274918";"F";"Antiproliferative activity against human Jurkat E6-1 cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Jurkat E6.1";"";"CHEMBL4270610";"30114661";"10.1016/j.ejmech.2018.08.023";"2018";"Eur J Med Chem";"157";"503";"526";"";"";"";"";"";""
"CHEMBL4420584";"F";"Cytotoxic activity against human U251MG cells assessed as reduction in cell viability in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"U-251";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363566";"F";"SANGER: Inhibition of human OAW-42 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OAW-42";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4189283";"F";"Antitumor activity against human HL60 cells xenografted in zebrafish embryo assessed as inhibition of cell migration at 200 ug/ml measured after 3 days of incubation by CM-Dil staining-based microscopic method relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4184316";"29641204";"10.1021/acs.jmedchem.8b00241";"2018";"J Med Chem";"61";"4155";"4164";"";"";"";"";"";""
"CHEMBL3285493";"A";"Half life in human";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3271997";"178871";"10.1021/jm00227a016";"1976";"J Med Chem";"19";"654";"662";"";"";"";"";"";""
"CHEMBL3583701";"F";"Cytotoxicity against human PC3 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3580643";"26010585";"10.1021/acs.jmedchem.5b00553";"2015";"J Med Chem";"58";"5108";"5120";"";"";"";"";"";""
"CHEMBL4420583";"F";"Cytotoxic activity against human U251MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"U-251";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420603";"F";"Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4028924";"A";"Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay";"Homo sapiens";"629";"629";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL3282415";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 100 umol/kg/day, ip using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4772200";"F";"Antiproliferative activity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL3231976";"F";"Antiviral activity against Herpes simplex virus-1 KOS infected in human skin fibroblast cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection";"Human herpesvirus 1 strain KOS";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10306";"";"";"Fibroblast";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL3231980";"A";"Antimetabolic activity against primary rabbit kidney cells assessed as inhibition of [2-14C]dUrd incorporation into DNA after 16 hrs";"Oryctolagus cuniculus";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9986";"";"";"kidney";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL4155625";"F";"Growth inhibition of human SMMC7721 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3223549";"F";"Antitumor activity against mouse S180 cells allografted in ICR mouse assessed as tumor growth inhibition at 0.089 mg/kg, ip qd for 7 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"standard_type:DOSE standard_relation:= standard_value:0.089 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3256559";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 40 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:40.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3254100";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 18.2 mg/kg, ip qd administered for 5 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:18.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3749812";"F";"Antitumor activity against human KG1 cells xenografted in mouse assessed as tumor regression at 100 mg/kg, po qd measured after 11 days post tumor implantation";"Homo sapiens";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KG-1";"";"CHEMBL3745712";"26505898";"10.1021/acs.jmedchem.5b01275";"2015";"J Med Chem";"58";"8373";"8386";"";"";"";"";"";""
"CHEMBL4420597";"F";"Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5134923";"F";"Cytotoxicity against human U-87 MG cells measured after 3 days by Celltiter-glo assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"U-87MG ATCC";"";"CHEMBL5131483";"35123007";"10.1016/j.bmcl.2022.128605";"2022";"Bioorg Med Chem Lett";"61";"128605";"128605";"";"";"";"";"";""
"CHEMBL710260";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 25 mg/kg/day x 5 was determined as Survival time in days; Range is 9-16 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL3256808";"F";"Antiviral activity against HSV1 CL101 infected in African green monkey Vero cells assessed as inhibition of plaque formation at 200 uM after 40 hrs relative to control";"Herpes simplex virus (type 1 / strain CL101)";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10302";"";"";"Vero";"";"CHEMBL3244133";"214555";"10.1021/jm00209a010";"1978";"J Med Chem";"21";"1141";"1146";"";"";"";"";"";""
"CHEMBL2013702";"F";"Growth inhibition of human BALL-1 cells after 24 hrs by WST-1 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"BALL-1";"";"CHEMBL2010709";"22264170";"10.1021/np200523b";"2012";"J Nat Prod";"75";"135";"141";"";"";"";"";"";""
"CHEMBL737999";"F";"Percentage increase in life span after 17-21 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL4420613";"F";"Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL703941";"F";"Antitumor activity was determined against the ip implanted L1210 leukemia in mice by change in tumor weight at 400 mg/kg (treatment of 1-5qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:400.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4420588";"F";"Ratio of cytotoxic IC50 for human THP1 cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells with low SAMHD1 expression";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420591";"F";"Ratio of cytotoxic IC50 for human THP1 cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells in presence of lentiviral protein X- virus-like particles";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3541982";"A";"Ratio of Km for human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells to Km for human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL3541972";"A";"Activity of human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells assessed as arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"P32320";"A70T"
"CHEMBL4339845";"F";"Induction of apoptosis in human U937 cells assessed as live cells at 0.3 uM measured after 1 day by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 95.05 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL2363706";"F";"SANGER: Inhibition of human TCCSUP cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TCC-SUP";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363143";"F";"SANGER: Inhibition of human COR-L105 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COR-L105";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363434";"F";"SANGER: Inhibition of human MMAC-SF cell growth in a cell viability assay.";"Homo sapiens";"128";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MMAC-SF";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363813";"F";"SANGER: Inhibition of human U251 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-251";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL737996";"F";"Percentage increase in life span after 13-15 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL2354221";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ";"";"172535";"175189";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL698915";"F";"In vitro inhibitory effect measured against human osteosarcoma MNNG-HOS tumor cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HOS-TE85";"";"CHEMBL1125651";"2002478";"10.1021/jm00107a018";"1991";"J Med Chem";"34";"999";"1002";"";"";"";"";"";""
"CHEMBL2354211";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ";"";"35070";"35135";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL740852";"F";"Range of survival days for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 1; range is 8-10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL2363381";"F";"SANGER: Inhibition of human LK-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LK-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4268705";"B";"Inhibition of MDM2 (unknown origin)";"Homo sapiens";"4";"4";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4265957";"30253242";"10.1016/j.ejmech.2018.09.044";"2018";"Eur J Med Chem";"159";"1";"9";"";"";"";"";"";""
"CHEMBL738156";"F";"Percentage increase in life span after 7 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL2013706";"A";"Growth inhibition of HDF cells after 72 hrs by WST-1 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HDF";"";"CHEMBL2010709";"22264170";"10.1021/np200523b";"2012";"J Nat Prod";"75";"135";"141";"";"";"";"";"";""
"CHEMBL4387669";"U";"Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human KB cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL3790093";"A";"Cytotoxicity against HDF cells after 72 hrs by SRB assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HDF";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL2363834";"F";"SANGER: Inhibition of human CAS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363328";"F";"SANGER: Inhibition of human KARPAS-299 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KARPAS-299";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363579";"F";"SANGER: Inhibition of human OVCAR-8 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363305";"F";"SANGER: Inhibition of human HuP-T3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuP-T3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5110568";"T";"Selectivity index, ratio IC50 for antiproliferative activity against human WI-38 cells over IC50 for antiproliferative activity against human A549 cells";"";"13";"13";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL5108023";"35963130";"10.1016/j.ejmech.2022.114651";"2022";"Eur J Med Chem";"241";"114651";"114651";"";"";"";"";"";""
"CHEMBL2363753";"F";"SANGER: Inhibition of human BE-13 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BE-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363588";"F";"SANGER: Inhibition of human PC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363536";"F";"SANGER: Inhibition of human NCI-H596 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H596";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363645";"F";"SANGER: Inhibition of human SK-MEL-2 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363320";"F";"SANGER: Inhibition of human JEG-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JEG-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363318";"F";"SANGER: Inhibition of human J82 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"J82";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363358";"F";"SANGER: Inhibition of human KYSE-410 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-410";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363244";"F";"SANGER: Inhibition of human GMS-10 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GMS-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363846";"F";"SANGER: Inhibition of human COLO-320-HSR cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-320-HSR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363623";"F";"SANGER: Inhibition of human SCC-15 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-15";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363713";"F";"SANGER: Inhibition of human 697 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"697";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363267";"F";"SANGER: Inhibition of human HCC70 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC70";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363373";"F";"SANGER: Inhibition of human LB771-HNC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB771-HNC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363829";"F";"SANGER: Inhibition of human ZR-75-30 cell growth in a cell viability assay.";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ZR-75-30";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2013707";"A";"Growth inhibition of HUVEC cells after 72 hrs by WST-1 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HUVEC";"";"CHEMBL2010709";"22264170";"10.1021/np200523b";"2012";"J Nat Prod";"75";"135";"141";"";"";"";"";"";""
"CHEMBL1061700";"F";"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as tumor weight at 89.28 umol/kg/day, ip administered for 7 consecutive days after 24 hrs of tumor implantation measured after 24 hrs post dose";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1153507";"19631550";"10.1016/j.bmc.2009.06.011";"2009";"Bioorg Med Chem";"17";"6085";"6095";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL2013701";"F";"Growth inhibition of human A549 cells after 24 hrs by WST-1 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL2010709";"22264170";"10.1021/np200523b";"2012";"J Nat Prod";"75";"135";"141";"";"";"";"";"";""
"CHEMBL743184";"F";"Dose producing greatest increase in life span expressed as optimum dose (L1210/ara-C I) (qd 1-9)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL4274917";"F";"Antiproliferative activity against human HL60 cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4270610";"30114661";"10.1016/j.ejmech.2018.08.023";"2018";"Eur J Med Chem";"157";"503";"526";"";"";"";"";"";""
"CHEMBL3790090";"F";"Cytotoxicity against human KB cells after 72 hrs by SRB assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL3790094";"F";"Selectivity index, ratio of IC50 for HDF cells to IC50 for human HeLa cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL3790100";"F";"Cytotoxicity against human thymidine kinase deficient 143B cells after 72 hrs by SRB assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"143B";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL2363702";"F";"SANGER: Inhibition of human T84 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T84";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363564";"F";"SANGER: Inhibition of human NY cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NY";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363368";"F";"SANGER: Inhibition of human LB1047-RCC cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB1047-RCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4303805";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging";"Homo sapiens";"5616";"5632";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"Caco-2";"";"CHEMBL4303101";"None";"10.21203/rs.3.rs-23951/v1";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4155960";"F";"Cytotoxicity against human SNU638 cells assessed as decrease in cell viability after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-638";"";"CHEMBL4152304";"29906687";"10.1016/j.ejmech.2018.06.003";"2018";"Eur J Med Chem";"155";"406";"417";"";"";"";"";"";""
"CHEMBL4420623";"F";"Cytotoxic activity against human TCCSUP cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"TCC-SUP";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420631";"F";"Cytotoxic activity against human KU-19-19 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"KU-19-19";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363682";"F";"SANGER: Inhibition of human SW1710 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1710";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420622";"F";"Cytotoxic activity against human RT112 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"RT-112";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4772197";"F";"Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay";"Homo sapiens";"35";"35";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL4772199";"F";"Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-87MG ATCC";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL4772201";"A";"Cytotoxicity against human HDF cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HDFa";"";"CHEMBL4765380";"32663707";"10.1016/j.ejmech.2020.112624";"2020";"Eur J Med Chem";"202";"112624";"112624";"";"";"";"";"";""
"CHEMBL3232586";"F";"Antiviral activity against Herpes simplex virus type 1 infected in Swiss albino mouse assessed as increase in mouse survival at 0.14 mg/kg, ic single dose after 6 hrs of infection relative to control";"Human herpesvirus 1";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10298";"";"";"";"";"CHEMBL3227966";"458802";"10.1021/jm00191a011";"1979";"J Med Chem";"22";"514";"518";"standard_type:DOSE standard_relation:= standard_value:0.14 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL3257011";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 5 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:5.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3541983";"A";"Ratio of Vmax for human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells to Vmax for human recombinant N-terminal His-tagged DCK Pro122Ser mutant expressed in Escherichia coli BL21(DE3) cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL3285079";"F";"Antiviral activity against Herpes simplex virus 1 Sheely assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method";"Human herpesvirus 1";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Sheely";"Scientific Literature";"10298";"";"";"";"";"CHEMBL3272294";"195054";"10.1021/jm00216a003";"1977";"J Med Chem";"20";"750";"756";"";"";"";"";"";""
"CHEMBL5216179";"F";"Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by AlamarBlue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL5214922";"35665692";"10.1016/j.ejmech.2022.114494";"2022";"Eur J Med Chem";"238";"114494";"114494";"";"";"";"";"";""
"CHEMBL4255732";"A";"Clearance in human";"Homo sapiens";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4251695";"29541361";"10.1021/acsmedchemlett.7b00462";"2018";"ACS Med Chem Lett";"9";"204";"209";"";"";"";"";"";""
"CHEMBL4138020";"A";"Growth inhibition of human umbilical cord cells";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4130641";"29995404";"10.1021/acs.jmedchem.8b00813";"2018";"J Med Chem";"61";"6892";"6903";"";"";"";"";"";""
"CHEMBL3231978";"F";"Antiviral activity against Herpes simplex virus-2 196 infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection";"Human herpesvirus 2";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"196";"Scientific Literature";"10310";"";"";"kidney";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL4189282";"F";"Antitumor activity against human HL60 cells xenografted in zebrafish embryo assessed as inhibition of cell proliferation at 200 ug/ml measured after 3 days of incubation by CM-Dil staining-based microscopic method relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4184316";"29641204";"10.1021/acs.jmedchem.8b00241";"2018";"J Med Chem";"61";"4155";"4164";"";"";"";"";"";""
"CHEMBL4420602";"F";"Cytotoxic activity against human THP1 cells assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420604";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420618";"F";"Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420620";"F";"Cytotoxic activity against human BFTC905 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"BFTC-905";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420615";"F";"Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4339849";"F";"Induction of apoptosis in human U937 cells assessed as live cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 95.05 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL3282412";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 100 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation in presence of THU 10 mg/kg/day on days 1 to 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4420581";"F";"Ratio of cytotoxic IC50 for human THP1 (+/+) cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells with CRISP/CAS9 SAMHD1 knockout";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420587";"F";"Ratio of cytotoxic IC50 for human THP1 cells to cytotoxic IC50 for human THP1 cells with CRISP/CAS9 SAMHD1 knockout";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4155958";"F";"Cytotoxicity against human A549 cells assessed as decrease in cell viability after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4152304";"29906687";"10.1016/j.ejmech.2018.06.003";"2018";"Eur J Med Chem";"155";"406";"417";"";"";"";"";"";""
"CHEMBL4155962";"F";"Cytotoxicity against human SKHEP1 cells assessed as decrease in cell viability after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-HEP1";"";"CHEMBL4152304";"29906687";"10.1016/j.ejmech.2018.06.003";"2018";"Eur J Med Chem";"155";"406";"417";"";"";"";"";"";""
"CHEMBL4420612";"F";"Cytotoxic activity against human HEL cells expressing wild type SAMHD1 assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4432293";"U";"Selectivity index, ratio of IC50 for HDF to IC50 for human HepG2 cells";"Homo sapiens";"11";"11";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL4303819";"F";"Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs";"Chlorocebus sabaeus";"1518";"1520";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303097";"None";"10.1101/2020.04.03.023846";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256561";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 20 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:20.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4420607";"F";"Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability in presence of 12.5 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2013704";"F";"Growth inhibition of human HeLa cells after 24 hrs by WST-1 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2010709";"22264170";"10.1021/np200523b";"2012";"J Nat Prod";"75";"135";"141";"";"";"";"";"";""
"CHEMBL3282175";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 100 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3232584";"F";"Antiviral activity against Myxoma virus infected in human KB cells assessed as inhibition of virus-induced cytopathic effect after 72 hrs by microscopically";"Myxoma virus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10273";"";"";"KB ";"";"CHEMBL3227966";"458802";"10.1021/jm00191a011";"1979";"J Med Chem";"22";"514";"518";"";"";"";"";"";""
"CHEMBL4420616";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363606";"F";"SANGER: Inhibition of human RPMI-2650 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-2650";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3231972";"F";"Antiviral activity against Vesicular stomatitis virus infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection";"Vesicular stomatitis virus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11276";"";"";"kidney";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL4420619";"F";"Cytotoxic activity against human HEL cells expressing SAMHD1 D311A mutant assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420595";"F";"Ratio of cytotoxic IC50 for human U251MG cells expressing wild type SAMHD1 to cytotoxic IC50 for human U251MG cells in presence of lentiviral protein X- virus-like particles";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"U-251";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252707";"F";"Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 100 uM after 6 days by [3H]thymidine incorporation method relative to control";"Rattus norvegicus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"T-cell";"";"CHEMBL3244180";"209191";"10.1021/jm00205a025";"1978";"J Med Chem";"21";"706";"709";"";"";"";"";"";""
"CHEMBL4346910";"F";"Cytotoxicity against human SMMC7721 cells incubated for 72 hrs by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4346655";"30852384";"10.1016/j.ejmech.2019.02.071";"2019";"Eur J Med Chem";"169";"21";"28";"";"";"";"";"";""
"CHEMBL3256555";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 200 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4432288";"A";"Cytotoxicity against HDF assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NHDF";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL4420626";"F";"Cytotoxic activity against human KU-19-19 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"KU-19-19";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3078118";"F";"Cytotoxicity against Homo sapiens (human) K562 cells assessed as growth inhibition at 2 ug/ml after 48 hr by MTT assay relative to untreated control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3045269";"None";"10.1007/s00044-012-0001-6";"2013";"Med Chem Res";"22";"22";"27";"";"";"";"";"";""
"CHEMBL4420592";"F";"Cytotoxic activity against human HEL cells assessed as reduction in cell viability at 10 to 50 ug/ml in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEL";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420630";"F";"Cytotoxic activity against human BFTC905 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"BFTC-905";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4339844";"F";"Cytotoxicity against human U937 cells assessed as reduction in cell viability measured after 3 days by CCK8 assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL4339853";"F";"Induction of apoptosis in human U937 cells assessed as live cells at 0.3 uM measured after 3 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 95.05 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL5110566";"F";"Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL5108023";"35963130";"10.1016/j.ejmech.2022.114651";"2022";"Eur J Med Chem";"241";"114651";"114651";"";"";"";"";"";""
"CHEMBL679427";"F";"Tested in vitro against human ovarian cancer cells (G-401) for anticancer activity at dose 10 uM (Cell number 1*10 e-4)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"G-401";"";"CHEMBL1127382";"7932594";"10.1021/jm00047a024";"1994";"J Med Chem";"37";"3668";"3670";"";"";"";"";"";""
"CHEMBL5134922";"F";"Antiviral activity against HCV by replicon assay";"Hepatitis C virus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11103";"";"";"";"";"CHEMBL5131483";"35123007";"10.1016/j.bmcl.2022.128605";"2022";"Bioorg Med Chem Lett";"61";"128605";"128605";"";"";"";"";"";""
"CHEMBL3284686";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 500 mg/kg, ip administered as single dose relative to vehicle-treated control";"Mus musculus";"18";"18";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL2071966";"A";"Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins";"Homo sapiens";"221";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL3284432";"F";"Cytotoxicity against human HeLa cells after 48 hrs by Coulter counter analysis";"Homo sapiens";"41";"41";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"";"";"";"";"";""
"CHEMBL641185";"F";"Compound was tested for the inhibition of AMML (acute myelomonocytic leukemia)";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"AMML";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"";"";"";"";""
"CHEMBL2071965";"A";"Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins";"Homo sapiens";"221";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2069259";"22931300";"10.1021/tx300075j";"2012";"Chem Res Toxicol";"25";"2067";"2082";"";"";"";"";"";""
"CHEMBL2363308";"F";"SANGER: Inhibition of human IGR-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IGR-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363274";"F";"SANGER: Inhibition of human HEC-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HEC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363345";"F";"SANGER: Inhibition of human KP-4 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KP-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363415";"F";"SANGER: Inhibition of human MEL-HO cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MEL-HO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3299593";"F";"Cytotoxicity against human K562 cells by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3297674";"24956556";"10.1016/j.ejmech.2014.06.031";"2014";"Eur J Med Chem";"83";"208";"225";"";"";"";"";"";""
"CHEMBL3257230";"F";"Antiviral activity against Herpes simplex virus 1 Sheely assessed as inhibition of virus-induced cytopathic effect at 37 degC after 72 hrs by two-fold dilution method";"Human herpesvirus 1";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Sheely";"Scientific Literature";"10298";"";"";"";"";"CHEMBL3244039";"195055";"10.1021/jm00216a004";"1977";"J Med Chem";"20";"757";"761";"";"";"";"";"";""
"CHEMBL2382974";"A";"Therapeutic index, ratio of IC50 for human CD34-positive blood stem/progenitor cells to IC50 for human MA9.3 cells";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2380239";"23578690";"10.1016/j.bmcl.2013.03.048";"2013";"Bioorg Med Chem Lett";"23";"2951";"2954";"";"";"";"";"";""
"CHEMBL3562135";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3231974";"F";"Antiviral activity against Vaccinia virus infected in human skin fibroblast cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection";"Vaccinia virus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10245";"";"";"Fibroblast";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL3231975";"F";"Antiviral activity against Herpes simplex virus-1 KOS infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection";"Human herpesvirus 1 strain KOS";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10306";"";"";"kidney";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL657235";"B";"Relative velocity was determined against deaminase purified from human acute myeloblastic leukemia cells";"Homo sapiens";"2";"2";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1123554";"2822932";"10.1021/jm00394a039";"1987";"J Med Chem";"30";"2154";"2157";"";"";"";"";"";""
"CHEMBL3223297";"F";"Antitumor activity against mouse S180 cells allografted in ICR mouse assessed as tumor growth inhibition at 8.9 mg/kg, ip qd for 7 days relative to control";"Mus musculus";"21";"21";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"standard_type:DOSE standard_relation:= standard_value:8.9 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3541980";"A";"Ratio of Vmax for human recombinant N-terminal His-SUMO fused wild type CDA expressed in Escherichia coli BL21(DE3) cells to Vmax for human recombinant N-terminal His-SUMO fused CDA Ala70Thr mutant expressed in Escherichia coli BL21(DE3) cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"";""
"CHEMBL2354220";"F";"PubChem BioAssay. Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ";"";"33";"33";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363615";"F";"SANGER: Inhibition of human RVH-421 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RVH-421";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363616";"F";"SANGER: Inhibition of human RXF393 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RXF 393";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363690";"F";"SANGER: Inhibition of human SW780 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW780";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363807";"F";"SANGER: Inhibition of human U-118-MG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-118-MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363476";"F";"SANGER: Inhibition of human NCI-H1573 cell growth in a cell viability assay.";"Homo sapiens";"85";"85";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1573";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363593";"F";"SANGER: Inhibition of human QIMR-WIL cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"QIMR-WIL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363709";"F";"SANGER: Inhibition of human 23132-87 cell growth in a cell viability assay.";"Homo sapiens";"78";"79";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"23132-87";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363176";"F";"SANGER: Inhibition of human DEL cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363492";"F";"SANGER: Inhibition of human NCI-H1838 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1838";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363618";"F";"SANGER: Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Ramos-2G6-4C10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363180";"F";"SANGER: Inhibition of human DMS-114 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-114";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363444";"F";"SANGER: Inhibition of human MV-4-11 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MV-4-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363539";"F";"SANGER: Inhibition of human NCI-H650 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H650";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363435";"F";"SANGER: Inhibition of human MN-60 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MN-60";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363430";"F";"SANGER: Inhibition of human MKN45 cell growth in a cell viability assay.";"Homo sapiens";"89";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-45";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363529";"F";"SANGER: Inhibition of human NCI-H446 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H446";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363676";"F";"SANGER: Inhibition of human SW1088 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1088";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363335";"F";"SANGER: Inhibition of human KINGS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KINGS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296188";"F";"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600";"Acinetobacter baumannii";"22588";"22685";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 19606";"CO-ADD antimicrobial screening data";"470";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2363418";"F";"SANGER: Inhibition of human MFE-280 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MFE-280";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363307";"F";"SANGER: Inhibition of human IA-LM cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IA-LM";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363531";"F";"SANGER: Inhibition of human NCI-H510A cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H510A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363832";"F";"SANGER: Inhibition of human CAMA-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAMA-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363714";"F";"SANGER: Inhibition of human 769-P cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"769-P";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214953";"F";"PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ";"";"20285";"20311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363152";"F";"SANGER: Inhibition of human CTB-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CTB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363708";"F";"SANGER: Inhibition of human 22RV1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CWR22R";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363504";"F";"SANGER: Inhibition of human NCI-H209 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H209";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363303";"F";"SANGER: Inhibition of human HuO-3N1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuO-3N1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363537";"F";"SANGER: Inhibition of human NCI-H630 cell growth in a cell viability assay.";"Homo sapiens";"74";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H630";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363454";"F";"SANGER: Inhibition of human NB13 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363741";"F";"SANGER: Inhibition of human AN3-CA cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AN3-CA";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363739";"F";"SANGER: Inhibition of human ALL-PO cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ALL-PO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363849";"F";"SANGER: Inhibition of human COLO-679 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-679";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363730";"F";"SANGER: Inhibition of human A431 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A-431";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363731";"F";"SANGER: Inhibition of human A498 cell growth in a cell viability assay.";"Homo sapiens";"131";"133";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A498";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363354";"F";"SANGER: Inhibition of human KYSE-140 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-140";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363836";"F";"SANGER: Inhibition of human CCRF-CEM cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CCRF-CEM";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363780";"F";"SANGER: Inhibition of human CAL-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363288";"F";"SANGER: Inhibition of human HSC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HSC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363817";"F";"SANGER: Inhibition of human UACC-893 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UACC-893";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363818";"F";"SANGER: Inhibition of human UM-UC-3 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UMUC3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363221";"F";"SANGER: Inhibition of human EW-11 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363293";"F";"SANGER: Inhibition of human HT-1376 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-1376";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363428";"F";"SANGER: Inhibition of human MKN1 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-1 ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363515";"F";"SANGER: Inhibition of human NCI-H2291 cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2291";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363556";"F";"SANGER: Inhibition of human NEC8 cell growth in a cell viability assay.";"Homo sapiens";"135";"137";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NEC8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363583";"F";"SANGER: Inhibition of human PA-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PA-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363585";"F";"SANGER: Inhibition of human PANC-08-13 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PANC-08-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363622";"F";"SANGER: Inhibition of human SBC-5 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SBC-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363657";"F";"SANGER: Inhibition of human SK-NEP-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-NEP-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363587";"F";"SANGER: Inhibition of human PC-14 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PC-14";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363302";"F";"SANGER: Inhibition of human HuH-7 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Huh-7 ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363701";"F";"SANGER: Inhibition of human T47D cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T47D";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363262";"F";"SANGER: Inhibition of human HCC1954 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1954";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363336";"F";"SANGER: Inhibition of human KLE cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KLE";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363367";"F";"SANGER: Inhibition of human LAN-6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LAN-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363581";"F";"SANGER: Inhibition of human P30-OHK cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"P30-OHK";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363572";"F";"SANGER: Inhibition of human OMC-1 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OMC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363686";"F";"SANGER: Inhibition of human SW620 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW-620";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363351";"F";"SANGER: Inhibition of human KU812 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KU812 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363605";"F";"SANGER: Inhibition of human RO82-W-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RO82-W-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363497";"F";"SANGER: Inhibition of human NCI-H1993 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1993";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363785";"F";"SANGER: Inhibition of human CAL-62 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-62";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363688";"F";"SANGER: Inhibition of human SW684 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW684";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363280";"F";"SANGER: Inhibition of human HMV-II cell growth in a cell viability assay.";"Homo sapiens";"89";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HMV-2 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363141";"F";"SANGER: Inhibition of human COLO-824 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-824";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363315";"F";"SANGER: Inhibition of human IST-SL1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IST-SL1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363178";"F";"SANGER: Inhibition of human DJM-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DJM-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3257008";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 12.5 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:12.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL2363703";"F";"SANGER: Inhibition of human T98G cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T98G";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363269";"F";"SANGER: Inhibition of human HCE-T cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCE-T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363306";"F";"SANGER: Inhibition of human HuP-T4 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuP-T4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL707128";"F";"Inhibition of L1210 lymphoid leukemia cells 24 hr after administration (length of preincubation=0 hr)";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126194";"1527783";"10.1021/jm00096a006";"1992";"J Med Chem";"35";"3344";"3349";"";"";"";"";"";""
"CHEMBL871954";"F";"Inhibitory activity against HL-60 (human, promyelocytic leukemia) cell line";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1145096";"12954073";"10.1021/jm020571x";"2003";"J Med Chem";"46";"4205";"4208";"";"";"";"";"";""
"CHEMBL756315";"F";"Antitumor activity was determined against the ip implanted P388 leukemia in mice by percent median survival rate (treated/control) at 200 mg/kg (treatment of 1-5qd schedule) dosage; 23.0/11.0";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL746057";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3256556";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 100 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL2401006";"B";"Inhibition of C-terminal His6-tagged Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate assessed as oxidation of NADH to NAD+ by fluorescence assay";"Francisella tularensis subsp. tularensis SCHU S4";"8";"8";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"177416";"";"";"";"";"CHEMBL2396561";"23815100";"10.1021/jm4001242";"2013";"J Med Chem";"56";"5275";"5287";"";"";"";"";"";""
"CHEMBL705251";"F";"Antitumor activity against ip implanted L1210 leukemia in mice expressed as active dose range (1-5qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 5-350";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL721881";"F";"Percent increase in life span of drug-treated mice relative to tumored, vehicle treated controls at a dose of 500 mg/kg oral treatment";"Mus musculus";"1";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125796";"1956046";"10.1021/jm00115a017";"1991";"J Med Chem";"34";"3280";"3284";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2363197";"F";"SANGER: Inhibition of human EC-GI-10 cell growth in a cell viability assay.";"Homo sapiens";"112";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EC-GI-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363630";"F";"SANGER: Inhibition of human SF126 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-126";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363710";"F";"SANGER: Inhibition of human 5637 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"5637";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363175";"F";"SANGER: Inhibition of human DBTRG-05MG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DBTRG-05MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363811";"F";"SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.";"Homo sapiens";"137";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-87MG ATCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363217";"F";"SANGER: Inhibition of human ESS-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ESS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363249";"F";"SANGER: Inhibition of human H-EMC-SS cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"H-EMC-SS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363251";"F";"SANGER: Inhibition of human H9 cell growth in a cell viability assay.";"Homo sapiens";"40";"40";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"H9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363284";"F";"SANGER: Inhibition of human HOP-92 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HOP-92";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363590";"F";"SANGER: Inhibition of human PFSK-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PFSK-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363822";"F";"SANGER: Inhibition of human VMRC-RCZ cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"VMRC-RCZ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363227";"F";"SANGER: Inhibition of human EW-24 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-24";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363795";"F";"SANGER: Inhibition of human TE-8 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363237";"F";"SANGER: Inhibition of human GAMG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GAMG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363186";"F";"SANGER: Inhibition of human DOK cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DOK";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363481";"F";"SANGER: Inhibition of human NCI-H1650 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1650";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363304";"F";"SANGER: Inhibition of human HuO9 cell growth in a cell viability assay.";"Homo sapiens";"74";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuO9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363718";"F";"SANGER: Inhibition of human 8505C cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"8505C";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363738";"F";"SANGER: Inhibition of human AGS cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AGS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363146";"F";"SANGER: Inhibition of human COR-L88 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COR-L88";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363256";"F";"SANGER: Inhibition of human HCC1395 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1395";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363767";"F";"SANGER: Inhibition of human Becker cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Becker";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363425";"F";"SANGER: Inhibition of human MHH-NB-11 cell growth in a cell viability assay.";"Homo sapiens";"132";"134";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MHH-NB-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363148";"F";"SANGER: Inhibition of human CP66-MEL cell growth in a cell viability assay.";"Homo sapiens";"117";"119";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CP66-MEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363287";"F";"SANGER: Inhibition of human HSC-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HSC-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363470";"F";"SANGER: Inhibition of human NCI-H1395 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1395";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363359";"F";"SANGER: Inhibition of human KYSE-450 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-450";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363330";"F";"SANGER: Inhibition of human KARPAS-45 cell growth in a cell viability assay.";"Homo sapiens";"124";"125";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KARPAS-45";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363557";"F";"SANGER: Inhibition of human NH-12 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NH-12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363592";"F";"SANGER: Inhibition of human PSN1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PSN1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363628";"F";"SANGER: Inhibition of human SCH cell growth in a cell viability assay.";"Homo sapiens";"131";"133";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCH";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363815";"F";"SANGER: Inhibition of human UACC-62 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UACC-62";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363433";"F";"SANGER: Inhibition of human MLMA cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MLMA";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363297";"F";"SANGER: Inhibition of human HT55 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT55";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363250";"F";"SANGER: Inhibition of human H4 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"H4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363236";"F";"SANGER: Inhibition of human GAK cell growth in a cell viability assay.";"Homo sapiens";"131";"133";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GAK";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363379";"F";"SANGER: Inhibition of human LCLC-103H cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LCLC-103H cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3223293";"F";"Antiproliferative activity against human K562 cells after 48 hrs by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"";"";"";"";"";""
"CHEMBL3299589";"F";"Cytotoxicity against human A549 cells by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3297674";"24956556";"10.1016/j.ejmech.2014.06.031";"2014";"Eur J Med Chem";"83";"208";"225";"";"";"";"";"";""
"CHEMBL2363292";"F";"SANGER: Inhibition of human HT-1197 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-1197";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363488";"F";"SANGER: Inhibition of human NCI-H1755 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1755";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363179";"F";"SANGER: Inhibition of human DK-MG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DK-MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363736";"F";"SANGER: Inhibition of human ACHN cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ACHN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363599";"F";"SANGER: Inhibition of human RH-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RH-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363611";"F";"SANGER: Inhibition of human RPMI-8866 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-8866";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363290";"F";"SANGER: Inhibition of human HT cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363678";"F";"SANGER: Inhibition of human SW13 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363369";"F";"SANGER: Inhibition of human LB2241-RCC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB2241-RCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363548";"F";"SANGER: Inhibition of human NCI-H810 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H810";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3078119";"F";"Cytotoxicity against Homo sapiens (human) U937 cells assessed as growth inhibition at 2 ug/ml after 48 hr by MTT assay relative to untreated control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL3045269";"None";"10.1007/s00044-012-0001-6";"2013";"Med Chem Res";"22";"22";"27";"";"";"";"";"";""
"CHEMBL2150107";"F";"Ratio of IC50 for doxorubicin-resistant human K562 cells to IC50 for human K562 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL4432291";"U";"Selectivity index, ratio of IC50 for HDF to IC50 for human KB cells";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL2363546";"F";"SANGER: Inhibition of human NCI-H747 cell growth in a cell viability assay.";"Homo sapiens";"137";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H747";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363595";"F";"SANGER: Inhibition of human RCM-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RCM-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3285573";"F";"Immunosuppression activity in rat assessed as reduction of adjuvant-induced acute inflammation administered po for days 1 to 5";"Rattus norvegicus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | MUSCULO-SKELETAL SYSTEM";"Methods for Testing Immunological Factors | Anti-Inflammatory Activity";"General Immunosuppressive Activity | General Anti-Inflammatory Models";"";""
"CHEMBL3282416";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 200 umol/kg/day, ip using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4138021";"A";"Growth inhibition of human bone marrow cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Bone marrow cell";"";"CHEMBL4130641";"29995404";"10.1021/acs.jmedchem.8b00813";"2018";"J Med Chem";"61";"6892";"6903";"";"";"";"";"";""
"CHEMBL4420610";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of control shRNA in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3257017";"P";"Half life of the compound";"";"1";"1";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"";"";"";"";"";""
"CHEMBL3282179";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 200 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4303810";"F";"Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)";"Homo sapiens";"1629";"1637";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"HRCE";"";"CHEMBL4303122";"None";"10.1101/2020.04.21.054387";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363347";"F";"SANGER: Inhibition of human KP-N-YN cell growth in a cell viability assay.";"Homo sapiens";"94";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KP-N-YN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3790098";"F";"Selectivity index, ratio of IC50 for HDF cells to IC50 for human 143B cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"143B";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL3790091";"F";"Cytotoxicity against human MCF7cells after 72 hrs by SRB assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL2363851";"F";"SANGER: Inhibition of human COLO-684 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-684";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363389";"F";"SANGER: Inhibition of human LS-411N cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-411N";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2077569";"F";"TP_TRANSPORTER: uptake in Xenopus laevis oocytes";"Xenopus laevis";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"8355";"";"";"Oocyte";"";"CHEMBL2074159";"10825466";"10.1016/s0006-2952(00)00334-8";"2000";"Biochem Pharmacol";"60";"215";"219";"";"";"";"";"";""
"CHEMBL2363166";"F";"SANGER: Inhibition of human D-263MG cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-263MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363261";"F";"SANGER: Inhibition of human HCC1937 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1937";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363331";"F";"SANGER: Inhibition of human KASUMI-1 cell growth in a cell viability assay.";"Homo sapiens";"74";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Kasumi 1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363498";"F";"SANGER: Inhibition of human NCI-H2009 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2009";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363532";"F";"SANGER: Inhibition of human NCI-H520 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H520";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363604";"F";"SANGER: Inhibition of human RMG-I cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RMG-I";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363847";"F";"SANGER: Inhibition of human COLO-668 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-668";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363170";"F";"SANGER: Inhibition of human D-423MG cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-423MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363727";"F";"SANGER: Inhibition of human A388 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A388";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363821";"F";"SANGER: Inhibition of human VM-CUB-1 cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"VM-CUB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363643";"F";"SANGER: Inhibition of human SK-LU-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-LU-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363387";"F";"SANGER: Inhibition of human LS-1034 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-1034";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363147";"F";"SANGER: Inhibition of human CP50-MEL-B cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CP50-MEL-B";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363322";"F";"SANGER: Inhibition of human JVM-3 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JVM-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363399";"F";"SANGER: Inhibition of human M059J cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"M059J";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363438";"F";"SANGER: Inhibition of human MOLT-4 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MOLT-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363786";"F";"SANGER: Inhibition of human CAL-72 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-72";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363168";"F";"SANGER: Inhibition of human D-336MG cell growth in a cell viability assay.";"Homo sapiens";"104";"106";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-336MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363576";"F";"SANGER: Inhibition of human OVCAR-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363208";"F";"SANGER: Inhibition of human EM-2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363465";"F";"SANGER: Inhibition of human NCI-H1155 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1155";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363467";"F";"SANGER: Inhibition of human NCI-H1299 cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1299";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363772";"F";"SANGER: Inhibition of human C32 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C32";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363230";"F";"SANGER: Inhibition of human EoL-1-cell cell growth in a cell viability assay.";"Homo sapiens";"119";"120";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EOL1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215017";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"26950";"27095";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363491";"F";"SANGER: Inhibition of human NCI-H1793 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1793";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363777";"F";"SANGER: Inhibition of human CAL-120 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-120";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363442";"F";"SANGER: Inhibition of human MS-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363172";"F";"SANGER: Inhibition of human D-542MG cell growth in a cell viability assay.";"Homo sapiens";"93";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-542MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363285";"F";"SANGER: Inhibition of human HOS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HOS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363321";"F";"SANGER: Inhibition of human JVM-2 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JVM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363324";"F";"SANGER: Inhibition of human K-562 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"K562";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363456";"F";"SANGER: Inhibition of human NB17 cell growth in a cell viability assay.";"Homo sapiens";"100";"101";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB17";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363392";"F";"SANGER: Inhibition of human LU-135 cell growth in a cell viability assay.";"Homo sapiens";"52";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-135";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363426";"F";"SANGER: Inhibition of human MHH-PREB-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MHH-PREB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363473";"F";"SANGER: Inhibition of human NCI-H1437 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1437";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363516";"F";"SANGER: Inhibition of human NCI-H23 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H23";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363242";"F";"SANGER: Inhibition of human GI-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GI-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363277";"F";"SANGER: Inhibition of human HH cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HH";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363733";"F";"SANGER: Inhibition of human A673 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A673";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363735";"F";"SANGER: Inhibition of human ABC-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ABC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363660";"F";"SANGER: Inhibition of human SK-UT-1 cell growth in a cell viability assay.";"Homo sapiens";"128";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-UT-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363647";"F";"SANGER: Inhibition of human SK-MEL-28 cell growth in a cell viability assay.";"Homo sapiens";"94";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363749";"F";"SANGER: Inhibition of human BB65-RCC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BB65-RCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363717";"F";"SANGER: Inhibition of human 8305C cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"8305C";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3223548";"F";"Antitumor activity against mouse S180 cells allografted in ICR mouse assessed as tumor growth inhibition at 0.89 mg/kg, ip qd for 7 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"standard_type:DOSE standard_relation:= standard_value:0.89 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3231977";"F";"Antiviral activity against Herpes simplex virus-2 LYONS infected in primary rabbit kidney cells assessed as inhibition of virus-induced cytopathogenicity treated immediately after virus adsorption measured 2 to 3 days after virus infection";"Human herpesvirus 2";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"LYONS";"Scientific Literature";"10310";"";"";"kidney";"";"CHEMBL3227988";"222908";"10.1021/jm00192a008";"1979";"J Med Chem";"22";"647";"653";"";"";"";"";"";""
"CHEMBL4420624";"F";"Cytotoxic activity against human T24 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"T-24";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL710140";"F";"Antitumor activity in the mice with intraperitoneal implanted L1210 lymphoid leukemia at the dose 18.2 mg/kg/day x 5 was determined and number of animals survived on 30 th day were reported; 0/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121364";"7452687";"10.1021/jm00186a011";"1980";"J Med Chem";"23";"1343";"1347";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL2150103";"F";"Ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL4513082";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"7218";"17404";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4495565";"None";"10.6019/CHEMBL4495565";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL739857";"F";"Increase of life span was determined against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 400 mg/kg per day after treatment 1";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL3256548";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 12.5 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:12.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4155616";"F";"Cytotoxicity against human SMMC7721 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL2354245";"F";"PubChem BioAssay. Viability counterscreen of potential LMP-1 inhibitors in HepG2 cell line Measured in Cell-Based System Using Plate Reader - 2122-07_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) ";"";"22";"23";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HepG2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282413";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 200 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation in presence of THU 10 mg/kg/day on days 1 to 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL703294";"F";"Tested in vitro for cytotoxicity against L1210 leukemia cell line in mouse";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL744519";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 100 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL742537";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change (%)) at the dose of 200 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:200.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4432284";"F";"Cytotoxicity against human HeLa cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL3137732";"T";"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137726";"T";"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3411293";"A";"Stimulation of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control";"Homo sapiens";"6";"6";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3407465";"25618019";"10.1016/j.ejmech.2015.01.011";"2015";"Eur J Med Chem";"92";"723";"731";"";"";"";"";"";""
"CHEMBL4420614";"F";"Cytotoxic activity against human THP1 cells assessed as reduction in cell viability in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256560";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 25 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3790095";"F";"Selectivity index, ratio of IC50 for HDF cells to IC50 for human KB cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HDF";"";"CHEMBL3784993";"27073055";"10.1016/j.bmc.2016.04.003";"2016";"Bioorg Med Chem";"24";"2330";"2341";"";"";"";"";"";""
"CHEMBL3232069";"F";"Antiviral activity against HSV1 2931 infected in African green monkey Vero cells assessed as inhibition of virus replication at 0.01 ug/ml after 24 hrs relative to control";"Human herpesvirus 1";"17";"17";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"2931";"Scientific Literature";"10298";"";"";"Vero";"";"CHEMBL3227997";"218006";"10.1021/jm00187a005";"1979";"J Med Chem";"22";"21";"24";"";"";"";"";"";""
"CHEMBL2363698";"F";"SANGER: Inhibition of human Saos-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SAOS-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363363";"F";"SANGER: Inhibition of human L-363 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"L-363";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363398";"F";"SANGER: Inhibition of human LoVo cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LoVo";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363436";"F";"SANGER: Inhibition of human MOLT-13 cell growth in a cell viability assay.";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MOLT-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363827";"F";"SANGER: Inhibition of human YKG-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"YKG-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363228";"F";"SANGER: Inhibition of human EW-3 cell growth in a cell viability assay.";"Homo sapiens";"119";"120";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363232";"F";"SANGER: Inhibition of human FTC-133 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"FTC-133";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363185";"F";"SANGER: Inhibition of human DOHH-2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DOHH-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363189";"F";"SANGER: Inhibition of human DU-4475 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DU-4475";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296186";"F";"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";"Klebsiella pneumoniae";"6160";"6262";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 700603";"CO-ADD antimicrobial screening data";"573";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2363514";"F";"SANGER: Inhibition of human NCI-H226 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H226";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363728";"F";"SANGER: Inhibition of human A4-Fuk cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A4-Fuk";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363707";"F";"SANGER: Inhibition of human TE-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363757";"F";"SANGER: Inhibition of human BHT-101 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BHT-101";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363796";"F";"SANGER: Inhibition of human TE-9 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363173";"F";"SANGER: Inhibition of human D-566MG cell growth in a cell viability assay.";"Homo sapiens";"61";"61";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-566MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363729";"F";"SANGER: Inhibition of human A427 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A-427";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363685";"F";"SANGER: Inhibition of human SW48 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW48";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363388";"F";"SANGER: Inhibition of human LS-123 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-123";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363352";"F";"SANGER: Inhibition of human KURAMOCHI cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KURAMOCHI";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363385";"F";"SANGER: Inhibition of human LOXIMVI cell growth in a cell viability assay.";"Homo sapiens";"137";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LOX IMVI ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363286";"F";"SANGER: Inhibition of human HPAF-II cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HPAF-II";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363437";"F";"SANGER: Inhibition of human MOLT-16 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MOLT-16";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363155";"F";"SANGER: Inhibition of human Ca-Ski cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Ca-Ski";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363390";"F";"SANGER: Inhibition of human LS-513 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-513";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363245";"F";"SANGER: Inhibition of human GOTO cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GOTO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363295";"F";"SANGER: Inhibition of human HT-29 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-29";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363517";"F";"SANGER: Inhibition of human NCI-H2342 cell growth in a cell viability assay.";"Homo sapiens";"95";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2342";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363763";"F";"SANGER: Inhibition of human BT-20 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BT-20";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363507";"F";"SANGER: Inhibition of human NCI-H2126 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2126";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363366";"F";"SANGER: Inhibition of human LAMA-84 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LAMA-84";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363612";"F";"SANGER: Inhibition of human RS4-11 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RS4-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215169";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ";"";"3383";"3728";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363580";"F";"SANGER: Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"P12-Ichikawa";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363238";"F";"SANGER: Inhibition of human GB-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363479";"F";"SANGER: Inhibition of human NCI-H1623 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1623";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363632";"F";"SANGER: Inhibition of human SF295 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-295";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4432290";"U";"Selectivity index, ratio of IC50 for HDF to IC50 for human HeLa cells";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4431333";"27501415";"10.1021/acs.jmedchem.6b00764";"2016";"J Med Chem";"59";"7963";"7973";"";"";"";"";"";""
"CHEMBL4420594";"F";"Cytotoxic activity against human MOLM13 cells assessed as reduction in cell viability at 10 to 50 ug/ml in presence of lentiviral protein X- virus-like particles incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"MOLM-13";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137735";"T";"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137740";"T";"Proposed mechanism(s) of liver damage. [column 'MEC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137730";"T";"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3254097";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 25 mg/kg, ip qd administered for 5 days (Rvb = 8 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3137737";"T";"Presence of at least one case with successful reintroduction. [column 'REINT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137725";"T";"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3583703";"F";"Cytotoxicity against human SNU638 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-638";"";"CHEMBL3580643";"26010585";"10.1021/acs.jmedchem.5b00553";"2015";"J Med Chem";"58";"5108";"5120";"";"";"";"";"";""
"CHEMBL2428705";"F";"Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL2424525";"23867603";"10.1016/j.ejmech.2013.06.047";"2013";"Eur J Med Chem";"67";"188";"195";"";"";"";"";"";""
"CHEMBL3257009";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 10 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4420590";"B";"Substrate activity at SAMHD1 (unknown origin) expressed in bacterial system expressed in bacteria assessed as triphospho-hydolase activity by measuring cytarabine tri-phosphate formation";"Homo sapiens";"2";"2";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Patent Bioactivity Data";"9606";"";"";"";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256543";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 80 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:80.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3256349";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 18.3 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisone (Rvb = 9 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3254576";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 18.2 mg/kg, ip qd administered for 5 days (Rvb = 10 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:18.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4339852";"F";"Induction of apoptosis in human U937 cells assessed as necrotic cells at 0.3 uM measured after 2 days by muse Annexin V/dead cell reagent staining-based flow cytometry (Rvb = 2.5 %)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4339205";"30954427";"10.1016/j.bmcl.2019.03.044";"2019";"Bioorg Med Chem Lett";"29";"1350";"1356";"";"";"";"";"";""
"CHEMBL3541973";"A";"Activity of human recombinant N-terminal His-SUMO fused CDA Lys27Gln mutant expressed in Escherichia coli BL21(DE3) cells assessed as arabinofuranosyl uridine formation by liquid chromatography-tandem mass spectrometry";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3525898";"23230131";"10.1124/dmd.112.048769";"2013";"Drug Metab Dispos";"41";"541";"545";"";"";"";"";"P32320";"K27N"
"CHEMBL3283267";"F";"Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as survival at 500 mg/kg, ip administered as single dose measured on day 30 relative to vehicle-treated control";"Mus musculus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL4155622";"F";"Growth inhibition of human SMMC7721 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3223295";"F";"Antiproliferative activity against mouse H22 cells after 48 hrs by MTT assay";"Mus musculus";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL3217570";"None";"10.1039/C0MD00208A";"2011";"Medchemcomm";"2";"126";"131";"";"";"";"";"";""
"CHEMBL4420589";"B";"Substrate activity at SAMHD1 in human THP1 cells assessed as reduction in cytarabine triphosphate formation at 10 ug/ml incubated for 6 hrs by liquid chromatography tandem mass spectrometry relative to control human THP1 cells with CRISP/CAS9 SAMHD1 knockout";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Patent Bioactivity Data";"9606";"";"";"";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284433";"A";"Half life in human";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3272036";"178873";"10.1021/jm00227a018";"1976";"J Med Chem";"19";"667";"674";"";"";"";"";"";""
"CHEMBL4420609";"F";"Cytotoxic activity against human THP1 cells with CRISP/CAS9 SAMHD1 knockout assessed as reduction in cell viability in presence of 25 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4059216";"F";"Antitumor activity against human MV4-11 cells xenografted in nu/nu mouse assessed as tumor growth inhibition at 50 mg/kg, iv qd measured on day 21 relative to vehicle-treated control";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL4052828";"29357250";"10.1021/acs.jmedchem.7b01261";"2018";"J Med Chem";"61";"1499";"1518";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL4420627";"F";"Cytotoxic activity against human RT112 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"RT-112";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4394734";"F";"Antitumor activity against human Z138 cells xenografted in nu/nu mouse assessed as tumor weight at 40 mg/kg, iv administered 5 times a week for 3 weeks and measured after 21 days (Rvb = 1.74 g)";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Z-138";"";"CHEMBL4393675";"30986571";"10.1016/j.ejmech.2019.03.062";"2019";"Eur J Med Chem";"173";"44";"62";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL3282414";"F";"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in life span at 300 umol/kg/day, po using 0.9% (W/V) aqueous NaCl vehicle for 5 days 24 hrs after tumor inoculation in presence of THU 10 mg/kg/day on days 1 to 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3256347";"T";"Toxicity in C3D2F1/J mouse allografted with mouse L1210 cells assessed as body weight change at 18.3 mg/kg, ip qd administered for 5 days measured on day 8 co-administered with 27 mg/kg prednisone (Rvb = 1.81 +/- 0.79 g)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"C3D2F1/J";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"";"";"";"";"";""
"CHEMBL4420634";"F";"Cytotoxic activity against human T24 cells assessed as reduction in cell viability incubated for 96 hrs in presence of lentiviral protein X- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"T-24";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420586";"F";"Ratio of cytotoxic IC50 for human SIG-M5 cells to cytotoxic IC50 for human SIG-M5 cells in presence of SAMHD1 shRNA";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"SIG-M5";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4832206";"F";"Antitumor activity against human MV4-11 cells xenografted in female nude mouse assessed as tumor weight growth inhibition at 100 mg/kg, ip measured after 21 days";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL4831498";"34225179";"10.1016/j.ejmech.2021.113677";"2021";"Eur J Med Chem";"223";"113677";"113677";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL700050";"F";"Tested in vitro inhibitory activity against murine L 1210 leukemia cells line";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210 (1565)";"";"CHEMBL1126561";"8258836";"10.1021/jm00077a017";"1993";"J Med Chem";"36";"4113";"4120";"";"";"";"";"";""
"CHEMBL3583611";"F";"Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL3580643";"26010585";"10.1021/acs.jmedchem.5b00553";"2015";"J Med Chem";"58";"5108";"5120";"";"";"";"";"";""
"CHEMBL3299588";"F";"Cytotoxicity against human HCT116 cells by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL3297674";"24956556";"10.1016/j.ejmech.2014.06.031";"2014";"Eur J Med Chem";"83";"208";"225";"";"";"";"";"";""
"CHEMBL2363486";"F";"SANGER: Inhibition of human NCI-H1703 cell growth in a cell viability assay.";"Homo sapiens";"81";"82";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1703";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3285571";"F";"Immunosuppression activity in rat assessed as reduction of adjuvant-induced polyarthritis administered po for days 1 to 5 measured on day 15";"Rattus norvegicus";"9";"9";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Methods for Testing Immunological Factors";"Adjuvant Arthritis in Rats | General Immunosuppressive Activity";"";""
"CHEMBL3285572";"F";"Immunosuppression activity in rat assessed as reduction of adjuvant-induced polyarthritis administered po for days 1 to 5 measured on day 21";"Rattus norvegicus";"9";"9";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3272176";"966247";"10.1021/jm00230a007";"1976";"J Med Chem";"19";"1013";"1017";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Methods for Testing Immunological Factors";"Adjuvant Arthritis in Rats | General Immunosuppressive Activity";"";""
"CHEMBL3256348";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as median survival time at 18.2 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisolone (Rvb = 9 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3256350";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 18.2 mg/kg, ip qd administered for 5 days co-administered with 27 mg/kg prednisolone relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL703695";"F";"Tested for in vitro cytotoxicity against LLC Lewis lung carcinoma cell line";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL740411";"F";"In vivo percent inhibition of Lewis Lung Carcinoma cell line in mice drug at 200 mg/Kg per day (p<0.001) compared with NCDAC";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Carcinoma Oncology Models | Carcinoma Oncology Models";"Carcinoma | Lewis Lung Carcinoma";"";""
"CHEMBL4420625";"F";"Cytotoxic activity against human BFTC905 cells assessed as reduction in cell viability incubated for 96 hrs in presence of viral protein R- virus-like particles by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"BFTC-905";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL743069";"T";"Toxicity in mice after 13-15 days at a dose of 60 mg/kg/day; 14/8.5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124302";"3411602";"10.1021/jm00117a020";"1988";"J Med Chem";"31";"1793";"1798";"";"";"";"";"";""
"CHEMBL708644";"F";"Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent increase in life span at 100 mg/kg (treatment of 1-9qd schedule) dosage";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"standard_type:DOSE standard_relation:= standard_value:100.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL742201";"F";"Range of survival days for antitumor activity against Ip implanted L1210 / 0 lymphoid leukemia in mice at a dose of 200 mg/kg per day after treatment 1-5; range is 15-17";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124763";"2329558";"10.1021/jm00167a016";"1990";"J Med Chem";"33";"1380";"1386";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL3561973";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL738726";"F";"Antitumor activity against L1210 leukemia in mice (Percent increase in life span.) at the dose of 500 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:500.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL739317";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Percent increase in life span.) at the dose of 1000 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:1000.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL730147";"F";"Antitumor activity against L1210 tumor in mice, at a dose of 500 mg/kg peroral administration in the presence of 10 mg/kg of zebularine.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125796";"1956046";"10.1021/jm00115a017";"1991";"J Med Chem";"34";"3280";"3284";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL757456";"F";"Antitumor activity against ip implanted P388 leukemia in mice expressed as active dose range (1 qd treatment schedule) required to produce increase in life span by >25% was determined; Range is 100-600";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123247";"3761322";"10.1021/jm00160a041";"1986";"J Med Chem";"29";"2038";"2044";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4420599";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420617";"F";"Cytotoxic activity against human OCI-AML3 cells assessed as reduction in cell viability in presence of shSAMHD1 in presence of 50 uM 3-deazauridin incubated for 96 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"OCI-AML-3";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL700751";"F";"Tested for in vitro cytotoxicity against KATO III human stomach adenocarcinoma cell line";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KATO III stomach cancer cell line";"";"CHEMBL1126569";"8277500";"10.1021/jm00078a007";"1993";"J Med Chem";"36";"4190";"4194";"";"";"";"";"";""
"CHEMBL745277";"F";"Antitumor activity against L1210 leukemia in mice (Average 7-day weight change) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL744547";"F";"Antitumor activity against L1210/ara-C leukemia in mice (Average 7-day weight change) at the dose of 50 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL742653";"F";"Antitumor activity against L1210/ara-C leukemia in mice (median survival) at the dose of 50 mg/kg; Value represented as Test/Control = 8/8";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122008";"7057424";"10.1021/jm00344a016";"1982";"J Med Chem";"25";"171";"178";"standard_type:DOSE standard_relation:= standard_value:50.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | Neoplasms";"";""
"CHEMBL4387670";"U";"Selectivity index, ratio of IC50 for cytotoxicity in human NHDF cells to IC50 for cytotoxicity in human A549 cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4385668";"31400940";"10.1016/j.bmcl.2019.08.003";"2019";"Bioorg Med Chem Lett";"29";"2587";"2594";"";"";"";"";"";""
"CHEMBL2363489";"F";"SANGER: Inhibition of human NCI-H1770 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1770";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363270";"F";"SANGER: Inhibition of human HCT-116 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCT-116";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363530";"F";"SANGER: Inhibition of human NCI-H460 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H460";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363455";"F";"SANGER: Inhibition of human NB14 cell growth in a cell viability assay.";"Homo sapiens";"100";"101";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB14";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363771";"F";"SANGER: Inhibition of human C2BBe1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C2BBe1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363501";"F";"SANGER: Inhibition of human NCI-H2052 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2052";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363745";"F";"SANGER: Inhibition of human AsPC-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ASPC1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363784";"F";"SANGER: Inhibition of human CAL-54 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-54";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363410";"F";"SANGER: Inhibition of human MDA-MB-415 cell growth in a cell viability assay.";"Homo sapiens";"91";"92";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-415";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363633";"F";"SANGER: Inhibition of human SF539 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-539";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363814";"F";"SANGER: Inhibition of human UACC-257 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UACC-257";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363343";"F";"SANGER: Inhibition of human KNS-81-FD cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KNS-81-FD";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363484";"F";"SANGER: Inhibition of human NCI-H1693 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1693";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL700926";"F";"Tested in vitro against KATO-III human stomach adenocarcinoma";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638185";"Stomach";"KATO III stomach cancer cell line";"";"CHEMBL1126568";"8277499";"10.1021/jm00078a006";"1993";"J Med Chem";"36";"4183";"4189";"";"";"";"";"";""
"CHEMBL3254093";"F";"Antitumor activity against mouse L1210 cells allografted in C3D2F1/J mouse assessed as increase in life span at 25 mg/kg, ip qd administered for 5 days relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244344";"118258";"10.1021/jm00197a030";"1979";"J Med Chem";"22";"1428";"1432";"standard_type:DOSE standard_relation:= standard_value:25.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4394731";"F";"Antitumor activity against human Z138 cells xenografted in nu/nu mouse assessed as inhibition in tumor growth at 40 mg/kg, iv administered 5 times a week for 3 weeks and measured twice per week by caliper method relative to control";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Z-138";"";"CHEMBL4393675";"30986571";"10.1016/j.ejmech.2019.03.062";"2019";"Eur J Med Chem";"173";"44";"62";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL3252708";"F";"Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 0.01 to 0.1 uM after 6 days by [3H]thymidine incorporation method relative to control";"Rattus norvegicus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"T-cell";"";"CHEMBL3244180";"209191";"10.1021/jm00205a025";"1978";"J Med Chem";"21";"706";"709";"";"";"";"";"";""
